data_2mtg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mtg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.401 ' HB3' HG21 ' A' ' 261' ' ' VAL . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 286' ' ' MET . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.434 ' N ' HD21 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.484 HD11 ' HB ' ' A' ' 255' ' ' THR . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.43 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.482 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.634 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.52 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.484 ' HB ' HD11 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.447 ' HB2' HD11 ' A' ' 233' ' ' LEU . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 263' ' ' PHE . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CZ ' HG23 ' A' ' 261' ' ' VAL . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 184' ' ' LYS . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 263' ' ' PHE . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.679 HG13 ' O ' ' A' ' 267' ' ' GLU . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.401 ' N ' HD11 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.613 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.404 ' HE3' ' CG1' ' A' ' 188' ' ' VAL . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 190' ' ' ASP . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.507 ' O ' ' CB ' ' A' ' 280' ' ' SER . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.467 HD12 HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.873 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.421 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.501 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.51 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.439 ' HA ' HD21 ' A' ' 197' ' ' LEU . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 221' ' ' PHE . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 217' ' ' LEU . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.508 ' CE1' ' CB ' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.712 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.712 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' VAL . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 227' ' ' ILE . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.508 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.475 ' O ' HG12 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.873 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 277' ' ' ILE . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' A' ' 187' ' ' LEU . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.6 tt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 290' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.679 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 286' ' ' MET . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 189' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.421 ' CE2' HG21 ' A' ' 209' ' ' VAL . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.402 ' HG3' ' CG ' ' A' ' 210' ' ' GLN . 1.9 ptt-85 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 192' ' ' TYR . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.402 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.401 ' O ' ' CD2' ' A' ' 216' ' ' HIS . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 212' ' ' LYS . 31.6 m-70 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.462 ' HA ' ' CE1' ' A' ' 224' ' ' PHE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 221' ' ' PHE . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.457 ' CG2' HG11 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.648 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.445 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.56 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.457 HG11 ' CG2' ' A' ' 227' ' ' ILE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.446 ' CZ ' ' CG1' ' A' ' 261' ' ' VAL . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 273' ' ' HIS . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 280' ' ' SER . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.465 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 190' ' ' ASP . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.679 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.476 HG11 ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 186' ' ' LEU . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 188' ' ' VAL . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.678 ' HB2' ' HB2' ' A' ' 287' ' ' LYS . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 198' ' ' TRP . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.454 ' N ' HD12 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 263' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.459 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 258' ' ' CYS . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.456 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.409 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.57 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.471 ' HB2' HD12 ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' ILE . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 267' ' ' GLU . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.518 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 273' ' ' HIS . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.54 HG22 ' OH ' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 273' ' ' HIS . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.452 ' HB ' ' HG3' ' A' ' 185' ' ' MET . 5.1 mm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.428 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.488 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.522 ' N ' ' HD1' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 286' ' ' MET . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 197' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.488 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.42 ' CD2' HD11 ' A' ' 191' ' ' LEU . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.733 0.301 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 191' ' ' LEU . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 221' ' ' PHE . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.667 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.558 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 7.3 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.488 ' CB ' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.42 ' CB ' ' HG2' ' A' ' 184' ' ' LYS . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 271' ' ' LYS . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.57 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 190' ' ' ASP . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 185' ' ' MET . 22.9 mm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.835 0.35 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.41 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.413 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.4 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.544 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 247' ' ' SER . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 254' ' ' GLY . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 252' ' ' GLN . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 253' ' ' VAL . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.9 OUTLIER -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 263' ' ' PHE . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.422 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.484 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.446 HG21 ' OH ' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.5 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.491 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.53 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 289' ' ' VAL . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 287' ' ' LYS . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.805 ' OH ' HG21 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.435 ' OD2' ' CG2' ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.457 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 221' ' ' PHE . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.42 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.463 ' O ' ' O ' ' A' ' 225' ' ' GLY . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 220' ' ' LEU . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.698 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.424 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 246' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.475 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.435 ' CG2' ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 261' ' ' VAL . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.556 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.429 ' CE ' HG12 ' A' ' 188' ' ' VAL . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 190' ' ' ASP . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.672 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.452 ' CA ' ' CE1' ' A' ' 189' ' ' TYR . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.805 HG21 ' OH ' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 185' ' ' MET . 8.9 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.446 ' CD ' HG22 ' A' ' 266' ' ' VAL . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.446 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.495 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.457 HG23 ' CD1' ' A' ' 263' ' ' PHE . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 259' ' ' ALA . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.413 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.408 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.559 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.607 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.408 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 232' ' ' ILE . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.413 HG23 ' CZ ' ' A' ' 263' ' ' PHE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 227' ' ' ILE . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.446 HG22 ' CD ' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.525 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.414 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 1.4 p30 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.495 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.444 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.489 HG23 ' CB ' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.783 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 286' ' ' MET . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.444 HD21 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.444 ' N ' HD21 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.507 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.423 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 227' ' ' ILE . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.427 ' HA ' ' HB3' ' A' ' 259' ' ' ALA . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.674 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 255' ' ' THR . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.489 ' CB ' HG23 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.429 ' CE1' HG12 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.605 ' O ' HD13 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.826 ' HA ' HD11 ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.403 ' HE2' ' HG2' ' A' ' 286' ' ' MET . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.826 HD11 ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.471 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 190' ' ' ASP . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.783 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.42 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.639 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 286' ' ' MET . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.426 ' HA ' HD22 ' A' ' 197' ' ' LEU . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.572 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.579 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 192' ' ' TYR . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.44 ' CG2' HG11 ' A' ' 261' ' ' VAL . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.637 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.637 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.466 HG13 ' HA ' ' A' ' 243' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.575 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.401 ' CG2' ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.46 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CZ ' ' CG1' ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 267' ' ' GLU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.639 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.499 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.46 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 261' ' ' VAL . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 257' ' ' GLU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ttp-105 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 192' ' ' TYR . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.427 ' CG ' HD12 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 263' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.475 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.623 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.623 ' CG1' ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 247' ' ' SER . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 243' ' ' ILE . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.544 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 233' ' ' LEU . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 186' ' ' LEU . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.485 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 266' ' ' VAL . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.578 ' CD2' ' N ' ' A' ' 274' ' ' GLU . 1.6 p-80 -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.578 ' N ' ' CD2' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.454 ' HE2' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 189' ' ' TYR . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.404 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.9 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' VAL . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.463 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.493 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 257' ' ' GLU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.441 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.426 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.431 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.676 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.493 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 271' ' ' LYS . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 275' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.452 ' C ' ' CD1' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.417 ' HE3' ' CB ' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.475 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.425 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.504 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.72 0.295 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 258' ' ' CYS . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.682 ' HB3' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.441 ' N ' HD23 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.418 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.492 ' CD1' ' HB1' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.436 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.496 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.514 ' HA ' HG13 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' HG ' ' A' ' 187' ' ' LEU . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 273' ' ' HIS . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.712 0.292 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HG ' ' CG1' ' A' ' 289' ' ' VAL . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' CYS . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 286' ' ' MET . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.416 ' CE2' HG23 ' A' ' 209' ' ' VAL . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.425 ' HA ' ' CZ3' ' A' ' 198' ' ' TRP . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.416 HG23 ' CE2' ' A' ' 192' ' ' TYR . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.465 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.494 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.443 HD12 ' CG ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.506 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.674 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 243' ' ' ILE . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.406 ' CG1' ' OD2' ' A' ' 190' ' ' ASP . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.401 ' N ' HG23 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.566 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 225' ' ' GLY . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.664 ' O ' HG12 ' A' ' 277' ' ' ILE . 2.3 t-160 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 286' ' ' MET . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 190' ' ' ASP . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.436 ' HA ' ' CE1' ' A' ' 273' ' ' HIS . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.594 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.427 ' CG ' ' CG1' ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.42 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.585 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.585 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB1' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.677 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.478 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.632 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.632 HG23 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.626 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.427 ' CG1' ' CG ' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.432 HG22 ' CZ ' ' A' ' 263' ' ' PHE . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.494 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 2.3 t60 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.425 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 280' ' ' SER . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.515 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 185' ' ' MET . 1.2 mm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.77 0.319 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.526 HG21 ' N ' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.49 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.437 ' CE1' HG22 ' A' ' 209' ' ' VAL . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.58 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.58 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 192' ' ' TYR . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.484 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.536 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 227' ' ' ILE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' HG ' ' A' ' 233' ' ' LEU . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.491 ' CB ' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 248' ' ' SER . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 247' ' ' SER . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.491 ' HB3' ' CB ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.563 ' O ' HG12 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.409 HG13 ' HG ' ' A' ' 187' ' ' LEU . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.522 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.463 HG12 ' CE ' ' A' ' 276' ' ' MET . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 250' ' ' TYR . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.465 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.463 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.611 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 243' ' ' ILE . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.586 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 253' ' ' VAL . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 231' ' ' ARG . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 271' ' ' LYS . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.516 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.463 ' CE ' HG12 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.522 HG12 ' HG ' ' A' ' 187' ' ' LEU . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 291' ' ' ILE . 4.2 tt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 184' ' ' LYS . 1.2 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 184' ' ' LYS . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.426 HD21 ' HB ' ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE1' ' A' ' 224' ' ' PHE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 221' ' ' PHE . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 262' ' ' GLU . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.519 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.435 ' HB2' HD11 ' A' ' 243' ' ' ILE . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.777 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.481 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 284' ' ' GLU . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.426 ' HB ' HD21 ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.407 ' HB3' HD12 ' A' ' 233' ' ' LEU . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.414 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 271' ' ' LYS . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.479 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.737 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.737 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . 0.435 ' CB ' HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.548 ' HB3' ' CE2' ' A' ' 189' ' ' TYR . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.425 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 266' ' ' VAL . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.612 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.473 ' OD2' ' CG2' ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.461 ' CD1' ' CD2' ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 198' ' ' TRP . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 192' ' ' TYR . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.481 ' HB3' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 214' ' ' MET . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' MET . . . . . 0.413 ' N ' ' CG2' ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.434 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 225' ' ' GLY . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.459 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.565 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.473 ' CG2' ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.438 HG22 ' OD1' ' A' ' 190' ' ' ASP . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 231' ' ' ARG . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 263' ' ' PHE . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.52 ' O ' HG12 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.412 ' CE ' ' O ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.612 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 277' ' ' ILE . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 185' ' ' MET . 3.3 mm . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 183' ' ' SER . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.508 ' HG ' HG11 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.669 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.504 ' OD2' HG21 ' A' ' 255' ' ' THR . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.497 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.418 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.609 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 192' ' ' TYR . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.579 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.436 HD12 ' CD2' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.413 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.419 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.709 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.709 HG21 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 255' ' ' THR . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.504 HG21 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' CYS . . . . . 0.404 ' HB3' HG23 ' A' ' 243' ' ' ILE . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 263' ' ' PHE . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.471 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.535 ' O ' HG12 ' A' ' 277' ' ' ILE . 1.7 p80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' MET . . . . . 0.467 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 273' ' ' HIS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.669 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 287' ' ' LYS . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.508 HG11 ' HG ' ' A' ' 187' ' ' LEU . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.421 ' CG2' HD21 ' A' ' 187' ' ' LEU . 3.1 tt . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.836 0.351 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.04 137.42 29.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.06 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -43.62 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m -157.39 150.71 23.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.229 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.401 ' HB3' HG21 ' A' ' 261' ' ' VAL . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 286' ' ' MET . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.434 ' N ' HD21 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.484 HD11 ' HB ' ' A' ' 255' ' ' THR . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -76.27 -41.56 48.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.04 -37.15 20.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 111.32 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 55.56 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 5.6 m -111.51 99.62 44.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.64 121.51 7.46 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 112.236 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.49 152.34 28.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -75.72 -28.17 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -70.23 -77.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -148.1 140.01 8.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.653 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 207' ' ' GLY . 2.6 ptp180 -49.21 -154.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.407 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.473 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.575 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.575 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.43 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.457 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.482 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.634 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.52 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.484 ' HB ' HD11 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.447 ' HB2' HD11 ' A' ' 233' ' ' LEU . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.457 HG23 ' CZ ' ' A' ' 263' ' ' PHE . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CZ ' HG23 ' A' ' 261' ' ' VAL . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 184' ' ' LYS . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 263' ' ' PHE . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.679 HG13 ' O ' ' A' ' 267' ' ' GLU . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.401 ' N ' HD11 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.512 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.613 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.416 ' O ' ' CG2' ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.404 ' HE3' ' CG1' ' A' ' 188' ' ' VAL . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.414 ' HB2' ' OD2' ' A' ' 190' ' ' ASP . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.507 ' O ' ' CB ' ' A' ' 280' ' ' SER . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.467 HD12 HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.11 119.82 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.95 80.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.609 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 3.9 tpp -113.68 174.74 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 110.755 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -77.32 132.35 70.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.264 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.03 144.15 32.3 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.88 -45.0 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.541 2.161 . . . . 0.0 112.438 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.1 150.73 31.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.873 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.421 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.613 ' CD1' ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.501 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.51 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.439 ' HA ' HD21 ' A' ' 197' ' ' LEU . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . -74.76 -41.86 59.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -18.71 60.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 64.23 101.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 110.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 62.0 p -69.52 122.68 86.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.14 161.28 45.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.455 2.104 . . . . 0.0 112.17 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.44 123.48 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.18 -63.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -162.65 -71.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -101.6 89.39 0.77 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.316 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.601 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.34 -155.49 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.69 0.396 . . . . 0.0 112.002 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 221' ' ' PHE . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 217' ' ' LEU . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.508 ' CE1' ' CB ' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.712 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.712 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 253' ' ' VAL . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 227' ' ' ILE . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.508 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.475 ' O ' HG12 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.873 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 277' ' ' ILE . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.496 HG23 ' HG ' ' A' ' 187' ' ' LEU . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.6 tt -117.78 143.03 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -155.56 78.68 0.19 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 mtt -176.21 96.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.83 153.09 17.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.541 2.161 . . . . 0.0 112.282 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.353 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 126.78 57.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.69 -63.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.486 2.124 . . . . 0.0 112.152 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m -162.78 150.96 14.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 290' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.679 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 286' ' ' MET . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 189' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.421 ' CE2' HG21 ' A' ' 209' ' ' VAL . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 200' ' ' LEU . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 195' ' ' PRO . . . -79.38 -6.35 56.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 196' ' ' LYS . 8.3 tp -87.99 -37.47 16.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.522 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.4 92.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.466 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.5 p -113.48 98.13 45.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.094 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.11 -20.03 66.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.494 2.129 . . . . 0.0 112.322 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.85 44.46 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.27 106.4 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -63.01 156.67 23.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 57.17 102.03 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.298 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.663 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.9 ptt-85 -42.31 -160.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 192' ' ' TYR . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.402 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.518 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.401 ' O ' ' CD2' ' A' ' 216' ' ' HIS . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 212' ' ' LYS . 31.6 m-70 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.462 ' HA ' ' CE1' ' A' ' 224' ' ' PHE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.462 ' CE1' ' HA ' ' A' ' 221' ' ' PHE . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.457 ' CG2' HG11 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.648 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.648 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.445 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.56 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.56 HG21 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.518 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.457 HG11 ' CG2' ' A' ' 227' ' ' ILE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.446 ' CZ ' ' CG1' ' A' ' 261' ' ' VAL . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 273' ' ' HIS . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.497 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.4 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.4 ' O ' ' CB ' ' A' ' 280' ' ' SER . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.465 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 190' ' ' ASP . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.679 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.476 HG11 ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 186' ' ' LEU . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.57 134.66 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -112.35 168.76 12.79 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.851 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.9 ttt -176.87 102.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.803 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -75.47 146.42 80.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.613 2.209 . . . . 0.0 112.312 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.827 0.346 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.3 tp -88.51 126.84 58.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.92 -52.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.388 2.059 . . . . 0.0 112.43 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -164.19 150.71 11.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.569 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 188' ' ' VAL . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.4 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.678 ' HB2' ' HB2' ' A' ' 287' ' ' LYS . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 198' ' ' TRP . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.454 ' N ' HD12 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -79.26 -14.11 59.24 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 7.2 tt -114.03 -37.23 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.909 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.58 122.09 38.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.0 111.888 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 7.8 t -132.97 86.56 42.69 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.336 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -92.83 -166.9 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.215 2.61 . . . . 0.0 112.814 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -156.8 29.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.603 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -174.66 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.035 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.06 -67.16 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -71.95 63.07 1.28 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.89 -156.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.731 0.412 . . . . 0.0 112.056 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.431 HG12 ' CE1' ' A' ' 263' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.573 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.459 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 258' ' ' CYS . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.456 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.456 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.409 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.57 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.57 HG21 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.471 ' HB2' HD12 ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 270' ' ' ILE . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 267' ' ' GLU . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.518 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 273' ' ' HIS . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.54 HG22 ' OH ' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 273' ' ' HIS . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.452 ' HB ' ' HG3' ' A' ' 185' ' ' MET . 5.1 mm -93.21 124.74 45.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -174.3 -126.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.247 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.47 149.36 16.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.862 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 116.54 21.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.318 2.012 . . . . 0.0 112.324 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 0.2 OUTLIER -89.08 126.51 58.77 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 5.0 Cg_exo -78.15 -56.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.648 2.232 . . . . 0.0 111.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -167.35 140.48 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.912 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.428 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.488 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.522 ' N ' ' HD1' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 286' ' ' MET . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 197' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.488 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.42 ' CD2' HD11 ' A' ' 191' ' ' LEU . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . -73.72 -15.38 61.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.29 -42.32 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.71 131.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.179 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 31.7 p -144.49 142.07 18.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.62 -175.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.437 2.091 . . . . 0.0 112.313 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.6 122.73 34.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -162.15 123.74 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.37 -78.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -153.0 124.83 1.67 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.583 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -48.86 -154.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.819 0.448 . . . . 0.0 111.808 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 191' ' ' LEU . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.43 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 221' ' ' PHE . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.667 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.558 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 7.3 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.488 ' CB ' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.447 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.42 ' CB ' ' HG2' ' A' ' 184' ' ' LYS . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 271' ' ' LYS . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.55 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.57 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 190' ' ' ASP . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 185' ' ' MET . 22.9 mm -85.85 105.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 92.85 163.38 37.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.6 ptm -173.97 115.7 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.42 96.02 5.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.481 2.121 . . . . 0.0 112.357 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.849 0.356 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.06 127.03 57.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.93 -43.95 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.52 2.147 . . . . 0.0 112.554 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m -147.42 150.98 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.41 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.413 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.55 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.413 ' CE2' HG22 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.4 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.544 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.21 -20.01 45.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -93.91 12.77 24.87 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.431 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 72.76 -156.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.856 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 81.4 p -112.31 99.91 48.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 111.053 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.56 127.75 13.57 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.434 2.09 . . . . 0.0 112.233 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -112.3 114.37 27.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -160.1 -56.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 121.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 60.56 79.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.02 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.6 -155.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.487 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.419 HG12 ' HB3' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.448 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 247' ' ' SER . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 254' ' ' GLY . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 252' ' ' GLN . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 253' ' ' VAL . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.9 OUTLIER -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.422 HG22 ' CZ ' ' A' ' 263' ' ' PHE . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.422 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.484 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.55 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.446 HG21 ' OH ' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.31 143.24 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.51 92.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.602 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -73.88 -177.59 2.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 110.842 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 133.78 25.47 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.375 2.05 . . . . 0.0 112.297 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.781 0.324 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.11 145.79 35.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.19 -55.57 2.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.451 2.101 . . . . 0.0 111.791 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.491 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m -164.11 149.78 10.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.936 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.53 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 289' ' ' VAL . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 287' ' ' LYS . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.805 ' OH ' HG21 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.435 ' OD2' ' CG2' ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.457 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -73.19 -25.16 60.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER -73.74 -37.56 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.675 0.274 . . . . 0.0 111.318 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 54.17 109.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.701 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 13.0 m -134.61 124.08 16.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.944 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.89 -166.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.396 2.064 . . . . 0.0 112.225 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.28 128.36 44.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.48 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -125.34 -177.18 3.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.002 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -53.44 95.49 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.386 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.617 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.3 ttp-105 -45.98 -155.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.422 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.424 HD23 ' CE2' ' A' ' 221' ' ' PHE . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.42 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.463 ' O ' ' O ' ' A' ' 225' ' ' GLY . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 220' ' ' LEU . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.476 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.698 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.424 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.698 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.456 ' N ' ' CG2' ' A' ' 246' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.475 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.435 ' CG2' ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.499 HG21 ' CZ ' ' A' ' 263' ' ' PHE . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.499 ' CZ ' HG21 ' A' ' 261' ' ' VAL . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.556 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.429 ' CE ' HG12 ' A' ' 188' ' ' VAL . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 190' ' ' ASP . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.672 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.452 ' CA ' ' CE1' ' A' ' 189' ' ' TYR . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.805 HG21 ' OH ' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 185' ' ' MET . 8.9 mm -99.2 128.39 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.68 -83.48 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.61 146.02 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 96.05 45.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.521 2.147 . . . . 0.0 112.351 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.786 0.327 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.5 mt -86.38 138.45 34.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.09 -51.03 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.296 1.997 . . . . 0.0 111.925 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER -164.14 150.17 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.563 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.446 ' CD ' HG22 ' A' ' 266' ' ' VAL . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.446 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.541 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.495 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.429 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -74.26 -41.89 60.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tp -63.18 -37.28 86.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.222 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 59.21 113.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.224 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.3 m -75.85 125.49 88.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.27 -45.56 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -92.11 166.76 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.55 105.48 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -172.53 105.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.29 48.56 81.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.833 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.3 OUTLIER -46.7 -155.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.917 0.487 . . . . 0.0 112.276 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.429 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.457 HG23 ' CD1' ' A' ' 263' ' ' PHE . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 259' ' ' ALA . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.413 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.408 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.559 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.559 HG21 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.607 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.408 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 232' ' ' ILE . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.413 HG23 ' CZ ' ' A' ' 263' ' ' PHE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CD1' HG23 ' A' ' 227' ' ' ILE . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.446 HG22 ' CD ' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.525 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.414 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 1.4 p30 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.495 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.444 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.86 138.46 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.94 139.71 14.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.354 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.1 ttp -80.94 -57.18 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.46 118.38 24.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.901 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.25 1.118 0 C-N-CA 122.457 2.104 . . . . 0.0 112.356 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.44 145.38 67.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.65 -50.02 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.569 2.179 . . . . 0.0 112.221 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m -166.46 140.77 4.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.439 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.489 HG23 ' CB ' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.783 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 286' ' ' MET . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.444 HD21 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.444 ' N ' HD21 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.507 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . -78.06 -7.4 56.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.8 tt -123.93 -47.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.321 . . . . 0.0 111.349 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -91.24 142.55 27.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.337 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.8 p -103.15 150.83 38.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.1 134.63 65.34 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.53 159.9 28.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.611 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.52 91.79 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 174.11 77.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.753 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 63.82 51.41 53.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.345 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.15 -158.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.887 0.475 . . . . 0.0 112.144 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.423 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 227' ' ' ILE . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.427 ' HA ' ' HB3' ' A' ' 259' ' ' ALA . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.674 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 255' ' ' THR . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.489 ' CB ' HG23 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.429 ' CE1' HG12 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.605 ' O ' HD13 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.826 ' HA ' HD11 ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.403 ' HE2' ' HG2' ' A' ' 286' ' ' MET . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.826 HD11 ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.534 ' N ' ' CD1' ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.471 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 190' ' ' ASP . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.783 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.42 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.18 129.55 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 174.29 82.75 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.61 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 5.7 mtm -162.84 137.84 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 129.63 83.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.787 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.373 2.048 . . . . 0.0 112.258 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.05 126.96 57.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.48 -52.48 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.361 2.041 . . . . 0.0 112.176 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.1 140.45 3.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.639 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 286' ' ' MET . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.426 ' HA ' HD22 ' A' ' 197' ' ' LEU . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.572 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.579 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 192' ' ' TYR . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -78.7 -14.36 59.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.96 -47.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.313 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.82 145.86 25.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.274 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 20.9 p -141.27 156.9 67.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.92 125.83 12.51 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.552 2.168 . . . . 0.0 112.381 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -169.0 -52.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.93 168.86 12.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.24 164.23 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 56.55 63.94 4.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 207' ' ' GLY . 4.3 ttm180 -47.29 -155.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.44 ' CG2' HG11 ' A' ' 261' ' ' VAL . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.637 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.637 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.521 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.466 HG13 ' HA ' ' A' ' 243' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.575 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.401 ' CG2' ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.46 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CZ ' ' CG1' ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 267' ' ' GLU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.432 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.551 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.639 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.499 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -119.56 124.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -111.75 -139.49 7.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.1 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.1 143.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 14.0 mttm 61.66 93.21 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.558 2.172 . . . . 0.0 112.267 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 132.61 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.25 -37.87 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.642 2.228 . . . . 0.0 112.287 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m -167.54 140.52 3.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.318 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.46 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.467 ' HB3' ' HB ' ' A' ' 261' ' ' VAL . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 257' ' ' GLU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.577 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -72.71 -10.97 60.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.7 tt -103.34 -47.2 4.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -176.57 144.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.188 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.8 m -114.79 116.8 42.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.07 174.71 8.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.389 2.059 . . . . 0.0 112.226 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.42 155.89 20.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.3 -70.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -165.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -64.1 79.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.357 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.619 ' O ' ' O ' ' A' ' 207' ' ' GLY . 3.5 ttp-105 -47.05 -155.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 0.0 111.959 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 192' ' ' TYR . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.427 ' CG ' HD12 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.46 HG12 ' CE1' ' A' ' 263' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.475 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.623 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.451 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.623 ' CG1' ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 247' ' ' SER . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 243' ' ' ILE . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.544 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.407 ' HB2' HD11 ' A' ' 233' ' ' LEU . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' CG ' ' A' ' 231' ' ' ARG . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 186' ' ' LEU . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.485 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 266' ' ' VAL . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.578 ' CD2' ' N ' ' A' ' 274' ' ' GLU . 1.6 p-80 -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.578 ' N ' ' CD2' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.454 ' HE2' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 189' ' ' TYR . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.404 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 35.9 mm -98.39 101.71 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 124.99 39.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -161.13 -89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.568 0.184 . . . . 0.0 110.936 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.07 91.81 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.439 2.093 . . . . 0.0 112.375 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.25 126.96 56.99 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.036 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.43 -42.12 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.63 140.5 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.409 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.544 ' HB3' HG23 ' A' ' 261' ' ' VAL . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.463 ' CG2' ' CB ' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.493 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.497 ' N ' ' CD1' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 257' ' ' GLU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.441 ' HA ' ' HB1' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 195' ' ' PRO . . . -73.34 -38.83 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.8 tp -104.75 -47.49 4.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 111.284 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.39 109.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.24 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 m -101.21 98.89 9.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.52 144.0 28.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.497 2.132 . . . . 0.0 112.413 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 62.07 119.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -177.37 -59.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.53 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -151.74 125.89 1.95 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.109 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.53 -157.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.428 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.494 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.426 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.431 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.676 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.493 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.525 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.421 ' HB1' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 271' ' ' LYS . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 275' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.452 ' C ' ' CD1' ' A' ' 275' ' ' PHE . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.417 ' HE3' ' CB ' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.405 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.475 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.541 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.425 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.504 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -117.43 121.36 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -101.99 147.4 17.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.912 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 53.9 mtm -83.33 -173.42 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.81 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 108.88 1.89 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 147.26 37.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.52 -50.19 2.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.657 2.238 . . . . 0.0 112.271 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.52 140.86 16.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.471 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 258' ' ' CYS . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.682 ' HB3' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.441 ' N ' HD23 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . -70.49 -26.69 63.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -26.76 54.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.052 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 65.93 125.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.203 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -148.3 107.5 3.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.55 -56.0 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.387 2.058 . . . . 0.0 112.418 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.46 145.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.963 0.411 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -156.02 -46.24 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -168.14 64.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.657 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 87.04 104.57 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.871 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.7 ttm180 -43.31 -158.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.518 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.418 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.492 ' CD1' ' HB1' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.498 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.436 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.436 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.496 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.514 ' HA ' HG13 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.498 HG12 ' HB3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.503 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.457 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.492 ' HB1' ' CD1' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.682 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.526 HG12 ' HG ' ' A' ' 187' ' ' LEU . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 273' ' ' HIS . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.14 144.45 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 93.74 40.9 4.55 Favored Glycine 0 C--N 1.32 -0.343 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.647 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 -39.75 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.709 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.9 109.31 53.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.422 2.082 . . . . 0.0 112.353 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.769 0.318 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 3.6 pp -89.05 128.51 51.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 3.1 Cg_exo -74.43 -70.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.581 2.187 . . . . 0.0 111.955 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 150.47 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.423 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 261' ' ' VAL . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HG ' ' CG1' ' A' ' 289' ' ' VAL . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 258' ' ' CYS . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 286' ' ' MET . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.406 ' CD1' ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.416 ' CE2' HG23 ' A' ' 209' ' ' VAL . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.425 ' HA ' ' CZ3' ' A' ' 198' ' ' TRP . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.5 -24.88 39.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.28 -37.02 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 67.52 -71.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.255 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 27.6 p -57.38 118.43 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 -167.96 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.541 2.161 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 143.71 24.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.31 129.28 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.777 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 103.25 88.87 2.08 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.656 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -43.94 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.416 HG23 ' CE2' ' A' ' 192' ' ' TYR . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.431 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.465 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.494 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.443 HD12 ' CG ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.506 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.434 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.674 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 243' ' ' ILE . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.406 ' CG1' ' OD2' ' A' ' 190' ' ' ASP . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.448 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.401 ' N ' HG23 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.566 ' CG2' ' HB3' ' A' ' 186' ' ' LEU . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' A' ' 225' ' ' GLY . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.664 ' O ' HG12 ' A' ' 277' ' ' ILE . 2.3 t-160 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 286' ' ' MET . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.483 ' N ' ' O ' ' A' ' 190' ' ' ASP . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.436 ' HA ' ' CE1' ' A' ' 273' ' ' HIS . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.402 ' O ' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -108.87 133.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 126.89 118.32 2.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.26 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -179.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 111.172 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.29 103.9 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.426 2.084 . . . . 0.0 112.343 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 139.2 34.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.19 -59.54 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.387 2.058 . . . . 0.0 112.597 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m -164.07 150.94 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.434 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.594 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.427 ' CG ' ' CG1' ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.42 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.585 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.585 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB1' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.25 -41.08 25.72 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -77.22 -37.11 54.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 111.065 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.71 162.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.2 p -134.69 104.16 10.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.89 -50.85 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.552 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -147.48 133.4 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 155.37 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.89 -69.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -94.3 68.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.604 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.61 -155.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.423 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.677 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.677 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.478 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.632 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.632 HG23 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.626 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.427 ' CG1' ' CG ' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.432 HG22 ' CZ ' ' A' ' 263' ' ' PHE . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 261' ' ' VAL . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.494 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 2.3 t60 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.425 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 280' ' ' SER . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.515 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.594 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 185' ' ' MET . 1.2 mm -84.97 108.31 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -109.21 -179.39 21.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.714 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -46.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.84 162.3 46.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.587 2.191 . . . . 0.0 112.266 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.782 0.325 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 pp -84.5 126.85 67.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.018 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.41 -49.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.65 2.233 . . . . 0.0 112.707 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m -164.0 150.88 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.676 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.526 HG21 ' N ' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.49 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.437 ' CE1' HG22 ' A' ' 209' ' ' VAL . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.58 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.58 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.23 -14.92 58.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.41 -35.65 13.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.55 110.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 33.9 p -134.61 101.06 12.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.29 -47.91 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.45 2.1 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 147.38 6.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -177.14 -50.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -177.55 102.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.634 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 58.48 74.07 0.39 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.107 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.628 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.8 ttm180 -43.93 -158.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.437 HG22 ' CE1' ' A' ' 192' ' ' TYR . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.453 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.484 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.536 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.536 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 227' ' ' ILE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.455 ' HD2' ' HG ' ' A' ' 233' ' ' LEU . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.491 ' CB ' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 248' ' ' SER . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 247' ' ' SER . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.491 ' HB3' ' CB ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.563 ' O ' HG12 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.409 HG13 ' HG ' ' A' ' 187' ' ' LEU . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 5.3 tt -110.3 143.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.09 87.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 -56.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -130.34 149.2 72.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.511 2.14 . . . . 0.0 112.362 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 p30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.745 0.307 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.14 126.89 84.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.82 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.59 -54.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.419 2.08 . . . . 0.0 112.72 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m -164.24 150.91 11.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.522 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.463 HG12 ' CE ' ' A' ' 276' ' ' MET . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.57 ' CE2' ' CZ ' ' A' ' 250' ' ' TYR . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.465 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . -75.18 -41.82 57.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.06 -37.27 61.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.379 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.32 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.063 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 10.5 p -80.35 147.49 64.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.57 -167.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.587 2.192 . . . . 0.0 112.27 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.67 152.5 18.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.97 -41.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -151.1 -67.78 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.614 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -135.72 129.45 5.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.44 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.614 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -48.03 -155.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.463 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.451 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.483 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.611 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 240' ' ' PRO . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 243' ' ' ILE . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.586 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 253' ' ' VAL . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 231' ' ' ARG . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 271' ' ' LYS . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.516 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.463 ' CE ' HG12 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.49 ' HB3' HG11 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.522 HG12 ' HG ' ' A' ' 187' ' ' LEU . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 291' ' ' ILE . 4.2 tt -117.95 141.79 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -130.34 84.51 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.559 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.91 138.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . 0.464 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -164.19 -65.33 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 294' ' ' LYS . 61.0 Cg_endo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 122.331 2.02 . . . . 0.0 112.336 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.795 0.331 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.01 127.12 56.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.027 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.15 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.411 2.074 . . . . 0.0 112.323 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' ' HB3' ' A' ' 184' ' ' LYS . 1.2 m -136.65 149.83 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 184' ' ' LYS . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 285' ' ' ASN . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.426 HD21 ' HB ' ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.47 ' HA ' ' HB2' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 195' ' ' PRO . . . -75.82 -9.27 58.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 14.8 tp -114.07 -37.1 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.443 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -55.6 117.37 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.47 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.9 t -118.41 144.44 35.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.01 121.39 8.02 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.515 2.144 . . . . 0.0 112.305 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.24 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -105.19 167.57 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.02 177.17 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.41 57.77 15.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.455 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -48.39 -155.17 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE1' ' A' ' 224' ' ' PHE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 221' ' ' PHE . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 262' ' ' GLU . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.519 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.435 ' HB2' HD11 ' A' ' 243' ' ' ILE . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.777 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.481 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.435 HG11 ' CB ' ' A' ' 284' ' ' GLU . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.426 ' HB ' HD21 ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.484 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.407 ' HB3' HD12 ' A' ' 233' ' ' LEU . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 263' ' ' PHE . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 261' ' ' VAL . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.414 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 271' ' ' LYS . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.479 ' CB ' ' CE1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.737 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.737 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . 0.435 ' CB ' HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.548 ' HB3' ' CE2' ' A' ' 189' ' ' TYR . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.425 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.95 114.98 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 133.67 51.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.4 ttm -108.68 -178.43 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -139.44 148.88 58.23 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.572 2.181 . . . . 0.0 112.278 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.706 0.288 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.41 136.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.94 -54.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.482 2.122 . . . . 0.0 112.652 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -164.05 150.59 11.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.735 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 266' ' ' VAL . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.612 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.473 ' OD2' ' CG2' ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 286' ' ' MET . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.461 ' CD1' ' CD2' ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 198' ' ' TRP . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 192' ' ' TYR . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . 0.529 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.481 ' HB3' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.78 -39.74 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.1 tt -92.47 -28.7 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.588 0.233 . . . . 0.0 111.486 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.56 -176.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 25.6 p -122.12 131.35 24.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.954 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.19 -167.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.355 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -67.67 113.07 5.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -175.48 147.77 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 132.82 46.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.772 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 93.96 62.41 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.275 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -47.28 -155.56 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 214' ' ' MET . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' MET . . . . . 0.413 ' N ' ' CG2' ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' CD2' ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.521 ' O ' ' O ' ' A' ' 225' ' ' GLY . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.448 HG22 ' CD1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.459 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.4 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.565 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.473 ' CG2' ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.438 HG22 ' OD1' ' A' ' 190' ' ' ASP . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 231' ' ' ARG . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 263' ' ' PHE . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.52 ' O ' HG12 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.412 ' CE ' ' O ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.612 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 277' ' ' ILE . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 185' ' ' MET . 3.3 mm -81.6 127.84 39.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.62 -154.8 25.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.559 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -72.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -150.28 148.72 25.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.521 2.148 . . . . 0.0 112.287 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 16.7 mt -89.0 127.69 54.74 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 19.9 Cg_exo -64.0 -59.74 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.308 2.005 . . . . 0.0 111.544 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m -158.0 150.51 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.165 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.404 ' CG ' ' O ' ' A' ' 183' ' ' SER . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.508 ' HG ' HG11 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.669 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.504 ' OD2' HG21 ' A' ' 255' ' ' THR . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.497 ' N ' ' CD2' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.418 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.609 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . -76.18 -39.09 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.03 -30.41 16.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.46 114.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.1 m -79.1 110.64 15.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.049 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.86 61.74 3.07 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.642 2.228 . . . . 0.0 112.119 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.86 156.0 16.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.83 31.05 4.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -148.62 -47.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -139.1 84.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.189 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.578 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.1 mtp-105 -48.71 -155.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.699 0.4 . . . . 0.0 111.838 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 192' ' ' TYR . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . 0.458 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.579 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.436 HD12 ' CD2' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 238' ' ' GLU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.413 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.419 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.709 ' HA ' HG21 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.709 HG21 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.456 ' C ' ' H ' ' A' ' 255' ' ' THR . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.504 HG21 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' CYS . . . . . 0.404 ' HB3' HG23 ' A' ' 243' ' ' ILE . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 232' ' ' ILE . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' A' ' 263' ' ' PHE . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.471 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.535 ' O ' HG12 ' A' ' 277' ' ' ILE . 1.7 p80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' MET . . . . . 0.467 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 273' ' ' HIS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.669 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.458 ' N ' ' CG ' ' A' ' 287' ' ' LYS . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.508 HG11 ' HG ' ' A' ' 187' ' ' LEU . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.421 ' CG2' HD21 ' A' ' 187' ' ' LEU . 3.1 tt -105.8 143.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.18 84.77 0.37 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.9 tpp -144.89 153.21 41.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -71.05 142.61 87.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.764 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.832 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 253' ' ' VAL . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.503 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.729 HD22 ' HG3' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.855 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.592 ' C ' HD13 ' A' ' 197' ' ' LEU . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 210' ' ' GLN . 2.6 ptp180 . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 213' ' ' VAL . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 208' ' ' ARG . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 209' ' ' VAL . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.477 ' N ' HG13 ' A' ' 213' ' ' VAL . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 220' ' ' LEU . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.709 HG22 HG21 ' A' ' 227' ' ' ILE . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.684 HG22 ' CB ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.661 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.506 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.661 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 246' ' ' ILE . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.522 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.591 HG13 ' HE3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.503 ' CG2' HD12 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.707 ' HB3' HG21 ' A' ' 243' ' ' ILE . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.832 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 227' ' ' ILE . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.781 HG22 HG23 ' A' ' 270' ' ' ILE . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 271' ' ' LYS . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.834 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.771 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.729 ' HG3' HD22 ' A' ' 193' ' ' LEU . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.591 ' HE3' HG13 ' A' ' 253' ' ' VAL . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.426 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 186' ' ' LEU . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.764 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.535 ' O ' HG22 ' A' ' 291' ' ' ILE . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.624 HD13 ' HB1' ' A' ' 269' ' ' ALA . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.891 HG13 HD12 ' A' ' 191' ' ' LEU . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.583 ' HB2' HG11 ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 1.047 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.901 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.887 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 197' ' ' LEU . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.469 ' HE ' HG12 ' A' ' 209' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.815 HG21 ' HB2' ' A' ' 192' ' ' TYR . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 191' ' ' LEU . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.509 ' HE1' HG23 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.775 HD13 ' O ' ' A' ' 213' ' ' VAL . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 227' ' ' ILE . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 261' ' ' VAL . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 232' ' ' ILE . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 243' ' ' ILE . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.512 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 239' ' ' LEU . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 237' ' ' ARG . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.575 ' CD ' HD22 ' A' ' 233' ' ' LEU . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.855 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 243' ' ' ILE . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.73 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 190' ' ' ASP . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 230' ' ' VAL . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 263' ' ' PHE . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.707 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.549 ' CE1' HD13 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.699 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.549 HD13 ' CE1' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.432 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.919 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.699 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.479 HG22 ' HE1' ' A' ' 189' ' ' TYR . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 186' ' ' LEU . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 185' ' ' MET . 5.6 tt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 186' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.692 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.542 ' HB2' HG11 ' A' ' 253' ' ' VAL . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 192' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.851 ' N ' HD12 ' A' ' 191' ' ' LEU . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 255' ' ' THR . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.966 HD21 HG13 ' A' ' 209' ' ' VAL . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HG3' ' CG ' ' A' ' 210' ' ' GLN . 1.9 ptt-85 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.966 HG13 HD21 ' A' ' 197' ' ' LEU . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.423 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.766 ' O ' HD13 ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.507 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' A' ' 275' ' ' PHE . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.718 ' HB2' HD11 ' A' ' 227' ' ' ILE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 261' ' ' VAL . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.934 HD21 HD12 ' A' ' 243' ' ' ILE . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.622 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.622 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.611 HD23 ' CD1' ' A' ' 233' ' ' LEU . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.834 ' HD2' HD22 ' A' ' 233' ' ' LEU . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.934 HD12 HD21 ' A' ' 233' ' ' LEU . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.834 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.629 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 186' ' ' LEU . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.631 HG13 HG22 ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.682 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' A' ' 220' ' ' LEU . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.682 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.585 ' HG2' ' HE1' ' A' ' 276' ' ' MET . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.692 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.738 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 266' ' ' VAL . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 185' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.522 ' HG2' HG11 ' A' ' 266' ' ' VAL . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.605 ' SD ' HG21 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.649 HD11 ' ND1' ' A' ' 273' ' ' HIS . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 291' ' ' ILE . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 289' ' ' VAL . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.918 ' HB2' HG21 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 192' ' ' TYR . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.409 ' N ' HD13 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.918 HG21 ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 209' ' ' VAL . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.636 ' O ' HG23 ' A' ' 223' ' ' THR . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.786 ' CB ' HD11 ' A' ' 227' ' ' ILE . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 219' ' ' LYS . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.479 ' CZ ' HD23 ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.786 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 1.1 HG22 HG12 ' A' ' 261' ' ' VAL . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.636 HG22 ' CB ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 233' ' ' LEU . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.437 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 233' ' ' LEU . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 233' ' ' LEU . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.488 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.681 ' HB2' HG22 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 259' ' ' ALA . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 230' ' ' VAL . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.703 ' CD1' HG23 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 270' ' ' ILE . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 266' ' ' VAL . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.505 ' N ' HG23 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.649 ' ND1' HD11 ' A' ' 186' ' ' LEU . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.649 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.649 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.744 HG23 ' CE1' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 290' ' ' LEU . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 187' ' ' LEU . 5.1 mm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.51 ' HE3' HG11 ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.709 HD22 ' HB1' ' A' ' 288' ' ' ALA . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 291' ' ' ILE . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.934 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.708 ' OD2' HG12 ' A' ' 253' ' ' VAL . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.7 ' N ' HD13 ' A' ' 191' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 193' ' ' LEU . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . 0.46 ' HB3' HD13 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 194' ' ' SER . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.733 0.301 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 209' ' ' VAL . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 ' SD ' ' A' ' 286' ' ' MET . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' VAL . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 222' ' ' GLY . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.941 HG21 HG22 ' A' ' 230' ' ' VAL . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.941 HG22 HG21 ' A' ' 227' ' ' ILE . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.577 HG13 ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.837 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 234' ' ' LYS . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.837 HD23 ' CD1' ' A' ' 233' ' ' LEU . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 291' ' ' ILE . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.704 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.409 ' CD ' ' HB3' ' A' ' 239' ' ' LEU . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.7 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.563 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.708 HG12 ' OD2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.415 HG23 ' OE1' ' A' ' 257' ' ' GLU . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 15.8 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' A' ' 255' ' ' THR . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.684 HD11 HD21 ' A' ' 233' ' ' LEU . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 230' ' ' VAL . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 227' ' ' ILE . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 270' ' ' ILE . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 266' ' ' VAL . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.63 ' ND1' HD12 ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.63 HD12 ' ND1' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.456 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 217' ' ' LEU . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.709 ' HB1' HD22 ' A' ' 186' ' ' LEU . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 187' ' ' LEU . 22.9 mm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.835 0.35 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.421 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.438 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 290' ' ' LEU . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.773 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CE1' HG23 ' A' ' 289' ' ' VAL . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.586 ' CG ' HG22 ' A' ' 255' ' ' THR . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.713 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.743 ' CD2' HG13 ' A' ' 209' ' ' VAL . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.685 HG12 HD13 ' A' ' 217' ' ' LEU . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 213' ' ' VAL . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 220' ' ' LEU . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 219' ' ' LYS . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.76 ' CB ' HD11 ' A' ' 227' ' ' ILE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.76 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.889 HG22 HG12 ' A' ' 261' ' ' VAL . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.759 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.759 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.586 HG22 ' CG ' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.455 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.8 tt0 -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 243' ' ' ILE . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.773 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.889 HG12 HG22 ' A' ' 230' ' ' VAL . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.607 ' CE1' HG23 ' A' ' 227' ' ' ILE . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.904 ' HA ' HD12 ' A' ' 270' ' ' ILE . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 267' ' ' GLU . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.606 ' NE2' HD11 ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.463 ' HE3' ' HG3' ' A' ' 286' ' ' MET . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.606 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 281' ' ' GLN . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 278' ' ' THR . 0.9 OUTLIER -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.599 ' CB ' HD21 ' A' ' 186' ' ' LEU . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.735 HG23 ' CE1' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 185' ' ' MET . 5.5 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.548 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.876 HD21 ' HB1' ' A' ' 288' ' ' ALA . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.906 HD23 HD11 ' A' ' 291' ' ' ILE . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.856 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.707 ' OD2' HG21 ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.724 ' N ' HD22 ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' LEU . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.911 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 213' ' ' VAL . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.487 HG21 ' HE2' ' A' ' 192' ' ' TYR . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.421 ' HG2' HD11 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.751 HG12 HD11 ' A' ' 217' ' ' LEU . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.607 ' HA ' HD12 ' A' ' 217' ' ' LEU . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.751 HD11 HG12 ' A' ' 213' ' ' VAL . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.93 ' HB2' HD11 ' A' ' 227' ' ' ILE . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 261' ' ' VAL . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.483 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.707 HG21 ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.605 HG23 ' OD1' ' A' ' 190' ' ' ASP . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.56 ' HG2' HD21 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.648 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.581 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.991 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.595 ' HE1' HD23 ' A' ' 217' ' ' LEU . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.709 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.991 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.856 HG23 ' CE1' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' ' 289' ' ' VAL . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.906 HD11 HD23 ' A' ' 187' ' ' LEU . 8.9 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.441 ' HB3' HG22 ' A' ' 266' ' ' VAL . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.772 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.566 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.64 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 209' ' ' VAL . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.505 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.675 ' CD2' HD21 ' A' ' 217' ' ' LEU . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.804 ' CG2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 227' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.488 HD22 ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ARG . . . . . 0.49 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 237' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.767 ' HD2' HD11 ' A' ' 243' ' ' ILE . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.767 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 191' ' ' LEU . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.42 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.772 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 227' ' ' ILE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.743 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 277' ' ' ILE . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.433 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 10.3 p-10 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.703 ' CD2' HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 266' ' ' VAL . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.944 HD21 ' HB1' ' A' ' 288' ' ' ALA . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 291' ' ' ILE . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.806 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.61 ' OD2' HD22 ' A' ' 193' ' ' LEU . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.628 ' H ' HD22 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.61 HD22 ' OD2' ' A' ' 190' ' ' ASP . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.63 HD11 HG22 ' A' ' 209' ' ' VAL . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 209' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 213' ' ' VAL . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.404 ' HD3' HD22 ' A' ' 197' ' ' LEU . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.464 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 214' ' ' MET . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 219' ' ' LYS . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 230' ' ' VAL . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.932 HG13 HG12 ' A' ' 261' ' ' VAL . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 260' ' ' ILE . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 232' ' ' ILE . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.762 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.762 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 246' ' ' ILE . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.705 ' OG ' HG22 ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.4 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.533 HD11 HD11 ' A' ' 243' ' ' ILE . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 230' ' ' VAL . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.765 ' CD1' HG23 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 184' ' ' LYS . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 267' ' ' GLU . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.918 ' O ' HD12 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.457 ' HA ' ' CD1' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.579 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 278' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.477 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.572 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.806 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.944 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.629 HG12 ' HE1' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.609 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.553 ' HG2' HG21 ' A' ' 266' ' ' VAL . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.674 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.681 ' HB2' HG11 ' A' ' 253' ' ' VAL . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.752 ' HE1' HG21 ' A' ' 209' ' ' VAL . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.637 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.453 HD21 HG13 ' A' ' 209' ' ' VAL . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 192' ' ' TYR . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.644 HG22 HD13 ' A' ' 217' ' ' LEU . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.487 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' THR . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.706 ' HB2' HD11 ' A' ' 227' ' ' ILE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' LYS . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 272' ' ' ALA . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 227' ' ' ILE . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.772 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.663 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.772 HD23 ' CD1' ' A' ' 233' ' ' LEU . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.523 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 246' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.576 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.571 HG21 ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.757 ' CB ' HG22 ' A' ' 188' ' ' VAL . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.85 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CZ ' HG11 ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 267' ' ' GLU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.668 ' CG2' HD21 ' A' ' 290' ' ' LEU . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.893 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 267' ' ' GLU . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.602 ' NE2' HD11 ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' HG22 ' A' ' 278' ' ' THR . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.587 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.602 HD11 ' NE2' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 274' ' ' GLU . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLU . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' THR . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 285' ' ' ASN . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.587 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.649 HG12 ' HG ' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.668 HD21 ' CG2' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.689 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.688 HD11 ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.799 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.926 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.846 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.926 HD13 ' HA ' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ttp-105 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 213' ' ' VAL . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.449 ' CG ' HD11 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.585 HD11 ' HE3' ' A' ' 286' ' ' MET . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.585 HD21 ' HE2' ' A' ' 275' ' ' PHE . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.84 ' CB ' HD11 ' A' ' 227' ' ' ILE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.737 ' CG2' HG21 ' A' ' 227' ' ' ILE . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.752 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.78 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.632 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.599 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.688 ' CG2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.52 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.548 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.799 HG21 ' HD2' ' A' ' 189' ' ' TYR . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.58 HD13 ' C ' ' A' ' 259' ' ' ALA . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 ' CG2' ' A' ' 227' ' ' ILE . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.606 ' HA ' ' CD2' ' A' ' 273' ' ' HIS . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.625 ' ND1' HD12 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.474 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.585 ' HE2' HD21 ' A' ' 220' ' ' LEU . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.459 ' HE1' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.625 HD12 ' ND1' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.585 ' HE3' HD11 ' A' ' 217' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 253' ' ' VAL . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 187' ' ' LEU . 35.9 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 1.057 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.0 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.505 ' O ' HD12 ' A' ' 197' ' ' LEU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.843 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 192' ' ' TYR . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 210' ' ' GLN . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.741 HG11 HD23 ' A' ' 191' ' ' LEU . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.874 ' HA ' HD12 ' A' ' 218' ' ' LEU . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 221' ' ' PHE . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' A' ' 215' ' ' GLU . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.552 ' HE1' HD22 ' A' ' 217' ' ' LEU . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.798 HG21 HG22 ' A' ' 230' ' ' VAL . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.798 HG22 HG21 ' A' ' 227' ' ' ILE . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.693 HG22 ' HB1' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.79 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.79 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.474 ' CD ' HD22 ' A' ' 233' ' ' LEU . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.826 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.649 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.748 ' HE2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.417 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.441 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 1.0 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 230' ' ' VAL . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.873 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 267' ' ' GLU . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.543 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 272' ' ' ALA . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.92 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 276' ' ' MET . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.438 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.509 ' HE2' HD12 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 1.057 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 266' ' ' VAL . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' A' ' 185' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.72 0.295 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.472 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.405 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 291' ' ' ILE . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.95 HG22 ' HB3' ' A' ' 259' ' ' ALA . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.499 ' CB ' HG11 ' A' ' 253' ' ' VAL . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.816 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.816 HD13 ' HA ' ' A' ' 192' ' ' TYR . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.467 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.623 ' CG ' ' HB2' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 227' ' ' ILE . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.523 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.692 HD11 ' NZ ' ' A' ' 234' ' ' LYS . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.63 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.692 ' NZ ' HD11 ' A' ' 232' ' ' ILE . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 233' ' ' LEU . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.59 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.41 ' O ' HG12 ' A' ' 246' ' ' ILE . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.641 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.589 ' CG2' HD13 ' A' ' 193' ' ' LEU . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.617 HD11 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.8 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.76 ' HA ' HD12 ' A' ' 270' ' ' ILE . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.8 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 267' ' ' GLU . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 278' ' ' THR . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 272' ' ' ALA . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 274' ' ' GLU . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.725 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.512 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.465 ' HB2' ' CE ' ' A' ' 276' ' ' MET . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.456 HG12 ' HE1' ' A' ' 189' ' ' TYR . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 187' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.712 0.292 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.562 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 1.021 HD21 ' HB1' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 259' ' ' ALA . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.622 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.747 ' OD1' HD23 ' A' ' 193' ' ' LEU . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.863 ' N ' HD12 ' A' ' 191' ' ' LEU . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.747 HD23 ' OD1' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 209' ' ' VAL . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 197' ' ' LEU . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 217' ' ' LEU . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.867 HD11 HG12 ' A' ' 213' ' ' VAL . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 215' ' ' GLU . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.491 ' CE1' HD22 ' A' ' 217' ' ' LEU . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.795 HG13 HG12 ' A' ' 261' ' ' VAL . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 232' ' ' ILE . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.428 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 246' ' ' ILE . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 189' ' ' TYR . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.683 ' OG1' HD21 ' A' ' 193' ' ' LEU . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.795 HG12 HG13 ' A' ' 230' ' ' VAL . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 227' ' ' ILE . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 184' ' ' LYS . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 267' ' ' GLU . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.678 ' O ' HG12 ' A' ' 277' ' ' ILE . 1.8 t-80 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 278' ' ' THR . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.521 ' HE3' ' HG2' ' A' ' 286' ' ' MET . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 274' ' ' GLU . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.521 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 1.021 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.412 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.798 HD12 HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.644 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.443 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.75 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.762 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.627 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.853 ' OD2' HG21 ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.624 ' N ' HD22 ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.944 HD13 HG21 ' A' ' 255' ' ' THR . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 209' ' ' VAL . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.601 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.968 HG23 HD12 ' A' ' 197' ' ' LEU . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 197' ' ' LEU . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 213' ' ' VAL . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.675 ' HB3' HD11 ' A' ' 227' ' ' ILE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 261' ' ' VAL . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.645 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.702 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.702 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.645 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.563 ' CD ' HD22 ' A' ' 233' ' ' LEU . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 246' ' ' ILE . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.853 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.944 HG21 HD13 ' A' ' 193' ' ' LEU . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.412 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.458 HG12 HD12 ' A' ' 187' ' ' LEU . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.641 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 270' ' ' ILE . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.75 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.554 ' CD1' HG22 ' A' ' 266' ' ' VAL . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.62 ' ND1' HD13 ' A' ' 290' ' ' LEU . 19.1 t-160 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.447 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.522 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.447 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 291' ' ' ILE . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 186' ' ' LEU . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 291' ' ' ILE . 1.2 mm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.77 0.319 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.543 ' O ' HG22 ' A' ' 291' ' ' ILE . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.837 ' OD2' HD22 ' A' ' 193' ' ' LEU . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.837 HD22 ' OD2' ' A' ' 190' ' ' ASP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.594 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.821 HG23 ' HG ' ' A' ' 191' ' ' LEU . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.69 HD21 ' CE2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 217' ' ' LEU . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.735 HG22 HG12 ' A' ' 261' ' ' VAL . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.609 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.768 ' HD2' HD11 ' A' ' 243' ' ' ILE . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.499 ' HB2' HD13 ' A' ' 243' ' ' ILE . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.768 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.661 HG21 HD13 ' A' ' 193' ' ' LEU . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 233' ' ' LEU . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 269' ' ' ALA . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.919 ' HA ' HD12 ' A' ' 270' ' ' ILE . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 263' ' ' PHE . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 267' ' ' GLU . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.731 ' CE1' HD13 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.731 HD13 ' CE1' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 186' ' ' LEU . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 185' ' ' MET . 5.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.555 ' O ' HG22 ' A' ' 291' ' ' ILE . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 1.062 HD21 ' HB1' ' A' ' 288' ' ' ALA . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.708 HD13 HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.938 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.676 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.676 ' N ' HD22 ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.9 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 191' ' ' LEU . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.547 ' CG1' HD21 ' A' ' 197' ' ' LEU . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.583 HD12 ' CE ' ' A' ' 286' ' ' MET . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 218' ' ' LEU . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 275' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 261' ' ' VAL . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.696 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.715 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 232' ' ' ILE . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.724 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.522 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 233' ' ' LEU . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.643 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.78 HG13 ' HB3' ' A' ' 284' ' ' GLU . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 233' ' ' LEU . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 230' ' ' VAL . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.74 HG23 HD21 ' A' ' 290' ' ' LEU . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 266' ' ' VAL . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.667 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.489 ' HE1' HD21 ' A' ' 220' ' ' LEU . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.574 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.667 HD11 ' NE2' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.78 ' HB3' HG13 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.582 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 1.062 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 189' ' ' TYR . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 185' ' ' MET . 4.2 tt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.673 ' HB2' HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.864 HD21 ' HB1' ' A' ' 288' ' ' ALA . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.736 ' HB3' HG11 ' A' ' 253' ' ' VAL . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.823 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 209' ' ' VAL . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.87 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG23 ' A' ' 209' ' ' VAL . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.784 HG23 HD23 ' A' ' 197' ' ' LEU . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 209' ' ' VAL . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.653 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.896 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.728 HG21 HG22 ' A' ' 230' ' ' VAL . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.728 HG22 HG21 ' A' ' 227' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.58 HG22 ' CB ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.501 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 246' ' ' ILE . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.884 HG21 ' SG ' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.486 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.736 HG11 ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.482 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 192' ' ' TYR . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.884 ' SG ' HG21 ' A' ' 243' ' ' ILE . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.709 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.501 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 270' ' ' ILE . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.501 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 266' ' ' VAL . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.746 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.896 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.751 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.741 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.636 ' HB2' HG12 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.673 ' HG3' HG22 ' A' ' 277' ' ' ILE . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.864 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.433 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 289' ' ' VAL . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.544 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.413 ' HE2' ' CG1' ' A' ' 266' ' ' VAL . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.844 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.69 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.873 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.623 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.881 ' OD2' HG21 ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.862 ' HA ' HD22 ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 255' ' ' THR . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.014 HD11 HG13 ' A' ' 209' ' ' VAL . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 197' ' ' LEU . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 209' ' ' VAL . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' MET . . . . . 0.475 ' N ' HG23 ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.699 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.699 ' CZ ' HD23 ' A' ' 217' ' ' LEU . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.788 HG23 ' CE1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.842 HG22 HG12 ' A' ' 261' ' ' VAL . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.772 HG22 ' HB1' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.726 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.726 HD23 ' CD1' ' A' ' 233' ' ' LEU . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.881 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.72 HG21 HD13 ' A' ' 193' ' ' LEU . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.873 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.423 HG12 HD12 ' A' ' 187' ' ' LEU . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 230' ' ' VAL . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.788 ' CE1' HG23 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.413 ' CG1' ' HE2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.753 ' HA ' HD12 ' A' ' 270' ' ' ILE . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.844 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 267' ' ' GLU . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.799 ' CE1' HD13 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.549 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.799 HD13 ' CE1' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.571 ' SD ' HD23 ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.623 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 187' ' ' LEU . 3.3 mm . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 266' ' ' VAL . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.494 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.831 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.791 ' O ' HD13 ' A' ' 191' ' ' LEU . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.807 ' CB ' HG11 ' A' ' 253' ' ' VAL . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.658 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.711 ' HG ' HG23 ' A' ' 209' ' ' VAL . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.711 HG23 ' HG ' ' A' ' 197' ' ' LEU . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 209' ' ' VAL . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' HIS . . . . . 0.408 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.538 HD23 ' CE2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 219' ' ' LYS . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.611 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.556 HG23 ' CE2' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 261' ' ' VAL . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.76 HG22 ' HB1' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.71 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.807 HG11 ' CB ' ' A' ' 190' ' ' ASP . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.716 HG22 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.831 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CE2' HG23 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 290' ' ' LEU . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.907 ' HA ' HD12 ' A' ' 270' ' ' ILE . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 267' ' ' GLU . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.611 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.56 ' HB3' HD11 ' A' ' 186' ' ' LEU . 5.3 p-80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 275' ' ' PHE . . . . . 0.419 ' HA ' HG22 ' A' ' 278' ' ' THR . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' MET . . . . . 0.659 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 287' ' ' LYS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 253' ' ' VAL . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.702 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 185' ' ' MET . 3.1 tt . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.836 0.351 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.489 HD13 ' HE2' ' A' ' 184' ' ' LYS . 1.1 pp -89.04 137.42 29.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.06 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -43.62 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m -157.39 150.71 23.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.229 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.764 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.832 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 253' ' ' VAL . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.503 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.729 HD22 ' HG3' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.855 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.592 ' C ' HD13 ' A' ' 197' ' ' LEU . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -76.27 -41.56 48.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.04 -37.15 20.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 111.32 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 55.56 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 5.6 m -111.51 99.62 44.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.64 121.51 7.46 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 112.236 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.49 152.34 28.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -75.72 -28.17 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -70.23 -77.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -148.1 140.01 8.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.653 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 207' ' ' GLY . 2.6 ptp180 -49.21 -154.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 213' ' ' VAL . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 208' ' ' ARG . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 209' ' ' VAL . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.477 ' N ' HG13 ' A' ' 213' ' ' VAL . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 220' ' ' LEU . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.709 HG22 HG21 ' A' ' 227' ' ' ILE . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.684 HG22 ' CB ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.661 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.506 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.661 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 246' ' ' ILE . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.522 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.591 HG13 ' HE3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.503 ' CG2' HD12 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.707 ' HB3' HG21 ' A' ' 243' ' ' ILE . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.832 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 227' ' ' ILE . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.781 HG22 HG23 ' A' ' 270' ' ' ILE . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 271' ' ' LYS . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.834 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.771 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.729 ' HG3' HD22 ' A' ' 193' ' ' LEU . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.591 ' HE3' HG13 ' A' ' 253' ' ' VAL . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.426 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 186' ' ' LEU . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.764 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -118.11 119.82 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 172.95 80.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.609 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 3.9 tpp -113.68 174.74 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 110.755 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -77.32 132.35 70.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.264 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -89.03 144.15 32.3 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.88 -45.0 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.541 2.161 . . . . 0.0 112.438 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.1 150.73 31.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 181' ' ' LEU . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.535 ' O ' HG22 ' A' ' 291' ' ' ILE . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.624 HD13 ' HB1' ' A' ' 269' ' ' ALA . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.891 HG13 HD12 ' A' ' 191' ' ' LEU . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.583 ' HB2' HG11 ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 1.047 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.901 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.887 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.762 HD22 ' CG2' ' A' ' 202' ' ' THR . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -74.76 -41.86 59.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -18.71 60.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 64.23 101.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 110.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.762 ' CG2' HD22 ' A' ' 197' ' ' LEU . 62.0 p -69.52 122.68 86.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.14 161.28 45.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.455 2.104 . . . . 0.0 112.17 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.44 123.48 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.18 -63.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -162.65 -71.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -101.6 89.39 0.77 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.316 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.601 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.34 -155.49 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.69 0.396 . . . . 0.0 112.002 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.815 HG21 ' HB2' ' A' ' 192' ' ' TYR . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.41 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 191' ' ' LEU . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.509 ' HE1' HG23 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.775 HD13 ' O ' ' A' ' 213' ' ' VAL . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 227' ' ' ILE . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 261' ' ' VAL . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 232' ' ' ILE . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 243' ' ' ILE . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.512 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 239' ' ' LEU . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 237' ' ' ARG . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.575 ' CD ' HD22 ' A' ' 233' ' ' LEU . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.855 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 243' ' ' ILE . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.73 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 190' ' ' ASP . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 230' ' ' VAL . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 263' ' ' PHE . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.707 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.549 ' CE1' HD13 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.699 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.549 HD13 ' CE1' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.432 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.919 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.699 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.479 HG22 ' HE1' ' A' ' 189' ' ' TYR . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 186' ' ' LEU . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 185' ' ' MET . 5.6 tt -117.78 143.03 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -155.56 78.68 0.19 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 mtt -176.21 96.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.83 153.09 17.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.541 2.161 . . . . 0.0 112.282 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.353 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 126.78 57.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.69 -63.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.486 2.124 . . . . 0.0 112.152 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m -162.78 150.96 14.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 186' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.692 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.542 ' HB2' HG11 ' A' ' 253' ' ' VAL . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 192' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.851 ' N ' HD12 ' A' ' 191' ' ' LEU . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 255' ' ' THR . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 200' ' ' LEU . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.966 HD21 HG13 ' A' ' 209' ' ' VAL . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -79.38 -6.35 56.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 196' ' ' LYS . 8.3 tp -87.99 -37.47 16.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.522 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.4 92.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.466 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.428 HG23 HD23 ' A' ' 200' ' ' LEU . 6.5 p -113.48 98.13 45.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.11 -20.03 66.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.494 2.129 . . . . 0.0 112.322 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 204' ' ' GLN . 0.0 OUTLIER -93.85 44.46 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.27 106.4 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -63.01 156.67 23.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 57.17 102.03 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.298 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.663 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.9 ptt-85 -42.31 -160.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.966 HG13 HD21 ' A' ' 197' ' ' LEU . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.423 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.541 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.766 ' O ' HD13 ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.507 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' A' ' 275' ' ' PHE . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.718 ' HB2' HD11 ' A' ' 227' ' ' ILE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 261' ' ' VAL . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.934 HD21 HD12 ' A' ' 243' ' ' ILE . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.622 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.622 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.611 HD23 ' CD1' ' A' ' 233' ' ' LEU . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.834 ' HD2' HD22 ' A' ' 233' ' ' LEU . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.934 HD12 HD21 ' A' ' 233' ' ' LEU . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.834 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.629 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 186' ' ' LEU . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.631 HG13 HG22 ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.682 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' A' ' 220' ' ' LEU . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.682 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.585 ' HG2' ' HE1' ' A' ' 276' ' ' MET . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.692 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.738 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 266' ' ' VAL . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 185' ' ' MET . 0.0 OUTLIER -117.57 134.66 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -112.35 168.76 12.79 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.851 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.9 ttt -176.87 102.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.803 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -75.47 146.42 80.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.613 2.209 . . . . 0.0 112.312 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.827 0.346 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 184' ' ' LYS . 2.3 tp -88.51 126.84 58.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.92 -52.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.388 2.059 . . . . 0.0 112.43 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -164.19 150.71 11.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 181' ' ' LEU . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.605 ' SD ' HG21 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.649 HD11 ' ND1' ' A' ' 273' ' ' HIS . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 291' ' ' ILE . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 289' ' ' VAL . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.918 ' HB2' HG21 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 192' ' ' TYR . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.409 ' N ' HD13 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . -79.26 -14.11 59.24 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 7.2 tt -114.03 -37.23 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.909 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.58 122.09 38.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.0 111.888 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 202' ' ' THR . 7.8 t -132.97 86.56 42.69 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.336 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -92.83 -166.9 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.215 2.61 . . . . 0.0 112.814 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -156.8 29.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.603 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -174.66 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.035 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.06 -67.16 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -71.95 63.07 1.28 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.89 -156.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.731 0.412 . . . . 0.0 112.056 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.918 HG21 ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 209' ' ' VAL . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.636 ' O ' HG23 ' A' ' 223' ' ' THR . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.786 ' CB ' HD11 ' A' ' 227' ' ' ILE . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 219' ' ' LYS . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.479 ' CZ ' HD23 ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.786 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 1.1 HG22 HG12 ' A' ' 261' ' ' VAL . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.636 HG22 ' CB ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 233' ' ' LEU . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.437 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 233' ' ' LEU . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 233' ' ' LEU . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.488 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.681 ' HB2' HG22 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 259' ' ' ALA . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 230' ' ' VAL . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.703 ' CD1' HG23 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 270' ' ' ILE . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 266' ' ' VAL . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.505 ' N ' HG23 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.649 ' ND1' HD11 ' A' ' 186' ' ' LEU . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.649 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.649 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.744 HG23 ' CE1' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 290' ' ' LEU . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 187' ' ' LEU . 5.1 mm -93.21 124.74 45.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -174.3 -126.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.247 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.47 149.36 16.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.862 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 116.54 21.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.318 2.012 . . . . 0.0 112.324 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 0.2 OUTLIER -89.08 126.51 58.77 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 5.0 Cg_exo -78.15 -56.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.648 2.232 . . . . 0.0 111.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -167.35 140.48 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.912 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.51 ' HE3' HG11 ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.709 HD22 ' HB1' ' A' ' 288' ' ' ALA . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 291' ' ' ILE . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.934 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.708 ' OD2' HG12 ' A' ' 253' ' ' VAL . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.7 ' N ' HD13 ' A' ' 191' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 193' ' ' LEU . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.46 ' HB3' HD13 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.555 ' HG2' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 194' ' ' SER . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.72 -15.38 61.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.555 HD13 ' HG2' ' A' ' 196' ' ' LYS . 0.5 OUTLIER -87.29 -42.32 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.71 131.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.179 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 31.7 p -144.49 142.07 18.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.62 -175.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.437 2.091 . . . . 0.0 112.313 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.6 122.73 34.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -162.15 123.74 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.37 -78.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -153.0 124.83 1.67 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.583 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -48.86 -154.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.819 0.448 . . . . 0.0 111.808 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 209' ' ' VAL . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 ' SD ' ' A' ' 286' ' ' MET . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' VAL . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 222' ' ' GLY . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.941 HG21 HG22 ' A' ' 230' ' ' VAL . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.941 HG22 HG21 ' A' ' 227' ' ' ILE . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.577 HG13 ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.837 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 234' ' ' LYS . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.837 HD23 ' CD1' ' A' ' 233' ' ' LEU . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 291' ' ' ILE . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.704 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.409 ' CD ' ' HB3' ' A' ' 239' ' ' LEU . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.7 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.563 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.708 HG12 ' OD2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.415 HG23 ' OE1' ' A' ' 257' ' ' GLU . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 15.8 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' A' ' 255' ' ' THR . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.684 HD11 HD21 ' A' ' 233' ' ' LEU . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 230' ' ' VAL . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 227' ' ' ILE . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 270' ' ' ILE . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 266' ' ' VAL . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.63 ' ND1' HD12 ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.63 HD12 ' ND1' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.456 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 217' ' ' LEU . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.709 ' HB1' HD22 ' A' ' 186' ' ' LEU . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 187' ' ' LEU . 22.9 mm -85.85 105.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 92.85 163.38 37.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.6 ptm -173.97 115.7 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.42 96.02 5.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.481 2.121 . . . . 0.0 112.357 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.849 0.356 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.06 127.03 57.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.93 -43.95 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.52 2.147 . . . . 0.0 112.554 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m -147.42 150.98 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.421 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.438 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 290' ' ' LEU . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.773 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CE1' HG23 ' A' ' 289' ' ' VAL . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.586 ' CG ' HG22 ' A' ' 255' ' ' THR . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.713 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.743 ' CD2' HG13 ' A' ' 209' ' ' VAL . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.21 -20.01 45.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -93.91 12.77 24.87 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.431 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 200' ' ' LEU . . . 72.76 -156.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 81.4 p -112.31 99.91 48.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 111.053 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.56 127.75 13.57 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.434 2.09 . . . . 0.0 112.233 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -112.3 114.37 27.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -160.1 -56.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 121.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 60.56 79.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.02 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.6 -155.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.685 HG12 HD13 ' A' ' 217' ' ' LEU . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 213' ' ' VAL . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 220' ' ' LEU . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 219' ' ' LYS . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.76 ' CB ' HD11 ' A' ' 227' ' ' ILE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.76 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.889 HG22 HG12 ' A' ' 261' ' ' VAL . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.759 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.759 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.586 HG22 ' CG ' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.455 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.8 tt0 -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 243' ' ' ILE . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.773 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.889 HG12 HG22 ' A' ' 230' ' ' VAL . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.607 ' CE1' HG23 ' A' ' 227' ' ' ILE . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.904 ' HA ' HD12 ' A' ' 270' ' ' ILE . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 267' ' ' GLU . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.606 ' NE2' HD11 ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.463 ' HE3' ' HG3' ' A' ' 286' ' ' MET . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.606 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 281' ' ' GLN . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 278' ' ' THR . 0.9 OUTLIER -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.599 ' CB ' HD21 ' A' ' 186' ' ' LEU . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.735 HG23 ' CE1' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 185' ' ' MET . 5.5 tt -116.31 143.24 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.51 92.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.602 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -73.88 -177.59 2.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 110.842 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 133.78 25.47 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.375 2.05 . . . . 0.0 112.297 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.781 0.324 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.11 145.79 35.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.19 -55.57 2.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.451 2.101 . . . . 0.0 111.791 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m -164.11 149.78 10.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.936 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.548 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.876 HD21 ' HB1' ' A' ' 288' ' ' ALA . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.906 HD23 HD11 ' A' ' 291' ' ' ILE . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.856 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.707 ' OD2' HG21 ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.724 ' N ' HD22 ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' LEU . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.911 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 213' ' ' VAL . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.19 -25.16 60.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER -73.74 -37.56 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.675 0.274 . . . . 0.0 111.318 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 54.17 109.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.701 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 13.0 m -134.61 124.08 16.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.944 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.89 -166.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.396 2.064 . . . . 0.0 112.225 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.28 128.36 44.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.48 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -125.34 -177.18 3.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.002 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -53.44 95.49 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.386 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.617 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.3 ttp-105 -45.98 -155.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.487 HG21 ' HE2' ' A' ' 192' ' ' TYR . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.421 ' HG2' HD11 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.751 HG12 HD11 ' A' ' 217' ' ' LEU . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.607 ' HA ' HD12 ' A' ' 217' ' ' LEU . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.751 HD11 HG12 ' A' ' 213' ' ' VAL . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.93 ' HB2' HD11 ' A' ' 227' ' ' ILE . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 261' ' ' VAL . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.483 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.707 HG21 ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.605 HG23 ' OD1' ' A' ' 190' ' ' ASP . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.56 ' HG2' HD21 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.648 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.581 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.991 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.595 ' HE1' HD23 ' A' ' 217' ' ' LEU . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.709 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.991 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.856 HG23 ' CE1' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' ' 289' ' ' VAL . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.906 HD11 HD23 ' A' ' 187' ' ' LEU . 8.9 mm -99.2 128.39 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.68 -83.48 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.61 146.02 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 96.05 45.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.521 2.147 . . . . 0.0 112.351 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.424 ' N ' HD21 ' A' ' 180' ' ' ASN . 1.4 m-80 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.786 0.327 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.448 HD13 ' HD3' ' A' ' 184' ' ' LYS . 18.5 mt -86.38 138.45 34.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.09 -51.03 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.296 1.997 . . . . 0.0 111.925 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER -164.14 150.17 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.563 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.448 ' HD3' HD13 ' A' ' 181' ' ' LEU . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.772 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.566 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.64 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 209' ' ' VAL . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -74.26 -41.89 60.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tp -63.18 -37.28 86.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.222 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 59.21 113.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.224 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.3 m -75.85 125.49 88.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.27 -45.56 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -92.11 166.76 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.55 105.48 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -172.53 105.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.29 48.56 81.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.833 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.3 OUTLIER -46.7 -155.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.917 0.487 . . . . 0.0 112.276 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.415 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.505 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.675 ' CD2' HD21 ' A' ' 217' ' ' LEU . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.804 ' CG2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 227' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.488 HD22 ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ARG . . . . . 0.49 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 237' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.767 ' HD2' HD11 ' A' ' 243' ' ' ILE . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.767 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 191' ' ' LEU . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.42 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.772 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 227' ' ' ILE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.743 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 277' ' ' ILE . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.433 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 10.3 p-10 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.703 ' CD2' HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -117.86 138.46 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 291' ' ' ILE . . . -99.94 139.71 14.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.354 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.1 ttp -80.94 -57.18 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.46 118.38 24.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.901 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.25 1.118 0 C-N-CA 122.457 2.104 . . . . 0.0 112.356 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 184' ' ' LYS . 4.1 pp -78.44 145.38 67.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.65 -50.02 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.569 2.179 . . . . 0.0 112.221 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m -166.46 140.77 4.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 266' ' ' VAL . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.944 HD21 ' HB1' ' A' ' 288' ' ' ALA . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 291' ' ' ILE . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.806 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.61 ' OD2' HD22 ' A' ' 193' ' ' LEU . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.628 ' H ' HD22 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.61 HD22 ' OD2' ' A' ' 190' ' ' ASP . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 200' ' ' LEU . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.63 HD11 HG22 ' A' ' 209' ' ' VAL . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -78.06 -7.4 56.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' A' ' 196' ' ' LYS . 4.8 tt -123.93 -47.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.321 . . . . 0.0 111.349 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 197' ' ' LEU . . . -91.24 142.55 27.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.337 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.8 p -103.15 150.83 38.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.1 134.63 65.34 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.53 159.9 28.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.611 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.52 91.79 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 174.11 77.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.753 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 63.82 51.41 53.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.345 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.15 -158.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.887 0.475 . . . . 0.0 112.144 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 213' ' ' VAL . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.401 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.404 ' HD3' HD22 ' A' ' 197' ' ' LEU . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.464 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 214' ' ' MET . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 219' ' ' LYS . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 230' ' ' VAL . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.932 HG13 HG12 ' A' ' 261' ' ' VAL . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 260' ' ' ILE . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 232' ' ' ILE . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.762 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.762 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 246' ' ' ILE . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.705 ' OG ' HG22 ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.4 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.533 HD11 HD11 ' A' ' 243' ' ' ILE . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 230' ' ' VAL . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.765 ' CD1' HG23 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 184' ' ' LYS . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 267' ' ' GLU . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.918 ' O ' HD12 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.457 ' HA ' ' CD1' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.579 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 278' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.477 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.572 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.806 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.944 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.629 HG12 ' HE1' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.657 HD13 ' N ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -118.18 129.55 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.657 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 174.29 82.75 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.61 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 5.7 mtm -162.84 137.84 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 129.63 83.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.787 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.373 2.048 . . . . 0.0 112.258 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 180' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -89.05 126.96 57.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.48 -52.48 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.361 2.041 . . . . 0.0 112.176 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.1 140.45 3.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.553 ' HG2' HG21 ' A' ' 266' ' ' VAL . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.674 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.681 ' HB2' HG11 ' A' ' 253' ' ' VAL . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.752 ' HE1' HG21 ' A' ' 209' ' ' VAL . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.637 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -78.7 -14.36 59.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.96 -47.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.313 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 197' ' ' LEU . . . -88.82 145.86 25.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 20.9 p -141.27 156.9 67.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.92 125.83 12.51 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.552 2.168 . . . . 0.0 112.381 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -169.0 -52.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.93 168.86 12.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.24 164.23 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 56.55 63.94 4.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 207' ' ' GLY . 4.3 ttm180 -47.29 -155.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 192' ' ' TYR . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.403 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.644 HG22 HD13 ' A' ' 217' ' ' LEU . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.487 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' THR . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.706 ' HB2' HD11 ' A' ' 227' ' ' ILE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' LYS . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 272' ' ' ALA . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 227' ' ' ILE . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.772 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.663 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.772 HD23 ' CD1' ' A' ' 233' ' ' LEU . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.523 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 246' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.576 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.571 HG21 ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.757 ' CB ' HG22 ' A' ' 188' ' ' VAL . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.85 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CZ ' HG11 ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.626 ' HG2' HD11 ' A' ' 181' ' ' LEU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.668 ' CG2' HD21 ' A' ' 290' ' ' LEU . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.893 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 267' ' ' GLU . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.602 ' NE2' HD11 ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' HG22 ' A' ' 278' ' ' THR . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.587 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.602 HD11 ' NE2' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 274' ' ' GLU . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLU . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' THR . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 285' ' ' ASN . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.587 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.649 HG12 ' HG ' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.668 HD21 ' CG2' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -119.56 124.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 291' ' ' ILE . . . -111.75 -139.49 7.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.1 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.1 143.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 14.0 mttm 61.66 93.21 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.558 2.172 . . . . 0.0 112.267 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 132.61 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.25 -37.87 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.642 2.228 . . . . 0.0 112.287 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m -167.54 140.52 3.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.318 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.689 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.688 HD11 ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.799 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.926 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.846 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.926 HD13 ' HA ' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -72.71 -10.97 60.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 201' ' ' ALA . 8.7 tt -103.34 -47.2 4.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' CB ' HD23 ' A' ' 200' ' ' LEU . . . -176.57 144.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.188 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.8 m -114.79 116.8 42.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.07 174.71 8.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.389 2.059 . . . . 0.0 112.226 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.42 155.89 20.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.3 -70.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -165.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -64.1 79.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.357 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.619 ' O ' ' O ' ' A' ' 207' ' ' GLY . 3.5 ttp-105 -47.05 -155.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 0.0 111.959 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 213' ' ' VAL . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.449 ' CG ' HD11 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.585 HD11 ' HE3' ' A' ' 286' ' ' MET . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.585 HD21 ' HE2' ' A' ' 275' ' ' PHE . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.84 ' CB ' HD11 ' A' ' 227' ' ' ILE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.737 ' CG2' HG21 ' A' ' 227' ' ' ILE . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.752 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.78 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.632 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.599 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.688 ' CG2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.52 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.548 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.799 HG21 ' HD2' ' A' ' 189' ' ' TYR . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.58 HD13 ' C ' ' A' ' 259' ' ' ALA . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 ' CG2' ' A' ' 227' ' ' ILE . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.416 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.606 ' HA ' ' CD2' ' A' ' 273' ' ' HIS . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.625 ' ND1' HD12 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.474 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.585 ' HE2' HD21 ' A' ' 220' ' ' LEU . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.459 ' HE1' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.625 HD12 ' ND1' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.585 ' HE3' HD11 ' A' ' 217' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 253' ' ' VAL . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 187' ' ' LEU . 35.9 mm -98.39 101.71 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 124.99 39.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -161.13 -89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.568 0.184 . . . . 0.0 110.936 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.07 91.81 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.439 2.093 . . . . 0.0 112.375 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -89.25 126.96 56.99 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.036 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.43 -42.12 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.63 140.5 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.409 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.057 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.0 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.505 ' O ' HD12 ' A' ' 197' ' ' LEU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.843 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 192' ' ' TYR . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.34 -38.83 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.8 tp -104.75 -47.49 4.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 111.284 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.39 109.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.24 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 m -101.21 98.89 9.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.52 144.0 28.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.497 2.132 . . . . 0.0 112.413 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 62.07 119.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -177.37 -59.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.53 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -151.74 125.89 1.95 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.109 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.53 -157.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.741 HG11 HD23 ' A' ' 191' ' ' LEU . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.874 ' HA ' HD12 ' A' ' 218' ' ' LEU . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 221' ' ' PHE . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' A' ' 215' ' ' GLU . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.552 ' HE1' HD22 ' A' ' 217' ' ' LEU . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.798 HG21 HG22 ' A' ' 230' ' ' VAL . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.798 HG22 HG21 ' A' ' 227' ' ' ILE . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.693 HG22 ' HB1' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.79 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.79 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.474 ' CD ' HD22 ' A' ' 233' ' ' LEU . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.826 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.649 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.748 ' HE2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.417 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.441 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 1.0 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 230' ' ' VAL . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.873 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 267' ' ' GLU . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.543 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 272' ' ' ALA . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.92 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 276' ' ' MET . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.438 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.509 ' HE2' HD12 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 1.057 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 266' ' ' VAL . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' A' ' 185' ' ' MET . 0.0 OUTLIER -117.43 121.36 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.491 ' N ' HD13 ' A' ' 291' ' ' ILE . . . -101.99 147.4 17.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.912 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 53.9 mtm -83.33 -173.42 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.81 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 108.88 1.89 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' H ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -89.3 147.26 37.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.52 -50.19 2.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.657 2.238 . . . . 0.0 112.271 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.52 140.86 16.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.472 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.405 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 291' ' ' ILE . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.95 HG22 ' HB3' ' A' ' 259' ' ' ALA . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.499 ' CB ' HG11 ' A' ' 253' ' ' VAL . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.816 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.816 HD13 ' HA ' ' A' ' 192' ' ' TYR . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -70.49 -26.69 63.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -26.76 54.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.052 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 65.93 125.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.203 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -148.3 107.5 3.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.55 -56.0 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.387 2.058 . . . . 0.0 112.418 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.46 145.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.963 0.411 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -156.02 -46.24 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -168.14 64.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.657 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 87.04 104.57 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.871 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.7 ttm180 -43.31 -158.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.467 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.623 ' CG ' ' HB2' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 227' ' ' ILE . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.523 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.692 HD11 ' NZ ' ' A' ' 234' ' ' LYS . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.63 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.692 ' NZ ' HD11 ' A' ' 232' ' ' ILE . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 233' ' ' LEU . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.59 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.41 ' O ' HG12 ' A' ' 246' ' ' ILE . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.641 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.589 ' CG2' HD13 ' A' ' 193' ' ' LEU . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.617 HD11 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.8 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.76 ' HA ' HD12 ' A' ' 270' ' ' ILE . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.8 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 267' ' ' GLU . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 278' ' ' THR . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 272' ' ' ALA . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 274' ' ' GLU . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.725 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.512 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.465 ' HB2' ' CE ' ' A' ' 276' ' ' MET . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.456 HG12 ' HE1' ' A' ' 189' ' ' TYR . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.14 144.45 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 93.74 40.9 4.55 Favored Glycine 0 C--N 1.32 -0.343 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.647 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 -39.75 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.709 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.9 109.31 53.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.422 2.082 . . . . 0.0 112.353 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.769 0.318 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.666 HD13 ' HD3' ' A' ' 184' ' ' LYS . 3.6 pp -89.05 128.51 51.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 3.1 Cg_exo -74.43 -70.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.581 2.187 . . . . 0.0 111.955 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 150.47 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.423 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.666 ' HD3' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.562 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.021 HD21 ' HB1' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 259' ' ' ALA . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.622 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.747 ' OD1' HD23 ' A' ' 193' ' ' LEU . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.863 ' N ' HD12 ' A' ' 191' ' ' LEU . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.747 HD23 ' OD1' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 209' ' ' VAL . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.5 -24.88 39.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 201' ' ' ALA . 0.4 OUTLIER -87.28 -37.02 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 200' ' ' LEU . . . 67.52 -71.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.255 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 27.6 p -57.38 118.43 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 -167.96 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.541 2.161 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 143.71 24.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.31 129.28 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.777 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 103.25 88.87 2.08 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.656 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -43.94 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 197' ' ' LEU . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 217' ' ' LEU . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.867 HD11 HG12 ' A' ' 213' ' ' VAL . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 215' ' ' GLU . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.491 ' CE1' HD22 ' A' ' 217' ' ' LEU . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.795 HG13 HG12 ' A' ' 261' ' ' VAL . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 232' ' ' ILE . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.428 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 246' ' ' ILE . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 189' ' ' TYR . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.683 ' OG1' HD21 ' A' ' 193' ' ' LEU . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.795 HG12 HG13 ' A' ' 230' ' ' VAL . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 227' ' ' ILE . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 184' ' ' LYS . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 267' ' ' GLU . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.678 ' O ' HG12 ' A' ' 277' ' ' ILE . 1.8 t-80 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 278' ' ' THR . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.521 ' HE3' ' HG2' ' A' ' 286' ' ' MET . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 274' ' ' GLU . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.521 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 1.021 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.412 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.798 HD12 HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.807 HD13 ' N ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -108.87 133.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.807 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 126.89 118.32 2.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.26 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -179.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 111.172 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.29 103.9 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.426 2.084 . . . . 0.0 112.343 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 139.2 34.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.19 -59.54 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.387 2.058 . . . . 0.0 112.597 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m -164.07 150.94 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.443 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.75 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.762 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.627 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.853 ' OD2' HG21 ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.624 ' N ' HD22 ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.944 HD13 HG21 ' A' ' 255' ' ' THR . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 209' ' ' VAL . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.601 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.25 -41.08 25.72 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -77.22 -37.11 54.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 111.065 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.71 162.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.2 p -134.69 104.16 10.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.89 -50.85 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.552 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -147.48 133.4 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 155.37 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.89 -69.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -94.3 68.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.604 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.61 -155.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.968 HG23 HD12 ' A' ' 197' ' ' LEU . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.437 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 197' ' ' LEU . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 213' ' ' VAL . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.675 ' HB3' HD11 ' A' ' 227' ' ' ILE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 261' ' ' VAL . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.645 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.702 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.702 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.645 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.563 ' CD ' HD22 ' A' ' 233' ' ' LEU . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 246' ' ' ILE . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.853 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.944 HG21 HD13 ' A' ' 193' ' ' LEU . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.412 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.458 HG12 HD12 ' A' ' 187' ' ' LEU . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.641 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 270' ' ' ILE . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.75 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.554 ' CD1' HG22 ' A' ' 266' ' ' VAL . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.62 ' ND1' HD13 ' A' ' 290' ' ' LEU . 19.1 t-160 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.447 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.522 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.447 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 291' ' ' ILE . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.638 HD12 HD12 ' A' ' 186' ' ' LEU . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 291' ' ' ILE . 1.2 mm -84.97 108.31 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -109.21 -179.39 21.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.714 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -46.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.84 162.3 46.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.587 2.191 . . . . 0.0 112.266 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.782 0.325 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.625 HD13 ' HD3' ' A' ' 184' ' ' LYS . 1.2 pp -84.5 126.85 67.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.41 -49.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.65 2.233 . . . . 0.0 112.707 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m -164.0 150.88 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.676 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.625 ' HD3' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.543 ' O ' HG22 ' A' ' 291' ' ' ILE . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.837 ' OD2' HD22 ' A' ' 193' ' ' LEU . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.837 HD22 ' OD2' ' A' ' 190' ' ' ASP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.594 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.23 -14.92 58.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.41 -35.65 13.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.55 110.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 33.9 p -134.61 101.06 12.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.29 -47.91 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.45 2.1 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 147.38 6.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -177.14 -50.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -177.55 102.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.634 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 58.48 74.07 0.39 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.107 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.628 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.8 ttm180 -43.93 -158.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.821 HG23 ' HG ' ' A' ' 191' ' ' LEU . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.69 HD21 ' CE2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 217' ' ' LEU . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.735 HG22 HG12 ' A' ' 261' ' ' VAL . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.609 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.768 ' HD2' HD11 ' A' ' 243' ' ' ILE . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.499 ' HB2' HD13 ' A' ' 243' ' ' ILE . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.768 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.661 HG21 HD13 ' A' ' 193' ' ' LEU . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 233' ' ' LEU . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 269' ' ' ALA . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.919 ' HA ' HD12 ' A' ' 270' ' ' ILE . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 263' ' ' PHE . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 267' ' ' GLU . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.731 ' CE1' HD13 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.731 HD13 ' CE1' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 186' ' ' LEU . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 185' ' ' MET . 5.3 tt -110.3 143.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.09 87.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 -56.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -130.34 149.2 72.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.511 2.14 . . . . 0.0 112.362 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.827 ' OD1' HD12 ' A' ' 181' ' ' LEU . 6.7 p30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.745 0.307 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.827 HD12 ' OD1' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -77.14 126.89 84.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.82 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.59 -54.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.419 2.08 . . . . 0.0 112.72 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m -164.24 150.91 11.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.555 ' O ' HG22 ' A' ' 291' ' ' ILE . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.062 HD21 ' HB1' ' A' ' 288' ' ' ALA . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.708 HD13 HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.938 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.676 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.676 ' N ' HD22 ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.9 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 191' ' ' LEU . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -75.18 -41.82 57.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.06 -37.27 61.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.379 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.32 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.063 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.525 HG21 ' CE ' ' A' ' 212' ' ' LYS . 10.5 p -80.35 147.49 64.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.57 -167.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.587 2.192 . . . . 0.0 112.27 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.67 152.5 18.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.97 -41.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -151.1 -67.78 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.614 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -135.72 129.45 5.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.44 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.614 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -48.03 -155.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.525 ' CE ' HG21 ' A' ' 202' ' ' THR . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.547 ' CG1' HD21 ' A' ' 197' ' ' LEU . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.583 HD12 ' CE ' ' A' ' 286' ' ' MET . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 218' ' ' LEU . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 275' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 261' ' ' VAL . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.696 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.715 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 232' ' ' ILE . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.724 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.522 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 233' ' ' LEU . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.643 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.78 HG13 ' HB3' ' A' ' 284' ' ' GLU . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 233' ' ' LEU . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 230' ' ' VAL . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.74 HG23 HD21 ' A' ' 290' ' ' LEU . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 266' ' ' VAL . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.667 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.489 ' HE1' HD21 ' A' ' 220' ' ' LEU . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.574 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.667 HD11 ' NE2' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.78 ' HB3' HG13 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.582 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 1.062 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 189' ' ' TYR . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 185' ' ' MET . 4.2 tt -117.95 141.79 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -130.34 84.51 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.559 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.91 138.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LYS . . . . . 0.464 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -164.19 -65.33 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 294' ' ' LYS . 61.0 Cg_endo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 122.331 2.02 . . . . 0.0 112.336 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.795 0.331 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.01 127.12 56.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.027 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.15 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.411 2.074 . . . . 0.0 112.323 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -136.65 149.83 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.673 ' HB2' HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.864 HD21 ' HB1' ' A' ' 288' ' ' ALA . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.736 ' HB3' HG11 ' A' ' 253' ' ' VAL . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.823 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 209' ' ' VAL . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.87 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG23 ' A' ' 209' ' ' VAL . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -75.82 -9.27 58.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 14.8 tp -114.07 -37.1 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.443 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 197' ' ' LEU . . . -55.6 117.37 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.47 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.9 t -118.41 144.44 35.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.01 121.39 8.02 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.515 2.144 . . . . 0.0 112.305 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.24 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -105.19 167.57 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.02 177.17 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.41 57.77 15.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.455 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -48.39 -155.17 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.784 HG23 HD23 ' A' ' 197' ' ' LEU . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.409 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 209' ' ' VAL . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.653 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.896 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.728 HG21 HG22 ' A' ' 230' ' ' VAL . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.728 HG22 HG21 ' A' ' 227' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.58 HG22 ' CB ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.501 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 246' ' ' ILE . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.884 HG21 ' SG ' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.486 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.736 HG11 ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.482 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 192' ' ' TYR . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.884 ' SG ' HG21 ' A' ' 243' ' ' ILE . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.709 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.501 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 270' ' ' ILE . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.501 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 266' ' ' VAL . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.746 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.896 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.751 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.741 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.636 ' HB2' HG12 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.673 ' HG3' HG22 ' A' ' 277' ' ' ILE . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.864 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.433 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 289' ' ' VAL . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.544 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.95 114.98 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.411 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 133.67 51.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.4 ttm -108.68 -178.43 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -139.44 148.88 58.23 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.572 2.181 . . . . 0.0 112.278 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.706 0.288 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.739 HD13 ' HD3' ' A' ' 184' ' ' LYS . 0.7 OUTLIER -83.41 136.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.94 -54.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.482 2.122 . . . . 0.0 112.652 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -164.05 150.59 11.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.735 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.739 ' HD3' HD13 ' A' ' 181' ' ' LEU . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.844 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.69 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.873 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.623 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.881 ' OD2' HG21 ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.862 ' HA ' HD22 ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 255' ' ' THR . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.686 ' HE2' HD13 ' A' ' 200' ' ' LEU . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.014 HD11 HG13 ' A' ' 209' ' ' VAL . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.78 -39.74 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.686 HD13 ' HE2' ' A' ' 196' ' ' LYS . 2.1 tt -92.47 -28.7 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.588 0.233 . . . . 0.0 111.486 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.56 -176.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.511 HG22 ' HE2' ' A' ' 212' ' ' LYS . 25.6 p -122.12 131.35 24.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.954 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.19 -167.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.355 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -67.67 113.07 5.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -175.48 147.77 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 132.82 46.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.772 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 93.96 62.41 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.275 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -47.28 -155.56 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 197' ' ' LEU . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.417 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.511 ' HE2' HG22 ' A' ' 202' ' ' THR . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 209' ' ' VAL . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' MET . . . . . 0.475 ' N ' HG23 ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.699 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.699 ' CZ ' HD23 ' A' ' 217' ' ' LEU . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.788 HG23 ' CE1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.842 HG22 HG12 ' A' ' 261' ' ' VAL . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.772 HG22 ' HB1' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.726 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.726 HD23 ' CD1' ' A' ' 233' ' ' LEU . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.881 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.72 HG21 HD13 ' A' ' 193' ' ' LEU . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.873 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.423 HG12 HD12 ' A' ' 187' ' ' LEU . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 230' ' ' VAL . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.788 ' CE1' HG23 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.413 ' CG1' ' HE2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.753 ' HA ' HD12 ' A' ' 270' ' ' ILE . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.844 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 267' ' ' GLU . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.799 ' CE1' HD13 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.549 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.799 HD13 ' CE1' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.571 ' SD ' HD23 ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.623 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 187' ' ' LEU . 3.3 mm -81.6 127.84 39.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.62 -154.8 25.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.559 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -72.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -150.28 148.72 25.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.521 2.148 . . . . 0.0 112.287 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 16.7 mt -89.0 127.69 54.74 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 19.9 Cg_exo -64.0 -59.74 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.308 2.005 . . . . 0.0 111.544 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m -158.0 150.51 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.165 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 266' ' ' VAL . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.494 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.831 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.791 ' O ' HD13 ' A' ' 191' ' ' LEU . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.807 ' CB ' HG11 ' A' ' 253' ' ' VAL . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.658 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.711 ' HG ' HG23 ' A' ' 209' ' ' VAL . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -76.18 -39.09 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.03 -30.41 16.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.46 114.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 204' ' ' GLN . 3.1 m -79.1 110.64 15.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.049 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 202' ' ' THR . 8.6 Cg_exo -71.86 61.74 3.07 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.642 2.228 . . . . 0.0 112.119 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.61 ' HG3' HG22 ' A' ' 202' ' ' THR . 31.4 mt-30 -96.86 156.0 16.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.83 31.05 4.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -148.62 -47.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -139.1 84.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.189 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.578 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.1 mtp-105 -48.71 -155.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.699 0.4 . . . . 0.0 111.838 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.711 HG23 ' HG ' ' A' ' 197' ' ' LEU . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . 0.484 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 209' ' ' VAL . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' HIS . . . . . 0.408 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.538 HD23 ' CE2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 219' ' ' LYS . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.611 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.556 HG23 ' CE2' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 261' ' ' VAL . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.76 HG22 ' HB1' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.71 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.807 HG11 ' CB ' ' A' ' 190' ' ' ASP . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.716 HG22 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.831 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CE2' HG23 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 290' ' ' LEU . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.907 ' HA ' HD12 ' A' ' 270' ' ' ILE . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 267' ' ' GLU . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.611 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.56 ' HB3' HD11 ' A' ' 186' ' ' LEU . 5.3 p-80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 275' ' ' PHE . . . . . 0.419 ' HA ' HG22 ' A' ' 278' ' ' THR . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' MET . . . . . 0.659 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 287' ' ' LYS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 253' ' ' VAL . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.702 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 185' ' ' MET . 3.1 tt -105.8 143.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.18 84.77 0.37 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.9 tpp -144.89 153.21 41.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -71.05 142.61 87.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.764 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.832 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 253' ' ' VAL . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.503 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.729 HD22 ' HG3' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.855 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.592 ' C ' HD13 ' A' ' 197' ' ' LEU . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 210' ' ' GLN . 2.6 ptp180 . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 213' ' ' VAL . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 208' ' ' ARG . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 209' ' ' VAL . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.477 ' N ' HG13 ' A' ' 213' ' ' VAL . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 220' ' ' LEU . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.709 HG22 HG21 ' A' ' 227' ' ' ILE . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.684 HG22 ' CB ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.661 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.506 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.661 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 246' ' ' ILE . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.522 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.591 HG13 ' HE3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.503 ' CG2' HD12 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.707 ' HB3' HG21 ' A' ' 243' ' ' ILE . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.832 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 227' ' ' ILE . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.781 HG22 HG23 ' A' ' 270' ' ' ILE . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 271' ' ' LYS . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.834 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.771 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.729 ' HG3' HD22 ' A' ' 193' ' ' LEU . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.591 ' HE3' HG13 ' A' ' 253' ' ' VAL . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.426 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 186' ' ' LEU . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.764 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.535 ' O ' HG22 ' A' ' 291' ' ' ILE . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.624 HD13 ' HB1' ' A' ' 269' ' ' ALA . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.891 HG13 HD12 ' A' ' 191' ' ' LEU . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.583 ' HB2' HG11 ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 1.047 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.901 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.887 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 197' ' ' LEU . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.469 ' HE ' HG12 ' A' ' 209' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.815 HG21 ' HB2' ' A' ' 192' ' ' TYR . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 191' ' ' LEU . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.509 ' HE1' HG23 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.775 HD13 ' O ' ' A' ' 213' ' ' VAL . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 227' ' ' ILE . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 261' ' ' VAL . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 232' ' ' ILE . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 243' ' ' ILE . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.512 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 239' ' ' LEU . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 237' ' ' ARG . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.575 ' CD ' HD22 ' A' ' 233' ' ' LEU . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.855 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 243' ' ' ILE . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.73 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 190' ' ' ASP . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 230' ' ' VAL . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 263' ' ' PHE . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.707 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.549 ' CE1' HD13 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.699 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.549 HD13 ' CE1' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.432 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.919 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.699 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.479 HG22 ' HE1' ' A' ' 189' ' ' TYR . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 186' ' ' LEU . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 185' ' ' MET . 5.6 tt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.87 0.366 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 186' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.692 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.542 ' HB2' HG11 ' A' ' 253' ' ' VAL . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 192' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.851 ' N ' HD12 ' A' ' 191' ' ' LEU . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 255' ' ' THR . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.966 HD21 HG13 ' A' ' 209' ' ' VAL . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.423 ' HG3' ' CG ' ' A' ' 210' ' ' GLN . 1.9 ptt-85 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.966 HG13 HD21 ' A' ' 197' ' ' LEU . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.423 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.401 ' O ' ' CD2' ' A' ' 216' ' ' HIS . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.766 ' O ' HD13 ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.507 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 212' ' ' LYS . 31.6 m-70 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' A' ' 275' ' ' PHE . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.718 ' HB2' HD11 ' A' ' 227' ' ' ILE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 261' ' ' VAL . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.934 HD21 HD12 ' A' ' 243' ' ' ILE . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.622 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.622 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.611 HD23 ' CD1' ' A' ' 233' ' ' LEU . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.834 ' HD2' HD22 ' A' ' 233' ' ' LEU . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.934 HD12 HD21 ' A' ' 233' ' ' LEU . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.834 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.629 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 186' ' ' LEU . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.631 HG13 HG22 ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.682 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' A' ' 220' ' ' LEU . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.682 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.585 ' HG2' ' HE1' ' A' ' 276' ' ' MET . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.692 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.738 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 266' ' ' VAL . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 185' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.522 ' HG2' HG11 ' A' ' 266' ' ' VAL . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.605 ' SD ' HG21 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.649 HD11 ' ND1' ' A' ' 273' ' ' HIS . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 291' ' ' ILE . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 289' ' ' VAL . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.918 ' HB2' HG21 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 192' ' ' TYR . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.409 ' N ' HD13 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.918 HG21 ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 209' ' ' VAL . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.636 ' O ' HG23 ' A' ' 223' ' ' THR . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.786 ' CB ' HD11 ' A' ' 227' ' ' ILE . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 219' ' ' LYS . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.479 ' CZ ' HD23 ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.786 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 1.1 HG22 HG12 ' A' ' 261' ' ' VAL . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.636 HG22 ' CB ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 233' ' ' LEU . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.437 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 233' ' ' LEU . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 233' ' ' LEU . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.488 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.681 ' HB2' HG22 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 259' ' ' ALA . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 230' ' ' VAL . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.703 ' CD1' HG23 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 270' ' ' ILE . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 266' ' ' VAL . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.505 ' N ' HG23 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.649 ' ND1' HD11 ' A' ' 186' ' ' LEU . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.649 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.649 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.744 HG23 ' CE1' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 290' ' ' LEU . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 187' ' ' LEU . 5.1 mm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.51 ' HE3' HG11 ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.709 HD22 ' HB1' ' A' ' 288' ' ' ALA . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 291' ' ' ILE . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.934 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.708 ' OD2' HG12 ' A' ' 253' ' ' VAL . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.7 ' N ' HD13 ' A' ' 191' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 193' ' ' LEU . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . 0.46 ' HB3' HD13 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 194' ' ' SER . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 120.733 0.301 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 209' ' ' VAL . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 ' SD ' ' A' ' 286' ' ' MET . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' VAL . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 222' ' ' GLY . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.941 HG21 HG22 ' A' ' 230' ' ' VAL . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.941 HG22 HG21 ' A' ' 227' ' ' ILE . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.577 HG13 ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.837 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 234' ' ' LYS . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.837 HD23 ' CD1' ' A' ' 233' ' ' LEU . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 291' ' ' ILE . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.704 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.409 ' CD ' ' HB3' ' A' ' 239' ' ' LEU . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.7 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.563 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.708 HG12 ' OD2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.415 HG23 ' OE1' ' A' ' 257' ' ' GLU . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 7.3 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' A' ' 255' ' ' THR . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.684 HD11 HD21 ' A' ' 233' ' ' LEU . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 230' ' ' VAL . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 227' ' ' ILE . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 270' ' ' ILE . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 266' ' ' VAL . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.63 ' ND1' HD12 ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.63 HD12 ' ND1' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.456 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 217' ' ' LEU . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.709 ' HB1' HD22 ' A' ' 186' ' ' LEU . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 187' ' ' LEU . 22.9 mm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.835 0.35 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.421 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.438 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 290' ' ' LEU . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.773 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CE1' HG23 ' A' ' 289' ' ' VAL . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.586 ' CG ' HG22 ' A' ' 255' ' ' THR . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.713 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.743 ' CD2' HG13 ' A' ' 209' ' ' VAL . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.685 HG12 HD13 ' A' ' 217' ' ' LEU . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 213' ' ' VAL . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 220' ' ' LEU . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 219' ' ' LYS . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.76 ' CB ' HD11 ' A' ' 227' ' ' ILE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.76 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.889 HG22 HG12 ' A' ' 261' ' ' VAL . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.759 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.759 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.586 HG22 ' CG ' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.477 HE22 HD11 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 243' ' ' ILE . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.773 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.889 HG12 HG22 ' A' ' 230' ' ' VAL . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.607 ' CE1' HG23 ' A' ' 227' ' ' ILE . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.904 ' HA ' HD12 ' A' ' 270' ' ' ILE . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 267' ' ' GLU . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.606 ' NE2' HD11 ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.463 ' HE3' ' HG3' ' A' ' 286' ' ' MET . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.606 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 281' ' ' GLN . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 278' ' ' THR . 2.1 tm0? -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.599 ' CB ' HD21 ' A' ' 186' ' ' LEU . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.735 HG23 ' CE1' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 185' ' ' MET . 5.5 tt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m . . . . . 0 CA--C 1.52 -0.199 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.548 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.876 HD21 ' HB1' ' A' ' 288' ' ' ALA . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.906 HD23 HD11 ' A' ' 291' ' ' ILE . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.856 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.707 ' OD2' HG21 ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.724 ' N ' HD22 ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' LEU . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.911 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 213' ' ' VAL . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.487 HG21 ' HE2' ' A' ' 192' ' ' TYR . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.421 ' HG2' HD11 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.751 HG12 HD11 ' A' ' 217' ' ' LEU . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.607 ' HA ' HD12 ' A' ' 217' ' ' LEU . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.751 HD11 HG12 ' A' ' 213' ' ' VAL . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.93 ' HB2' HD11 ' A' ' 227' ' ' ILE . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 261' ' ' VAL . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.483 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.707 HG21 ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.605 HG23 ' OD1' ' A' ' 190' ' ' ASP . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.56 ' HG2' HD21 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.648 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.581 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.991 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.595 ' HE1' HD23 ' A' ' 217' ' ' LEU . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.709 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.991 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.856 HG23 ' CE1' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' ' 289' ' ' VAL . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.906 HD11 HD23 ' A' ' 187' ' ' LEU . 8.9 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.441 ' HB3' HG22 ' A' ' 266' ' ' VAL . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.772 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.566 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.64 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 209' ' ' VAL . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.505 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.675 ' CD2' HD21 ' A' ' 217' ' ' LEU . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.804 ' CG2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 227' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.488 HD22 ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . 0.49 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 237' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.767 ' HD2' HD11 ' A' ' 243' ' ' ILE . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.767 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 191' ' ' LEU . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.42 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.772 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 227' ' ' ILE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.743 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 277' ' ' ILE . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.433 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 1.4 p30 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.703 ' CD2' HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 266' ' ' VAL . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.944 HD21 ' HB1' ' A' ' 288' ' ' ALA . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 291' ' ' ILE . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.806 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.61 ' OD2' HD22 ' A' ' 193' ' ' LEU . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.628 ' H ' HD22 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.61 HD22 ' OD2' ' A' ' 190' ' ' ASP . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.63 HD11 HG22 ' A' ' 209' ' ' VAL . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 209' ' ' VAL . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 213' ' ' VAL . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.404 ' HD3' HD22 ' A' ' 197' ' ' LEU . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.464 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 214' ' ' MET . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 219' ' ' LYS . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 230' ' ' VAL . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.932 HG13 HG12 ' A' ' 261' ' ' VAL . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 260' ' ' ILE . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 232' ' ' ILE . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.762 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.762 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 246' ' ' ILE . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.705 ' OG ' HG22 ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.4 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.533 HD11 HD11 ' A' ' 243' ' ' ILE . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 230' ' ' VAL . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.765 ' CD1' HG23 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 184' ' ' LYS . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 267' ' ' GLU . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.918 ' O ' HD12 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.457 ' HA ' ' CD1' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.579 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.477 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.572 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.806 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.944 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.629 HG12 ' HE1' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.609 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.812 0.339 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.553 ' HG2' HG21 ' A' ' 266' ' ' VAL . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.674 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.681 ' HB2' HG11 ' A' ' 253' ' ' VAL . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.752 ' HE1' HG21 ' A' ' 209' ' ' VAL . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.637 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.453 HD21 HG13 ' A' ' 209' ' ' VAL . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 192' ' ' TYR . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.644 HG22 HD13 ' A' ' 217' ' ' LEU . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.487 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' THR . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.706 ' HB2' HD11 ' A' ' 227' ' ' ILE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' LYS . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 272' ' ' ALA . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 227' ' ' ILE . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.772 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.663 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.772 HD23 ' CD1' ' A' ' 233' ' ' LEU . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.523 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 246' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.576 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.571 HG21 ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.757 ' CB ' HG22 ' A' ' 188' ' ' VAL . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.85 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CZ ' HG11 ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.529 ' HB3' ' HG3' ' A' ' 267' ' ' GLU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.668 ' CG2' HD21 ' A' ' 290' ' ' LEU . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.893 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 267' ' ' GLU . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.602 ' NE2' HD11 ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' HG22 ' A' ' 278' ' ' THR . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.587 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.602 HD11 ' NE2' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 274' ' ' GLU . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' THR . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 285' ' ' ASN . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.587 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.649 HG12 ' HG ' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.668 HD21 ' CG2' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 246' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m . . . . . 0 CA--C 1.516 -0.335 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.689 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.688 HD11 ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.799 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.926 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.846 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.926 HD13 ' HA ' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 3.5 ttp-105 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 213' ' ' VAL . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.449 ' CG ' HD11 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.585 HD11 ' HE3' ' A' ' 286' ' ' MET . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.585 HD21 ' HE2' ' A' ' 275' ' ' PHE . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.84 ' CB ' HD11 ' A' ' 227' ' ' ILE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.737 ' CG2' HG21 ' A' ' 227' ' ' ILE . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.752 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.78 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.632 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.599 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.688 ' CG2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.52 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.548 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.799 HG21 ' HD2' ' A' ' 189' ' ' TYR . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.58 HD13 ' C ' ' A' ' 259' ' ' ALA . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 ' CG2' ' A' ' 227' ' ' ILE . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 266' ' ' VAL . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.825 ' CD2' HD12 ' A' ' 277' ' ' ILE . 1.6 p-80 -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.578 ' N ' ' CD2' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.585 ' HE2' HD21 ' A' ' 220' ' ' LEU . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.459 ' HE1' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.825 HD12 ' CD2' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.585 ' HE3' HD11 ' A' ' 217' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 253' ' ' VAL . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 187' ' ' LEU . 35.9 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 1.057 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.0 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.505 ' O ' HD12 ' A' ' 197' ' ' LEU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.843 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 192' ' ' TYR . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 210' ' ' GLN . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.741 HG11 HD23 ' A' ' 191' ' ' LEU . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.874 ' HA ' HD12 ' A' ' 218' ' ' LEU . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 221' ' ' PHE . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' A' ' 215' ' ' GLU . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.552 ' HE1' HD22 ' A' ' 217' ' ' LEU . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.798 HG21 HG22 ' A' ' 230' ' ' VAL . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.798 HG22 HG21 ' A' ' 227' ' ' ILE . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.693 HG22 ' HB1' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.79 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.79 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.474 ' CD ' HD22 ' A' ' 233' ' ' LEU . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.826 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.649 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.748 ' HE2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.417 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.441 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 1.0 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 230' ' ' VAL . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.873 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 267' ' ' GLU . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.543 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 272' ' ' ALA . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.92 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 276' ' ' MET . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.438 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.509 ' HE2' HD12 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 1.057 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 266' ' ' VAL . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' A' ' 185' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.72 0.295 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.472 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.405 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 291' ' ' ILE . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.95 HG22 ' HB3' ' A' ' 259' ' ' ALA . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.499 ' CB ' HG11 ' A' ' 253' ' ' VAL . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.816 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.816 HD13 ' HA ' ' A' ' 192' ' ' TYR . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.467 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.623 ' CG ' ' HB2' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 227' ' ' ILE . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.523 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.692 HD11 ' NZ ' ' A' ' 234' ' ' LYS . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.63 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.692 ' NZ ' HD11 ' A' ' 232' ' ' ILE . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 233' ' ' LEU . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.59 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.41 ' O ' HG12 ' A' ' 246' ' ' ILE . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.641 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.589 ' CG2' HD13 ' A' ' 193' ' ' LEU . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.617 HD11 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.8 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.76 ' HA ' HD12 ' A' ' 270' ' ' ILE . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.8 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 267' ' ' GLU . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 278' ' ' THR . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 272' ' ' ALA . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 274' ' ' GLU . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.725 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.512 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.465 ' HB2' ' CE ' ' A' ' 276' ' ' MET . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.456 HG12 ' HE1' ' A' ' 189' ' ' TYR . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 187' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.712 0.292 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.562 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 1.021 HD21 ' HB1' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 259' ' ' ALA . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.622 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.747 ' OD1' HD23 ' A' ' 193' ' ' LEU . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.863 ' N ' HD12 ' A' ' 191' ' ' LEU . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.747 HD23 ' OD1' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 209' ' ' VAL . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 197' ' ' LEU . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 217' ' ' LEU . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.867 HD11 HG12 ' A' ' 213' ' ' VAL . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 215' ' ' GLU . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.491 ' CE1' HD22 ' A' ' 217' ' ' LEU . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.795 HG13 HG12 ' A' ' 261' ' ' VAL . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 232' ' ' ILE . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.428 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 246' ' ' ILE . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 189' ' ' TYR . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.683 ' OG1' HD21 ' A' ' 193' ' ' LEU . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.795 HG12 HG13 ' A' ' 230' ' ' VAL . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 227' ' ' ILE . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 184' ' ' LYS . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 267' ' ' GLU . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.678 ' O ' HG12 ' A' ' 277' ' ' ILE . 2.3 t-160 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 278' ' ' THR . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.521 ' HE3' ' HG2' ' A' ' 286' ' ' MET . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 274' ' ' GLU . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.521 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 1.021 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.445 ' HA ' ' CE1' ' A' ' 273' ' ' HIS . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.798 HD12 HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.644 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.443 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.75 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.762 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.627 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.853 ' OD2' HG21 ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.624 ' N ' HD22 ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.944 HD13 HG21 ' A' ' 255' ' ' THR . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 209' ' ' VAL . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.601 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.968 HG23 HD12 ' A' ' 197' ' ' LEU . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 197' ' ' LEU . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 213' ' ' VAL . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.675 ' HB3' HD11 ' A' ' 227' ' ' ILE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 261' ' ' VAL . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.645 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.702 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.702 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.645 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.563 ' CD ' HD22 ' A' ' 233' ' ' LEU . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 246' ' ' ILE . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.853 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.944 HG21 HD13 ' A' ' 193' ' ' LEU . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.412 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.458 HG12 HD12 ' A' ' 187' ' ' LEU . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.641 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 270' ' ' ILE . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.75 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.554 ' CD1' HG22 ' A' ' 266' ' ' VAL . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.82 ' CD2' HD13 ' A' ' 290' ' ' LEU . 2.3 t60 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.447 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.522 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.447 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 291' ' ' ILE . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.82 HD13 ' CD2' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 291' ' ' ILE . 1.2 mm . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.77 0.319 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.543 ' O ' HG22 ' A' ' 291' ' ' ILE . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.837 ' OD2' HD22 ' A' ' 193' ' ' LEU . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.837 HD22 ' OD2' ' A' ' 190' ' ' ASP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.594 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.821 HG23 ' HG ' ' A' ' 191' ' ' LEU . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.69 HD21 ' CE2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 217' ' ' LEU . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.735 HG22 HG12 ' A' ' 261' ' ' VAL . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.609 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.768 ' HD2' HD11 ' A' ' 243' ' ' ILE . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.499 ' HB2' HD13 ' A' ' 243' ' ' ILE . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.768 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.661 HG21 HD13 ' A' ' 193' ' ' LEU . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 233' ' ' LEU . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 269' ' ' ALA . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.919 ' HA ' HD12 ' A' ' 270' ' ' ILE . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 263' ' ' PHE . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 267' ' ' GLU . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.731 ' CE1' HD13 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.731 HD13 ' CE1' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 186' ' ' LEU . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 185' ' ' MET . 5.3 tt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.555 ' O ' HG22 ' A' ' 291' ' ' ILE . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 1.062 HD21 ' HB1' ' A' ' 288' ' ' ALA . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.708 HD13 HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.938 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.676 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.676 ' N ' HD22 ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.9 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 191' ' ' LEU . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.547 ' CG1' HD21 ' A' ' 197' ' ' LEU . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.583 HD12 ' CE ' ' A' ' 286' ' ' MET . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 218' ' ' LEU . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 275' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 261' ' ' VAL . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.696 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.715 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 232' ' ' ILE . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.724 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.522 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 233' ' ' LEU . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.643 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.78 HG13 ' HB3' ' A' ' 284' ' ' GLU . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 233' ' ' LEU . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 230' ' ' VAL . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.74 HG23 HD21 ' A' ' 290' ' ' LEU . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 266' ' ' VAL . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.667 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.489 ' HE1' HD21 ' A' ' 220' ' ' LEU . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.574 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.667 HD11 ' NE2' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.78 ' HB3' HG13 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.582 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 1.062 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 189' ' ' TYR . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 185' ' ' MET . 4.2 tt . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.673 ' HB2' HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.864 HD21 ' HB1' ' A' ' 288' ' ' ALA . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.736 ' HB3' HG11 ' A' ' 253' ' ' VAL . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.823 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 209' ' ' VAL . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.87 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG23 ' A' ' 209' ' ' VAL . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.784 HG23 HD23 ' A' ' 197' ' ' LEU . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 209' ' ' VAL . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.653 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.896 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.728 HG21 HG22 ' A' ' 230' ' ' VAL . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.728 HG22 HG21 ' A' ' 227' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.58 HG22 ' CB ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.501 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 246' ' ' ILE . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.884 HG21 ' SG ' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.486 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.736 HG11 ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.482 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 192' ' ' TYR . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.884 ' SG ' HG21 ' A' ' 243' ' ' ILE . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.709 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.501 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 270' ' ' ILE . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.501 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 266' ' ' VAL . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.746 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.896 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.751 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.741 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.636 ' HB2' HG12 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.673 ' HG3' HG22 ' A' ' 277' ' ' ILE . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.864 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.433 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 289' ' ' VAL . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.544 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.413 ' HE2' ' CG1' ' A' ' 266' ' ' VAL . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.844 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.69 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.873 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.623 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.881 ' OD2' HG21 ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.862 ' HA ' HD22 ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 255' ' ' THR . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.014 HD11 HG13 ' A' ' 209' ' ' VAL . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 197' ' ' LEU . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 209' ' ' VAL . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . 0.475 ' N ' HG23 ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.699 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.699 ' CZ ' HD23 ' A' ' 217' ' ' LEU . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.788 HG23 ' CE1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.842 HG22 HG12 ' A' ' 261' ' ' VAL . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.772 HG22 ' HB1' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.726 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.726 HD23 ' CD1' ' A' ' 233' ' ' LEU . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.881 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.72 HG21 HD13 ' A' ' 193' ' ' LEU . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.873 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.423 HG12 HD12 ' A' ' 187' ' ' LEU . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 230' ' ' VAL . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.788 ' CE1' HG23 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.413 ' CG1' ' HE2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.753 ' HA ' HD12 ' A' ' 270' ' ' ILE . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.844 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 267' ' ' GLU . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.799 ' CE1' HD13 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.549 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.799 HD13 ' CE1' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.571 ' SD ' HD23 ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.623 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 187' ' ' LEU . 3.3 mm . . . . . 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 266' ' ' VAL . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.494 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.831 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.791 ' O ' HD13 ' A' ' 191' ' ' LEU . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.807 ' CB ' HG11 ' A' ' 253' ' ' VAL . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.658 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.711 ' HG ' HG23 ' A' ' 209' ' ' VAL . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 7.1 mtp-105 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.935 0.398 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.711 HG23 ' HG ' ' A' ' 197' ' ' LEU . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 209' ' ' VAL . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' HIS . . . . . 0.408 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.538 HD23 ' CE2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 219' ' ' LYS . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.611 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.556 HG23 ' CE2' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 261' ' ' VAL . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.76 HG22 ' HB1' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.71 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.807 HG11 ' CB ' ' A' ' 190' ' ' ASP . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.716 HG22 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.831 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CE2' HG23 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 290' ' ' LEU . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.907 ' HA ' HD12 ' A' ' 270' ' ' ILE . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 267' ' ' GLU . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.611 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.56 ' HB3' HD11 ' A' ' 186' ' ' LEU . 1.7 p80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' PHE . . . . . 0.419 ' HA ' HG22 ' A' ' 278' ' ' THR . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' MET . . . . . 0.659 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 287' ' ' LYS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 253' ' ' VAL . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.702 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 185' ' ' MET . 3.1 tt . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.836 0.351 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.489 HD13 ' HE2' ' A' ' 184' ' ' LYS . 1.1 pp -89.04 137.42 29.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.06 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -43.62 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.584 2.189 . . . . 0.0 112.41 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 72.4 m -157.39 150.71 23.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.229 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -162.1 72.76 0.38 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.108 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 22.0 ttp -127.22 155.58 43.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.029 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.1 tt -134.35 141.61 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.764 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -116.08 147.25 41.49 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.832 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -110.07 170.59 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 287' ' ' LYS . 0.1 OUTLIER -166.86 154.03 9.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.546 ' HB2' HG11 ' A' ' 253' ' ' VAL . 12.1 t0 52.47 53.23 12.64 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 111.798 -2.455 . . . . 0.0 113.786 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.18 -29.09 13.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.434 178.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.503 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.18 -11.78 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.729 HD22 ' HG3' ' A' ' 284' ' ' GLU . 0.2 OUTLIER -80.52 10.91 4.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.02 138.61 79.32 Favored Pre-proline 0 N--CA 1.452 -0.341 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.855 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.6 Cg_endo -53.01 -23.95 23.28 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.316 2.011 . . . . 0.0 112.044 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -36.93 51.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.848 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.592 ' C ' HD13 ' A' ' 197' ' ' LEU . 3.4 tm? -85.18 -49.45 8.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -90.91 -40.58 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -76.27 -41.56 48.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.984 -0.287 . . . . 0.0 111.716 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.04 -37.15 20.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.712 0.291 . . . . 0.0 111.32 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 55.56 99.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.064 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 5.6 m -111.51 99.62 44.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.64 121.51 7.46 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.488 2.125 . . . . 0.0 112.236 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.49 152.34 28.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.969 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -75.72 -28.17 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -70.23 -77.24 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -148.1 140.01 8.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.653 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.574 ' O ' ' O ' ' A' ' 207' ' ' GLY . 2.6 ptp180 -49.21 -154.77 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.898 0.38 . . . . 0.0 111.765 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 213' ' ' VAL . 41.5 t -40.67 -28.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 208' ' ' ARG . 1.9 pt20 -62.31 -43.0 99.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.692 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.42 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -75.31 -46.64 32.12 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 111.52 -179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -54.92 -47.66 74.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.782 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 209' ' ' VAL . 13.0 p -74.51 -44.29 47.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.477 ' N ' HG13 ' A' ' 213' ' ' VAL . 11.4 tpp -58.23 -45.96 86.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.812 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.54 -53.91 16.7 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -56.04 -34.56 66.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.618 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.485 ' HG ' ' CE1' ' A' ' 221' ' ' PHE . 6.0 mp -71.84 -30.59 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 tp -52.29 -57.02 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.535 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -66.72 -48.58 68.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.774 0.321 . . . . 0.0 110.973 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.795 ' O ' HD13 ' A' ' 220' ' ' LEU . 1.7 tm? -58.14 -30.18 66.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 3.6 m-85 -88.57 -39.07 14.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.049 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.49 -28.88 71.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.524 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.2 t -65.43 -45.62 83.17 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.914 -0.168 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.0 p90 -94.6 -18.52 21.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.563 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 171.54 110.71 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.644 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.4 t -54.8 147.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.713 0.292 . . . . 0.0 111.057 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.709 HG21 HG22 ' A' ' 230' ' ' VAL . 0.9 OUTLIER -101.0 135.67 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.078 0.466 . . . . 0.0 110.96 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.6 OUTLIER -79.63 -33.45 41.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -167.22 143.82 4.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.732 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.709 HG22 HG21 ' A' ' 227' ' ' ILE . 27.8 t -128.61 107.48 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.992 0.425 . . . . 0.0 110.297 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.92 107.63 18.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.393 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.684 HG22 ' CB ' ' A' ' 259' ' ' ALA . 16.9 pt -103.93 131.31 52.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.486 0.66 . . . . 0.0 112.582 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.661 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.46 110.22 13.65 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.556 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -80.69 166.41 39.55 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.01 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 19.6 Cg_endo -61.54 163.82 17.15 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.354 2.036 . . . . 0.0 113.452 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 28.23 49.98 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.412 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.37 -85.32 0.31 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.458 0.629 . . . . 0.0 112.124 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.506 ' O ' HD13 ' A' ' 233' ' ' LEU . 8.5 mt-10 -132.69 101.77 5.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.38 0.133 . . . . 0.0 111.143 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.661 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.9 mt -112.44 94.73 28.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.666 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 31.3 Cg_exo -58.92 153.97 47.55 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.063 2.508 . . . . 0.0 112.437 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 6.5 Cg_endo -48.48 -29.77 14.44 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.226 2.618 . . . . 0.0 113.107 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 246' ' ' ILE . 2.0 m-20 -69.16 -37.04 78.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -100.92 -40.54 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 24.2 ptt180 -53.5 -35.56 60.76 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.948 -0.47 . . . . 0.0 110.735 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -46.01 11.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.967 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 243' ' ' ILE . 8.5 tt -84.23 -45.03 18.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 243' ' ' ILE . 6.2 t -59.13 -47.32 85.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.451 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.9 t -75.89 -2.24 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.817 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -90.73 -40.58 11.76 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.522 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 7.5 p90 -92.33 39.09 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.53 118.17 2.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.667 0.27 . . . . 0.0 110.639 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.47 -26.37 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.591 HG13 ' HE3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -75.79 17.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 55.88 7.49 1.68 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.502 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.503 ' CG2' HD12 ' A' ' 193' ' ' LEU . 6.0 t -167.47 136.87 2.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -104.58 96.16 6.4 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.376 -0.529 . . . . 0.0 111.103 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -123.59 123.8 41.38 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.707 ' HB3' HG21 ' A' ' 243' ' ' ILE . 2.3 m -114.09 146.12 40.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.258 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.832 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -144.48 141.5 29.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.07 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 231' ' ' ARG . 6.0 mt -116.35 113.2 42.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.19 0.519 . . . . 0.0 111.417 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 1.4 m -108.31 143.65 18.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.145 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 228' ' ' SER . 34.9 mt-10 -127.79 100.75 6.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 227' ' ' ILE . 12.5 m-85 -95.59 -179.75 4.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.946 0.403 . . . . 0.0 111.061 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -36.6 84.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.984 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -164.44 162.47 22.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.168 0.509 . . . . 0.0 111.706 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.781 HG22 HG23 ' A' ' 270' ' ' ILE . 14.3 p -65.25 -22.81 31.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.389 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 270' ' ' ILE . 1.0 OUTLIER -58.36 -50.82 72.29 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -56.87 -60.47 3.52 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.54 -45.46 63.0 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 271' ' ' LYS . 2.8 pp -56.72 -29.91 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.039 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.834 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -72.47 -35.4 68.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 0.0 110.257 179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.851 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.35 -32.99 22.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.136 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.636 ' O ' HG12 ' A' ' 277' ' ' ILE . 18.4 t-80 -52.29 -56.36 15.31 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 278' ' ' THR . 0.0 OUTLIER -60.91 -49.33 77.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.345 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -56.93 -32.53 66.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.927 0.394 . . . . 0.0 110.414 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.771 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -75.84 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.217 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 273' ' ' HIS . 25.4 pt -70.95 -32.77 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 274' ' ' GLU . 75.9 p -67.75 -45.68 74.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.747 0.308 . . . . 0.0 110.997 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -32.84 62.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 110.235 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 286' ' ' MET . 9.8 p -92.29 12.6 21.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.808 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -68.6 143.25 54.92 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.271 0.558 . . . . 0.0 112.026 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.53 -36.08 1.17 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.725 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -103.98 146.83 28.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.017 0.409 . . . . 0.0 110.952 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.729 ' HG3' HD22 ' A' ' 193' ' ' LEU . 5.8 pt-20 -75.82 76.8 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.753 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' CG ' ' A' ' 287' ' ' LYS . 13.7 m120 -133.34 -178.94 5.21 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.569 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 34.4 mtp -30.23 126.1 0.15 Allowed 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.591 ' HE3' HG13 ' A' ' 253' ' ' VAL . 4.0 mttt -143.17 167.93 20.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.045 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 1.029 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -152.46 146.24 25.12 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 111.368 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.426 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 11.5 p -140.91 134.64 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 186' ' ' LEU . 12.2 mt -65.89 118.87 10.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.764 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -118.11 119.82 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.699 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.5 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 172.95 80.23 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.609 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 3.9 tpp -113.68 174.74 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 110.755 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -77.32 132.35 70.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.394 2.063 . . . . 0.0 112.264 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -89.03 144.15 32.3 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.88 -45.0 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.541 2.161 . . . . 0.0 112.438 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.1 150.73 31.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.008 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HB2' HD13 ' A' ' 181' ' ' LEU . 4.6 mttp 172.5 76.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.547 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.535 ' O ' HG22 ' A' ' 291' ' ' ILE . 11.1 mtm -114.54 155.35 26.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.073 0.463 . . . . 0.0 111.181 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.624 HD13 ' HB1' ' A' ' 269' ' ' ALA . 5.4 tt -136.51 142.09 43.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.022 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -115.64 145.68 42.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.786 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.891 HG13 HD12 ' A' ' 191' ' ' LEU . 0.3 OUTLIER -89.48 157.1 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 286' ' ' MET . 4.0 m-85 -125.82 130.13 50.78 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 118.332 2.716 . . . . 0.0 118.332 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.583 ' HB2' HG11 ' A' ' 253' ' ' VAL . 25.5 t70 37.25 44.71 0.46 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 1.047 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -70.46 -25.05 63.0 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.901 ' N ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.66 -1.35 53.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.554 HD12 ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -96.39 12.89 29.65 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.4 m -71.54 144.45 88.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.408 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.887 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -52.91 -29.31 43.04 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.715 2.276 . . . . 0.0 112.246 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -32.24 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.052 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.762 HD22 ' CG2' ' A' ' 202' ' ' THR . 2.5 tm? -85.53 -50.38 7.3 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -91.8 -40.45 11.2 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -74.76 -41.86 59.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.12 -18.71 60.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.394 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 64.23 101.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.328 . . . . 0.0 110.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.762 ' CG2' HD22 ' A' ' 197' ' ' LEU . 62.0 p -69.52 122.68 86.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.14 161.28 45.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.455 2.104 . . . . 0.0 112.17 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.44 123.48 27.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.989 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.18 -63.3 0.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -162.65 -71.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.778 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -101.6 89.39 0.77 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.316 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.601 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.34 -155.49 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.69 0.396 . . . . 0.0 112.002 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.815 HG21 ' HB2' ' A' ' 192' ' ' TYR . 6.3 p -40.92 -27.93 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.16 81.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.358 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.41 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 1.7 tt0 -75.45 -46.14 34.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.782 0.325 . . . . 0.0 111.564 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -54.1 -42.98 70.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.894 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.868 HG11 HD23 ' A' ' 191' ' ' LEU . 35.2 m -74.42 -45.23 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.509 ' HE1' HG23 ' A' ' 230' ' ' VAL . 0.0 OUTLIER -67.27 -38.23 84.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.648 0.261 . . . . 0.0 111.645 -179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -69.62 -54.15 15.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -35.12 75.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.906 0.384 . . . . 0.0 111.195 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.775 HD13 ' O ' ' A' ' 213' ' ' VAL . 8.3 mp -68.87 -31.1 69.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.357 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.76 -57.17 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.396 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -58.25 -49.19 77.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.762 0.315 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.485 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -58.66 -42.66 88.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.188 0.518 . . . . 0.0 110.034 179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.65 ' HB3' HD11 ' A' ' 227' ' ' ILE . 8.2 m-85 -76.81 -2.43 33.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.746 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.42 -45.16 2.2 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.323 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.8 m -59.63 -42.61 93.11 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.872 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 1.3 p90 -103.25 -14.68 16.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' PHE . . . 169.26 95.88 0.1 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 118.842 -1.647 . . . . 0.0 113.256 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.0 t -51.52 160.83 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.593 0.235 . . . . 0.0 110.815 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.2 OUTLIER -112.25 137.15 46.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.487 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -78.75 -26.59 44.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.26 143.57 10.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 261' ' ' VAL . 3.1 m -134.1 107.62 10.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.058 0.456 . . . . 0.0 110.336 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 31.2 mtt180 -105.91 108.08 19.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.467 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 232' ' ' ILE . 1.6 tt -96.52 121.45 47.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.172 0.511 . . . . 0.0 111.952 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 243' ' ' ILE . 1.2 pp -121.07 122.84 40.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.245 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.512 ' CB ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.17 170.8 7.73 Favored Pre-proline 0 C--N 1.323 -0.573 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.515 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 18.6 Cg_endo -60.58 165.22 11.79 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.284 1.989 . . . . 0.0 113.565 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 53.6 14.58 3.73 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.259 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 239' ' ' LEU . 9.3 mtp180 -132.25 -153.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.353 0.576 . . . . 0.0 111.195 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 46.7 mt-10 -55.35 97.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 111.496 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 237' ' ' ARG . 1.6 mm? -115.6 95.27 42.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.575 ' CD ' HD22 ' A' ' 233' ' ' LEU . 37.7 Cg_exo -61.18 153.28 66.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.885 2.39 . . . . 0.0 113.011 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 87.1 Cg_exo -47.26 -28.27 7.83 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.799 2.333 . . . . 0.0 112.119 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.559 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.7 m-20 -61.13 -44.24 97.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.27 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.855 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -102.07 -42.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -53.64 -37.77 63.43 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.168 -0.333 . . . . 0.0 111.415 -178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 3.0 mpp_? -84.36 -44.83 13.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.824 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.7 tt -84.13 -45.56 18.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 243' ' ' ILE . 24.8 m -67.56 -34.67 77.52 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -82.26 -1.82 50.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -36.67 10.14 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.73 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.1 p90 -90.69 44.79 1.21 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 12.6 m -45.08 123.44 3.9 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.794 0.331 . . . . 0.0 111.149 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -179.72 -26.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -86.73 29.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.79 15.09 0.05 OUTLIER Glycine 0 CA--C 1.523 0.588 0 N-CA-C 114.268 0.467 . . . . 0.0 114.268 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.551 HG22 ' OD1' ' A' ' 190' ' ' ASP . 0.9 OUTLIER -168.42 171.91 8.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.223 0.512 . . . . 0.0 110.887 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -131.04 95.66 3.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.919 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 134.32 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.913 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 48.4 m -152.31 150.94 30.28 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.781 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 187' ' ' LEU . . . -126.43 141.49 51.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.079 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.5 mt -101.31 113.22 36.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.094 0.474 . . . . 0.0 111.163 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 1.041 HG12 HG12 ' A' ' 230' ' ' VAL . 4.8 m -115.61 134.31 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.156 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.7 mt-10 -125.58 97.4 5.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.89 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.707 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.4 OUTLIER -87.34 -179.54 6.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 111.232 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.44 -20.03 65.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.939 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -174.26 174.22 2.9 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.168 0.509 . . . . 0.0 112.188 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.736 HG22 HG13 ' A' ' 270' ' ' ILE . 6.8 p -67.51 -22.08 28.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.341 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.77 -15.8 63.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 263' ' ' PHE . . . -82.52 -58.31 2.97 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.155 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.707 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -67.46 -24.62 65.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.998 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 266' ' ' VAL . 17.9 mt -68.97 -50.13 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.619 0.247 . . . . 0.0 110.854 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -38.38 79.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.872 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -80.24 -50.94 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.843 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.549 ' CE1' HD13 ' A' ' 277' ' ' ILE . 54.0 t-80 -49.68 -55.93 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.299 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -49.76 69.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.45 -32.25 73.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.699 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 4.2 mtp -76.76 -58.62 3.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.896 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.549 HD13 ' CE1' ' A' ' 273' ' ' HIS . 3.6 pt -66.46 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.432 ' N ' HG13 ' A' ' 277' ' ' ILE . 52.1 m -66.17 -45.28 81.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.275 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -29.53 32.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.333 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 9.6 t -54.91 -34.29 62.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.66 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 145.95 55.12 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.333 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.16 -37.83 3.32 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.096 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.01 -174.75 2.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.187 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -123.76 56.51 1.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -128.97 -172.5 2.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.295 0.569 . . . . 0.0 112.218 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.919 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.8 mtp -30.77 130.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.518 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -137.12 168.44 19.61 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.699 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -145.44 145.11 30.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.736 -0.786 . . . . 0.0 112.506 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.479 HG22 ' HE1' ' A' ' 189' ' ' TYR . 6.5 m -139.02 136.87 42.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 186' ' ' LEU . 6.0 mt -89.16 128.56 35.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.229 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 185' ' ' MET . 5.6 tt -117.78 143.03 29.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.727 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -155.56 78.68 0.19 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.581 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 mtt -176.21 96.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.0 110.917 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.83 153.09 17.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 122.541 2.161 . . . . 0.0 112.282 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.842 0.353 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.07 126.78 57.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.69 -63.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.486 2.124 . . . . 0.0 112.152 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.8 m -162.78 150.96 14.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.4 73.24 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.741 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.8 OUTLIER -127.59 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.12 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 186' ' ' LEU . 1.6 pp -114.06 141.9 46.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.397 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 2.4 pp -97.26 145.74 25.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.713 0.292 . . . . 0.0 110.684 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 50.8 t -85.81 160.54 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.758 0.789 . . . . 0.0 113.0 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.692 ' HB2' ' CB ' ' A' ' 287' ' ' LYS . 2.0 m-85 -115.05 -179.46 3.63 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 113.454 -1.703 . . . . 0.0 112.766 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.542 ' HB2' HG11 ' A' ' 253' ' ' VAL . 52.7 t0 -18.57 72.46 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 113.631 -1.622 . . . . 0.0 115.13 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 192' ' ' TYR . 1.4 pp -99.39 -20.76 16.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.886 0.374 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.851 ' N ' HD12 ' A' ' 191' ' ' LEU . 37.4 t80 -82.13 -31.99 30.33 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 255' ' ' THR . 2.3 tp -81.2 11.12 4.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.4 ' CB ' ' OD1' ' A' ' 285' ' ' ASN . 8.6 t -74.03 125.92 89.74 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.083 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.2 Cg_endo -53.01 -23.64 22.29 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 110.989 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 200' ' ' LEU . 20.3 mtmt -77.37 -32.82 55.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.966 HD21 HG13 ' A' ' 209' ' ' VAL . 1.2 tt -86.07 -51.09 6.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 5.8 p-90 -92.72 -42.75 9.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -79.38 -6.35 56.61 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 196' ' ' LYS . 8.3 tp -87.99 -37.47 16.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.522 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 44.4 92.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.466 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.428 HG23 HD23 ' A' ' 200' ' ' LEU . 6.5 p -113.48 98.13 45.77 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.094 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.11 -20.03 66.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.494 2.129 . . . . 0.0 112.322 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -93.85 44.46 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.049 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.27 106.4 4.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -63.01 156.67 23.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.663 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 57.17 102.03 0.01 OUTLIER Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.298 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.663 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.9 ptt-85 -42.31 -160.13 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.966 HG13 HD21 ' A' ' 197' ' ' LEU . 42.3 t -40.95 -28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.423 ' CG ' ' HG3' ' A' ' 208' ' ' ARG . 0.0 OUTLIER -62.5 -45.24 93.92 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.541 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -75.49 -43.34 49.78 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.843 0.354 . . . . 0.0 111.486 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.401 ' O ' ' CD2' ' A' ' 216' ' ' HIS . 2.0 tttt -53.98 -47.94 70.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.755 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.766 ' O ' HD13 ' A' ' 217' ' ' LEU . 34.4 m -74.41 -47.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.507 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -62.43 -44.76 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -68.28 -53.69 22.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.664 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 212' ' ' LYS . 31.6 m-70 -58.39 -44.39 88.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.706 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.766 HD13 ' O ' ' A' ' 213' ' ' VAL . 9.9 mp -63.57 -31.97 73.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.325 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -55.83 20.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.741 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -49.27 69.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.666 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' A' ' 275' ' ' PHE . 0.6 OUTLIER -57.16 -50.74 71.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.354 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.718 ' HB2' HD11 ' A' ' 227' ' ' ILE . 24.5 m-85 -69.76 -49.63 51.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.849 0.357 . . . . 0.0 110.714 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.71 -21.76 51.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.844 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.7 m -65.39 -47.72 75.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.683 0.241 . . . . 0.0 111.283 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 272' ' ' ALA . 2.4 p90 -102.53 -12.05 18.07 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -171.86 142.64 7.04 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 119.953 -1.117 . . . . 0.0 113.291 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 6.3 m -76.14 136.94 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.601 0.239 . . . . 0.0 110.993 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -95.11 134.02 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.33 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.0 OUTLIER -85.28 -35.66 21.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.983 179.226 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.73 144.13 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.867 0.365 . . . . 0.0 110.201 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 261' ' ' VAL . 24.7 t -128.3 107.75 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.587 ' O ' HG13 ' A' ' 260' ' ' ILE . 0.0 OUTLIER -105.08 108.36 19.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.524 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.7 117.87 42.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.278 0.561 . . . . 0.0 112.162 -178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.934 HD21 HD12 ' A' ' 243' ' ' ILE . 2.7 pp -106.5 110.22 22.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.596 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.622 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 5.5 tppt? -93.27 144.96 29.16 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.174 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.622 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 8.1 Cg_endo -46.78 165.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 124.047 3.165 . . . . 0.0 115.089 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.81 19.5 14.68 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 113.945 -1.48 . . . . 0.0 113.755 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -135.32 -87.31 0.36 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.565 0.682 . . . . 0.0 111.724 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 24.3 tt0 -127.05 110.02 12.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.071 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.611 HD23 ' CD1' ' A' ' 233' ' ' LEU . 2.9 mt -121.6 95.82 47.84 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.389 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.834 ' HD2' HD22 ' A' ' 233' ' ' LEU . 47.6 Cg_exo -56.31 148.11 63.12 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.407 2.071 . . . . 0.0 112.385 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.35 -31.35 37.48 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.58 2.186 . . . . 0.0 112.021 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.6 p-10 -64.56 -28.92 69.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.934 HD12 HD21 ' A' ' 233' ' ' LEU . 0.9 OUTLIER -101.57 -35.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.915 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.445 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.7 mtp180 -59.06 -49.64 77.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.409 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -73.86 -36.55 64.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.338 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 5.8 tt -84.13 -48.35 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.696 0.284 . . . . 0.0 111.592 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 8.4 t -61.41 -39.76 91.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -82.82 -2.57 55.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.582 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.24 -40.69 12.02 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.531 0.205 . . . . 0.0 111.457 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 17.4 p90 -96.63 39.18 1.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.748 0.308 . . . . 0.0 111.518 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 22.8 m -47.29 121.08 3.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.813 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -178.33 -25.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.98 20.47 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.36 15.73 0.08 OUTLIER Glycine 0 CA--C 1.522 0.48 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.834 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.6 OUTLIER -160.11 169.77 22.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.77 0.785 . . . . 0.0 110.365 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -135.33 96.36 3.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 0.0 111.758 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 235' ' ' PRO . 5.7 mp0 -143.31 139.07 29.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 14.2 m -147.94 147.94 30.24 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.106 -1.037 . . . . 0.0 113.437 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.705 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -125.3 141.55 52.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.102 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -112.55 112.99 42.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 0.0 109.951 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.629 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 15.7 t -114.41 144.23 22.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.066 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -132.59 109.35 9.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.288 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 17.9 m-85 -96.79 176.6 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.926 0.393 . . . . 0.0 111.33 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.33 -17.43 63.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 0.8 OUTLIER -173.77 158.09 3.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.081 0.467 . . . . 0.0 111.607 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.631 HG22 HG13 ' A' ' 270' ' ' ILE . 9.5 p -61.84 -22.81 29.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.002 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.7 -17.33 62.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.023 0.916 . . . . 0.0 108.82 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -83.11 -60.87 2.01 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 186' ' ' LEU . . . -59.78 -29.07 67.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.746 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.631 HG13 HG22 ' A' ' 266' ' ' VAL . 16.8 mt -65.64 -50.0 74.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.553 0.216 . . . . 0.0 111.006 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -36.3 73.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.035 0.445 . . . . 0.0 110.397 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -84.39 -30.25 25.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.508 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.682 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-160 -54.66 -56.28 20.79 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.731 0.3 . . . . 0.0 110.683 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 0.9 OUTLIER -67.74 -36.11 79.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.543 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' A' ' 220' ' ' LEU . 30.7 t80 -63.91 -48.08 78.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.83 0.348 . . . . 0.0 110.282 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.738 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 2.8 mmm -73.09 -30.98 64.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.177 0.513 . . . . 0.0 109.623 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.682 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.8 mt -70.64 -53.02 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.205 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 21.2 m -65.4 -45.64 83.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.371 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -28.41 69.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.009 0.433 . . . . 0.0 110.675 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 287' ' ' LYS . 43.1 t -85.37 -40.2 16.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.801 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -51.57 142.99 13.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.375 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.45 -37.31 3.41 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.62 -168.65 1.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.95 61.0 1.44 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.4 ' OD1' ' CB ' ' A' ' 194' ' ' SER . 4.3 t30 -132.67 -174.3 3.42 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.382 0.611 . . . . 0.0 112.491 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.585 ' HG2' ' HE1' ' A' ' 276' ' ' MET . 18.7 ttt -32.97 110.34 0.08 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.759 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.692 ' CB ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -125.34 169.68 12.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.857 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.738 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -136.77 148.26 47.14 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.435 ' CG1' ' HG ' ' A' ' 187' ' ' LEU . 5.7 p -148.16 126.86 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 266' ' ' VAL . 0.1 OUTLIER -69.09 118.65 12.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.461 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 185' ' ' MET . 0.0 OUTLIER -117.57 134.66 60.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.804 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -112.35 168.76 12.79 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.851 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.9 ttt -176.87 102.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.752 0.31 . . . . 0.0 110.803 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -75.47 146.42 80.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.988 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.613 2.209 . . . . 0.0 112.312 179.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.827 0.346 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.615 HD21 ' HB2' ' A' ' 184' ' ' LYS . 2.3 tp -88.51 126.84 58.81 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.92 -52.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.388 2.059 . . . . 0.0 112.43 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -164.19 150.71 11.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.68 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.615 ' HB2' HD21 ' A' ' 181' ' ' LEU . 3.8 mttp 176.79 75.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.605 ' SD ' HG21 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.51 156.15 29.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.649 HD11 ' ND1' ' A' ' 273' ' ' HIS . 7.5 tt -106.45 142.21 36.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.15 0.5 . . . . 0.0 111.431 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HB3' HD11 ' A' ' 291' ' ' ILE . 0.6 OUTLIER -117.9 145.87 44.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.112 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -111.18 162.71 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.744 ' CE1' HG23 ' A' ' 289' ' ' VAL . 2.3 m-85 -119.43 177.6 4.85 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.239 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 193' ' ' LEU . 66.1 t0 -23.42 87.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.386 177.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.573 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.41 -20.39 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.918 ' HB2' HG21 ' A' ' 209' ' ' VAL . 0.1 OUTLIER -83.62 -17.81 40.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -178.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.487 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 2.9 tp -78.52 11.07 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -73.62 137.95 77.32 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.597 ' HA ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.27 -24.16 25.83 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.288 1.992 . . . . 0.0 111.989 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 7.3 tttp -77.44 -35.11 54.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.561 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 192' ' ' TYR . 2.0 tm? -85.73 -50.9 6.81 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.409 ' N ' HD13 ' A' ' 197' ' ' LEU . 6.3 p-90 -92.98 -41.93 9.73 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.597 ' HB3' ' HA ' ' A' ' 195' ' ' PRO . . . -79.26 -14.11 59.24 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 7.2 tt -114.03 -37.23 4.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.909 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.58 122.09 38.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.954 0.407 . . . . 0.0 111.888 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.574 HG23 ' O ' ' A' ' 202' ' ' THR . 7.8 t -132.97 86.56 42.69 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.336 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -92.83 -166.9 0.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.215 2.61 . . . . 0.0 112.814 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -156.8 29.96 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.603 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -174.66 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.035 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.06 -67.16 0.48 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.618 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -71.95 63.07 1.28 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.329 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.89 -156.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.731 0.412 . . . . 0.0 112.056 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.918 HG21 ' HB2' ' A' ' 192' ' ' TYR . 9.3 p -41.14 -28.32 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.704 0.288 . . . . 0.0 111.757 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -54.89 -45.96 74.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -32.63 61.21 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.785 0.326 . . . . 0.0 111.285 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.16 -48.68 67.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.614 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.538 HG23 HG22 ' A' ' 209' ' ' VAL . 43.2 t -65.44 -53.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.781 0.324 . . . . 0.0 111.862 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -51.7 -43.59 62.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.586 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.53 -53.82 17.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -37.79 78.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.618 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 221' ' ' PHE . 4.9 mp -67.21 -35.7 80.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.517 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.48 -45.76 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.74 0.305 . . . . 0.0 111.809 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.636 ' O ' HG23 ' A' ' 223' ' ' THR . 8.3 mttp -73.26 -48.93 30.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.766 0.317 . . . . 0.0 111.472 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 224' ' ' PHE . 6.1 tt -62.39 -43.36 99.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.567 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.786 ' CB ' HD11 ' A' ' 227' ' ' ILE . 5.8 m-85 -75.5 -43.23 50.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.69 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -67.12 -24.66 73.34 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.613 -179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.636 HG23 ' O ' ' A' ' 219' ' ' LYS . 3.9 p -64.26 -48.29 76.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.479 ' CZ ' HD23 ' A' ' 220' ' ' LEU . 2.1 p90 -103.18 -20.19 14.24 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -140.42 171.37 24.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.404 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.81 112.28 33.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.585 0.193 . . . . 0.0 110.934 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.786 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -96.0 130.93 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.289 0.566 . . . . 0.0 111.06 179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 262' ' ' GLU . 58.4 m -80.1 -32.68 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.896 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.8 t -167.82 144.14 4.07 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.0 110.132 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 1.1 HG22 HG12 ' A' ' 261' ' ' VAL . 69.4 t -130.42 107.46 14.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.825 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 1.3 ptp85 -106.85 109.11 20.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.274 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.636 HG22 ' CB ' ' A' ' 259' ' ' ALA . 1.8 pt -98.27 120.01 47.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.775 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 233' ' ' LEU . 2.7 pp -105.4 110.93 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.756 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.437 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -91.12 141.16 26.14 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.437 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 2.5 Cg_endo -44.33 165.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.24 2.627 . . . . 0.0 113.152 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 60.44 28.44 67.37 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.332 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -149.01 -82.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.994 0.397 . . . . 0.0 111.135 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 233' ' ' LEU . 33.3 mt-10 -129.95 117.09 19.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.465 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.543 HD23 ' CD1' ' A' ' 233' ' ' LEU . 10.7 mt -129.02 95.91 30.23 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.375 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.488 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.4 Cg_exo -64.63 153.21 78.63 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.579 2.186 . . . . 0.0 112.055 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 50.5 Cg_exo -54.1 -34.15 76.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.724 2.283 . . . . 0.0 112.777 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -55.34 -36.54 66.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.649 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -100.89 -28.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 111.44 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 4.1 mtp85 -54.09 -49.53 68.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.847 0.356 . . . . 0.0 111.392 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -84.74 -40.01 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.9 tt -83.99 -43.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.681 ' HB2' HG22 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -72.77 -43.73 62.47 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.8 t -76.43 -2.13 30.5 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 3.9 mmt-85 -103.51 -24.65 13.42 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -93.19 42.55 1.1 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.95 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.96 94.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.611 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.43 -32.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.459 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -2.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.715 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.2 20.99 0.59 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.002 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 44.2 m -154.03 145.7 23.31 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.414 ' O ' ' CD ' ' A' ' 235' ' ' PRO . 11.7 mm-40 -111.25 95.44 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.267 0.556 . . . . 0.0 111.806 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.408 ' OE2' ' CD1' ' A' ' 192' ' ' TYR . 5.2 mt-10 -145.24 111.71 5.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.846 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 94.3 m -111.45 146.84 36.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.891 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -141.57 140.79 33.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.79 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.566 HD13 ' C ' ' A' ' 259' ' ' ALA . 1.0 OUTLIER -121.15 113.26 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.129 0.49 . . . . 0.0 110.936 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 230' ' ' VAL . 4.2 m -101.12 146.84 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.716 0.77 . . . . 0.0 111.356 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.1 OUTLIER -120.2 95.25 4.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.902 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.703 ' CD1' HG23 ' A' ' 227' ' ' ILE . 4.9 m-85 -89.27 165.48 14.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.23 0.538 . . . . 0.0 112.036 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.82 -19.18 57.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.237 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -172.52 143.93 1.41 Allowed 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 121.078 0.466 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 270' ' ' ILE . 29.0 m -57.61 -22.21 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.433 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -64.6 -29.8 70.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.47 0.653 . . . . 0.0 109.394 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.07 -58.97 2.97 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 273' ' ' HIS . . . -50.26 -45.11 53.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.199 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 266' ' ' VAL . 9.1 tt -58.23 -47.12 88.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.505 ' N ' HG23 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -58.45 -44.64 89.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.048 0.452 . . . . 0.0 110.859 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.422 ' HB2' ' CE1' ' A' ' 224' ' ' PHE . . . -78.04 -29.98 49.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.469 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.649 ' ND1' HD11 ' A' ' 186' ' ' LEU . 2.7 t60 -52.95 -57.35 10.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 111.209 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -66.15 -35.72 81.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -57.99 -49.7 75.92 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.594 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.649 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 27.9 ptm -78.41 -45.17 23.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.494 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 11.7 mt -58.28 -49.35 82.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.287 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 33.7 m -66.19 -45.71 79.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.52 -36.64 79.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.709 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 286' ' ' MET . 87.4 p -69.81 -27.19 64.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.918 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -53.01 130.33 33.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.649 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 94.36 -36.89 3.57 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -105.99 130.25 53.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.5 0.19 . . . . 0.0 110.656 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.85 67.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 t-20 -129.1 -172.01 2.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.73 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 280' ' ' SER . 9.0 ttt -37.74 115.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.618 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 189' ' ' TYR . 15.4 mtmt -126.08 169.74 12.47 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.015 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.649 ' HB2' ' HE1' ' A' ' 276' ' ' MET . . . -142.6 155.55 44.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.744 HG23 ' CE1' ' A' ' 189' ' ' TYR . 3.2 t -130.95 153.8 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.398 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 290' ' ' LEU . 11.5 mt -95.26 113.98 25.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.055 178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 187' ' ' LEU . 5.1 mm -93.21 124.74 45.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -174.3 -126.93 0.96 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.247 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.47 149.36 16.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.767 0.318 . . . . 0.0 110.862 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 116.54 21.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.318 2.012 . . . . 0.0 112.324 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.766 0.317 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 0.2 OUTLIER -89.08 126.51 58.77 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.952 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 5.0 Cg_exo -78.15 -56.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.648 2.232 . . . . 0.0 111.515 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -167.35 140.48 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.912 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.51 ' HE3' HG11 ' A' ' 266' ' ' VAL . 2.4 mttp -173.33 79.1 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.054 0.454 . . . . 0.0 111.335 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 291' ' ' ILE . 4.5 mtm -114.24 156.6 24.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.988 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.709 HD22 ' HB1' ' A' ' 288' ' ' ALA . 1.0 OUTLIER -121.72 129.12 52.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 111.534 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 291' ' ' ILE . 0.5 OUTLIER -110.72 147.17 34.94 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.934 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 23.5 m -112.24 170.15 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -164.67 156.85 16.15 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 120.074 3.361 . . . . 0.0 120.074 176.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.708 ' OD2' HG12 ' A' ' 253' ' ' VAL . 3.2 t0 51.1 52.02 15.8 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 111.121 -2.763 . . . . 0.0 114.082 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -99.23 -32.53 11.16 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.7 ' N ' HD13 ' A' ' 191' ' ' LEU . 90.4 t80 -77.85 -8.04 57.51 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 193' ' ' LEU . 2.8 tp -83.52 10.57 8.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.954 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.46 ' HB3' HD13 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.73 139.71 80.74 Favored Pre-proline 0 N--CA 1.454 -0.239 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.882 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.2 Cg_endo -53.65 -30.84 57.45 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.336 2.024 . . . . 0.0 112.09 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.555 ' HG2' HD13 ' A' ' 200' ' ' LEU . 0.0 OUTLIER -77.99 -25.45 48.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.375 -179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 194' ' ' SER . 11.0 mp -84.99 -58.25 2.77 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -92.12 -38.58 12.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.72 -15.38 61.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.555 HD13 ' HG2' ' A' ' 196' ' ' LYS . 0.5 OUTLIER -87.29 -42.32 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.71 131.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.179 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 31.7 p -144.49 142.07 18.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.62 -175.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.437 2.091 . . . . 0.0 112.313 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -91.6 122.73 34.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -162.15 123.74 2.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.058 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.37 -78.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.068 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -153.0 124.83 1.67 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.583 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -48.86 -154.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.819 0.448 . . . . 0.0 111.808 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 213' ' ' VAL . 9.8 p -40.68 -27.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 214' ' ' MET . 24.3 mt-30 -59.01 -47.5 84.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.562 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.72 -51.48 12.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -49.09 69.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 209' ' ' VAL . 4.6 m -74.73 -42.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.1 OUTLIER -51.49 -39.97 58.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 0.0 111.406 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -69.72 -54.23 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.829 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -58.09 -40.08 80.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.528 HD11 ' SD ' ' A' ' 286' ' ' MET . 0.3 OUTLIER -65.99 -30.42 70.97 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.145 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.22 -56.83 12.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.709 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -64.3 -43.63 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.634 0.254 . . . . 0.0 111.148 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -30.95 71.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.705 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.1 m-85 -86.21 -34.99 20.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.468 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' VAL . . . -67.52 -26.89 73.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.005 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.35 -47.44 84.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.612 0.244 . . . . 0.0 111.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.3 p90 -98.74 -14.96 19.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.97 0.19 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.882 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 222' ' ' GLY . 16.8 t -52.05 150.33 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.511 0.196 . . . . 0.0 110.824 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.941 HG21 HG22 ' A' ' 230' ' ' VAL . 1.4 mt -101.38 131.2 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.0 111.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -79.82 -30.65 40.51 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.497 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.18 143.77 7.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.941 HG22 HG21 ' A' ' 227' ' ' ILE . 3.3 t -133.48 109.04 13.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.287 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.42 105.76 16.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.577 HG13 ' HB2' ' A' ' 259' ' ' ALA . 4.0 tt -97.01 123.68 49.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.622 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.837 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -126.12 111.12 14.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.395 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 237' ' ' ARG . 0.0 OUTLIER -89.16 163.89 32.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.433 ' CG ' ' O ' ' A' ' 256' ' ' GLN . 52.5 Cg_exo -53.1 156.61 9.72 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.525 2.15 . . . . 0.0 113.497 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 59.13 13.35 20.08 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.244 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 234' ' ' LYS . 2.1 ttt-85 -114.07 -86.84 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 6.8 mt-10 -143.49 104.97 4.3 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.273 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.837 HD23 ' CD1' ' A' ' 233' ' ' LEU . 42.4 mt -108.11 103.44 50.19 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.524 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 15.7 Cg_exo -68.11 153.52 74.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.878 2.386 . . . . 0.0 112.214 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.83 -28.55 39.19 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.985 2.457 . . . . 0.0 112.632 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.563 ' OD2' HD12 ' A' ' 291' ' ' ILE . 5.2 t70 -57.88 -42.49 84.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.704 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.53 -28.01 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.706 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.409 ' CD ' ' HB3' ' A' ' 239' ' ' LEU . 1.2 tpt180 -57.45 -45.1 85.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.972 0.415 . . . . 0.0 110.877 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 19.8 ttt180 -84.61 -40.59 17.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.176 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.7 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.3 tt -84.46 -46.15 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.8 t -70.9 -43.08 69.04 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -2.38 25.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.701 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 1.0 OUTLIER -97.8 -35.86 10.39 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.563 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -94.21 38.69 1.09 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.111 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' GLN . 4.0 m -49.92 121.04 4.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.57 0.224 . . . . 0.0 110.819 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 251' ' ' SER . 15.8 tp60 178.53 -26.03 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.708 HG12 ' OD2' ' A' ' 190' ' ' ASP . 11.2 t -71.49 14.67 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.7 14.33 0.38 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.661 0.625 . . . . 0.0 114.661 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.415 HG23 ' OE1' ' A' ' 257' ' ' GLU . 0.3 OUTLIER -160.09 148.26 16.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.749 0.774 . . . . 0.0 110.553 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 235' ' ' PRO . 7.3 pt20 -120.77 97.13 5.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.378 0.609 . . . . 0.0 111.873 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.415 ' OE1' HG23 ' A' ' 255' ' ' THR . 0.8 OUTLIER -144.01 120.66 11.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 177.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 57.2 m -128.5 146.43 50.82 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.683 -178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.934 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.06 141.71 29.09 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.396 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.684 HD11 HD21 ' A' ' 233' ' ' LEU . 0.4 OUTLIER -106.14 113.86 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.374 0.606 . . . . 0.0 111.988 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.627 HG12 HG13 ' A' ' 230' ' ' VAL . 34.2 m -100.74 146.12 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.078 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.3 OUTLIER -127.02 98.68 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.885 178.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.495 ' CE1' HG23 ' A' ' 227' ' ' ILE . 7.0 m-30 -89.25 -179.69 5.92 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.951 0.405 . . . . 0.0 111.111 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -44.2 89.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.763 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.71 139.86 19.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 111.266 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 270' ' ' ILE . 15.0 p -54.47 -23.8 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.838 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.463 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 7.5 mm-40 -54.68 -55.84 25.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.96 -54.48 15.4 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.14 -43.89 61.3 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.732 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 266' ' ' VAL . 0.7 OUTLIER -52.19 -34.77 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.217 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.558 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -80.34 -37.45 32.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.562 178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.495 ' CB ' ' CD1' ' A' ' 224' ' ' PHE . . . -70.96 -51.15 27.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.298 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.63 ' ND1' HD12 ' A' ' 277' ' ' ILE . 0.9 OUTLIER -59.25 -50.39 74.2 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.571 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.506 ' N ' ' ND1' ' A' ' 273' ' ' HIS . 4.3 mt-10 -51.81 -30.5 23.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -77.57 -47.92 18.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.063 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 2.1 ttp -75.63 -50.5 15.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.194 0.521 . . . . 0.0 110.267 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.63 HD12 ' ND1' ' A' ' 273' ' ' HIS . 7.1 mt -50.57 -41.85 21.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.069 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.2 m -76.51 -45.82 29.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.941 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.75 -36.7 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.115 0.483 . . . . 0.0 110.176 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 286' ' ' MET . 23.3 t -85.18 2.05 45.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.662 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.85 145.84 55.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.199 0.523 . . . . 0.0 112.096 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 77.8 -37.04 1.66 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.957 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.45 153.64 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.743 0.306 . . . . 0.0 110.256 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 190' ' ' ASP . 5.7 pt-20 -90.06 77.5 6.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.456 ' C ' ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -134.87 -176.91 4.4 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.573 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.528 ' SD ' HD11 ' A' ' 217' ' ' LEU . 4.1 tpt -27.9 114.75 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.536 ' HG3' ' CD2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.95 168.04 23.31 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.924 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.709 ' HB1' HD22 ' A' ' 186' ' ' LEU . . . -140.47 147.21 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 189' ' ' TYR . 22.5 t -124.89 122.79 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.05 120.61 12.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.224 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 187' ' ' LEU . 22.9 mm -85.85 105.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 92.85 163.38 37.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.6 ptm -173.97 115.7 0.22 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.42 96.02 5.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.481 2.121 . . . . 0.0 112.357 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.849 0.356 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.06 127.03 57.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.93 -43.95 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.52 2.147 . . . . 0.0 112.554 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 61.0 m -147.42 150.98 35.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.421 ' CB ' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -164.39 73.49 0.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.438 ' O ' HG22 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.48 155.33 26.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.538 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.884 HD12 HD22 ' A' ' 290' ' ' LEU . 0.8 OUTLIER -133.11 131.44 40.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.972 0.415 . . . . 0.0 110.9 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 146.75 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.36 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.773 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.1 OUTLIER -109.13 171.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -177.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CE1' HG23 ' A' ' 289' ' ' VAL . 3.7 p90 -168.87 152.2 5.24 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.586 ' CG ' HG22 ' A' ' 255' ' ' THR . 0.9 OUTLIER 55.92 51.37 12.26 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 112.803 -1.998 . . . . 0.0 115.017 177.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.713 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.2 -14.45 20.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.28 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 209' ' ' VAL . 21.9 t80 -71.57 -28.25 63.71 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.371 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 198' ' ' TRP . 0.4 OUTLIER -77.84 13.84 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 4.0 m -71.79 144.68 88.52 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 Cg_endo -51.95 -31.69 44.56 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.464 2.109 . . . . 0.0 112.901 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 8.5 tptm -78.14 -39.15 41.96 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.637 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.743 ' CD2' HG13 ' A' ' 209' ' ' VAL . 0.7 OUTLIER -87.56 -48.3 8.02 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.557 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.6 -44.25 11.37 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.21 -20.01 45.67 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 200' ' ' LEU . 1.0 OUTLIER -93.91 12.77 24.87 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.431 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 200' ' ' LEU . . . 72.76 -156.93 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 81.4 p -112.31 99.91 48.09 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.588 0.232 . . . . 0.0 111.053 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.56 127.75 13.57 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.434 2.09 . . . . 0.0 112.233 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -112.3 114.37 27.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -160.1 -56.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 121.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.646 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 60.56 79.44 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.02 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -46.6 -155.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 192' ' ' TYR . 41.1 t -40.84 -28.45 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -61.3 -46.3 90.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.192 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.504 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -75.3 -46.05 35.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.737 0.304 . . . . 0.0 111.521 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.65 71.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.685 HG12 HD13 ' A' ' 217' ' ' LEU . 23.8 t -74.4 -49.76 30.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.416 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.71 -43.05 62.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.758 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -69.48 -54.02 16.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.751 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -34.43 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.685 HD13 HG12 ' A' ' 213' ' ' VAL . 2.1 mp -70.7 -32.53 69.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.503 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.5 tp -52.75 -51.93 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 220' ' ' LEU . 41.9 pttt -70.1 -48.88 55.75 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 219' ' ' LYS . 0.6 OUTLIER -61.42 -37.69 84.39 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.76 ' CB ' HD11 ' A' ' 227' ' ' ILE . 11.2 m-85 -82.96 -39.37 21.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.19 -17.23 75.68 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.796 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.33 -47.7 72.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.786 0.293 . . . . 0.0 111.129 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 221' ' ' PHE . 1.6 p90 -96.1 -12.35 24.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.67 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 173.76 113.66 0.32 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.638 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 21.4 t -51.88 139.3 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.763 0.316 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.76 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.1 136.86 23.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.962 0.41 . . . . 0.0 110.804 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 4.1 t -79.69 -33.36 41.11 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.668 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.5 m -171.63 144.16 1.82 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.889 HG22 HG12 ' A' ' 261' ' ' VAL . 61.6 t -128.07 107.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.8 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 260' ' ' ILE . 29.9 mtt180 -104.33 108.03 19.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.905 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.6 pt -100.99 126.13 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 111.854 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.759 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -118.16 110.19 17.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.18 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.86 153.89 57.96 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 256' ' ' GLN . 9.3 Cg_endo -52.73 162.42 2.47 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.818 2.346 . . . . 0.0 113.528 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.11 28.1 53.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.116 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.74 -86.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.086 0.443 . . . . 0.0 111.48 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.2 tt0 -132.69 106.33 7.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.091 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.759 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -114.21 94.84 36.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.777 0.322 . . . . 0.0 111.12 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 23.7 Cg_exo -64.81 153.62 76.94 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.084 2.523 . . . . 0.0 112.595 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.549 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 89.3 Cg_exo -47.37 -29.49 9.88 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.974 2.449 . . . . 0.0 113.103 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 246' ' ' ILE . 43.8 m-20 -63.93 -41.89 97.5 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.61 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -100.89 -41.47 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.549 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 1.0 OUTLIER -53.64 -36.42 62.03 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.861 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 5.6 mmm-85 -84.89 -49.15 8.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.22 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.8 tt -84.18 -44.36 17.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.536 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.2 OUTLIER -64.95 -39.4 93.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.787 0.327 . . . . 0.0 111.542 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -2.23 47.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -91.83 -40.71 11.04 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.536 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 2.2 p90 -86.88 39.65 0.86 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.2 t -45.97 116.32 1.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.813 0.34 . . . . 0.0 110.969 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -177.76 -26.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.709 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 284' ' ' GLU . 0.0 OUTLIER -71.67 13.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 44.87 14.93 0.05 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.586 HG22 ' CG ' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -155.39 171.91 19.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.619 0.709 . . . . 0.0 109.959 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.477 HE22 HD11 ' A' ' 239' ' ' LEU . 0.9 OUTLIER -137.29 97.8 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.127 0.489 . . . . 0.0 111.907 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.6 115.69 8.39 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 243' ' ' ILE . 10.7 m -110.86 146.88 35.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.435 0.636 . . . . 0.0 112.524 -178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.773 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -145.33 141.45 28.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 231' ' ' ARG . 15.0 mt -121.9 113.58 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.154 0.502 . . . . 0.0 111.63 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.889 HG12 HG22 ' A' ' 230' ' ' VAL . 2.3 m -106.76 145.48 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.525 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.45 ' O ' ' CB ' ' A' ' 228' ' ' SER . 20.6 mt-10 -129.77 100.89 5.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.17 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.607 ' CE1' HG23 ' A' ' 227' ' ' ILE . 22.5 m-85 -92.63 -179.69 5.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.219 0.533 . . . . 0.0 112.205 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.45 -27.15 65.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.754 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -163.24 147.52 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.112 0.482 . . . . 0.0 111.768 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 184' ' ' LYS . 11.5 p -57.36 -23.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.163 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.904 ' HA ' HD12 ' A' ' 270' ' ' ILE . 11.1 mt-10 -62.56 -54.2 43.34 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.337 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.11 -56.39 11.09 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.4 -38.93 30.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.011 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 267' ' ' GLU . 15.1 mt -59.29 -40.11 80.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -43.43 85.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.031 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.503 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -79.82 -36.36 36.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.873 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.606 ' NE2' HD11 ' A' ' 277' ' ' ILE . 15.2 t-160 -48.87 -56.27 9.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.745 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.407 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 5.0 mt-10 -67.25 -33.69 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.857 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.69 -48.22 80.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.463 ' HE3' ' HG3' ' A' ' 286' ' ' MET . 10.9 mtp -76.61 -31.94 57.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.155 0.503 . . . . 0.0 109.828 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.606 HD11 ' NE2' ' A' ' 273' ' ' HIS . 2.0 mt -70.11 -38.26 74.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.654 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 281' ' ' GLN . 61.1 m -76.54 -45.75 29.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -29.33 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.053 0.454 . . . . 0.0 110.347 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 286' ' ' MET . 2.5 p -98.6 28.1 4.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 278' ' ' THR . 2.1 tm0? -68.49 125.46 26.55 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.61 -36.37 1.0 Allowed Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.942 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -91.63 128.34 37.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.012 0.434 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 253' ' ' VAL . 0.0 OUTLIER -67.16 73.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.535 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 190' ' ' ASP . 1.4 m-80 -132.65 -172.28 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.055 0.455 . . . . 0.0 111.746 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -33.32 104.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.393 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 31.0 tttt -146.67 167.89 22.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.57 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.599 ' CB ' HD21 ' A' ' 186' ' ' LEU . . . -149.69 162.78 39.55 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.735 HG23 ' CE1' ' A' ' 189' ' ' TYR . 51.7 t -123.83 153.62 29.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.479 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.884 HD22 HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -91.99 114.62 27.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.971 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 185' ' ' MET . 5.5 tt -116.31 143.24 26.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -164.51 92.95 0.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.602 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -73.88 -177.59 2.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 110.842 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 133.78 25.47 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.925 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--O 1.249 1.067 0 C-N-CA 122.375 2.05 . . . . 0.0 112.297 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.781 0.324 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.11 145.79 35.05 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.19 -55.57 2.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.451 2.101 . . . . 0.0 111.791 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.474 ' O ' ' HD3' ' A' ' 184' ' ' LYS . 75.5 m -164.11 149.78 10.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.936 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 183' ' ' SER . 23.6 mmtm -156.35 74.75 0.84 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.626 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.548 ' O ' HG12 ' A' ' 291' ' ' ILE . 0.7 OUTLIER -116.21 156.31 26.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.409 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.876 HD21 ' HB1' ' A' ' 288' ' ' ALA . 4.1 tt -120.33 137.71 54.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.902 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.906 HD23 HD11 ' A' ' 291' ' ' ILE . 1.4 pp -109.54 146.86 33.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.061 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.89 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 11.4 t -109.8 160.25 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.856 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -124.06 -173.0 2.66 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.623 176.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.707 ' OD2' HG21 ' A' ' 253' ' ' VAL . 3.8 m-20 -11.33 72.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.066 -2.334 . . . . 0.0 116.205 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.724 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.11 -14.21 20.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.724 ' N ' HD22 ' A' ' 191' ' ' LEU . 50.1 t80 -81.45 -18.36 45.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.2 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' LEU . 3.4 tp -78.46 10.33 3.23 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.92 137.86 76.35 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.911 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.4 Cg_exo -52.66 -23.69 20.72 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.053 1.835 . . . . 0.0 112.364 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 200' ' ' LEU . 0.1 OUTLIER -78.05 -34.73 50.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 213' ' ' VAL . 0.4 OUTLIER -85.39 -50.18 7.52 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -91.5 -40.19 11.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.19 -25.16 60.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 196' ' ' LYS . 0.4 OUTLIER -73.74 -37.56 65.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.675 0.274 . . . . 0.0 111.318 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 54.17 109.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.701 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 13.0 m -134.61 124.08 16.7 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.944 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.89 -166.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.396 2.064 . . . . 0.0 112.225 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.28 128.36 44.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.48 -44.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -125.34 -177.18 3.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.002 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.617 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -53.44 95.49 0.02 OUTLIER Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.386 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.617 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.3 ttp-105 -45.98 -155.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.487 HG21 ' HE2' ' A' ' 192' ' ' TYR . 79.7 t -40.99 -28.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.976 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.421 ' HG2' HD11 ' A' ' 232' ' ' ILE . 0.3 OUTLIER -58.7 -47.38 84.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.414 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.436 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 2.3 tt0 -75.8 -50.53 14.91 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -53.86 -48.77 69.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.751 HG12 HD11 ' A' ' 217' ' ' LEU . 38.5 t -72.8 -47.9 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.607 ' HA ' HD12 ' A' ' 217' ' ' LEU . 2.6 ttm -51.45 -36.47 44.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.66 -53.14 20.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.552 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -56.02 -36.01 67.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.542 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.751 HD11 HG12 ' A' ' 213' ' ' VAL . 9.7 mt -67.54 -31.21 71.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.335 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 222' ' ' GLY . 1.4 tp -62.67 -37.37 86.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.089 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -73.16 -49.55 27.59 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 224' ' ' PHE . 0.5 OUTLIER -65.02 -50.61 65.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 0.0 109.833 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.93 ' HB2' HD11 ' A' ' 227' ' ' ILE . 10.6 m-30 -81.11 0.56 35.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.115 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 218' ' ' LEU . . . -87.57 -44.74 5.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.079 -1.057 . . . . 0.0 112.623 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.2 m -80.07 -47.57 14.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 3.4 p90 -103.82 -20.37 13.95 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -139.74 75.48 0.36 Allowed Glycine 0 C--N 1.338 0.643 0 C-N-CA 118.574 -1.774 . . . . 0.0 114.335 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.2 m -51.45 124.86 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.834 0.317 . . . . 0.0 110.239 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.93 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -105.84 131.66 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.27 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 262' ' ' GLU . 57.1 m -79.06 -26.61 43.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.048 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 24.1 m -168.44 143.93 3.57 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.212 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 261' ' ' VAL . 18.2 t -129.84 107.62 15.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.934 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -104.59 108.23 19.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.707 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 11.2 pt -101.33 125.69 55.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.637 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 238' ' ' GLU . 0.8 OUTLIER -118.32 109.96 16.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.11 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.28 151.1 56.07 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -46.66 162.72 0.14 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.623 2.215 . . . . 0.0 113.07 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.64 58.08 Favored Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.621 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.58 -85.29 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.328 0.564 . . . . 0.0 111.294 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.65 ' O ' HD13 ' A' ' 233' ' ' LEU . 10.4 mt-10 -132.74 112.87 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.725 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.574 HD23 ' CD1' ' A' ' 233' ' ' LEU . 11.6 mt -120.3 94.92 48.99 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.813 0.34 . . . . 0.0 111.609 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.472 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 25.4 Cg_exo -62.71 153.87 69.34 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.026 2.484 . . . . 0.0 112.214 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 7.9 Cg_endo -49.72 -40.63 47.21 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.128 2.552 . . . . 0.0 112.96 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.575 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.4 OUTLIER -55.02 -37.25 66.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.92 -21.31 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.641 0.258 . . . . 0.0 111.502 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 29.7 mtp85 -58.18 -50.08 74.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.91 0.386 . . . . 0.0 111.223 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.433 ' O ' ' CB ' ' A' ' 249' ' ' ARG . 9.3 ptt180 -84.97 -36.68 21.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.9 tt -84.64 -46.99 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -74.54 -47.28 33.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.39 -2.22 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 245' ' ' ARG . 4.1 ttt180 -106.6 -19.46 13.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.483 ' C ' ' HD1' ' A' ' 250' ' ' TYR . 0.1 OUTLIER -95.28 38.38 1.14 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.714 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.2 m -55.52 115.46 2.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.834 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.86 -26.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.707 HG21 ' OD2' ' A' ' 190' ' ' ASP . 2.4 t -83.93 21.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 48.33 18.4 0.89 Allowed Glycine 0 CA--C 1.523 0.567 0 N-CA-C 114.506 0.562 . . . . 0.0 114.506 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.605 HG23 ' OD1' ' A' ' 190' ' ' ASP . 14.7 t -160.89 167.32 26.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.475 0.638 . . . . 0.0 109.916 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.78 109.28 4.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.56 ' HG2' HD21 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -143.41 124.62 14.56 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 97.9 m -111.24 147.14 35.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 112.557 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -146.29 141.53 27.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.041 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.59 113.02 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.05 0.453 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -105.65 145.12 14.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.615 0.721 . . . . 0.0 111.765 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.8 OUTLIER -119.45 95.12 4.66 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.484 178.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 33.8 m-85 -86.16 173.13 10.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.088 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.58 -26.69 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.104 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -161.27 153.28 19.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.097 0.475 . . . . 0.0 111.645 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.41 -23.15 32.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.127 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -69.43 -17.71 63.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.674 0.75 . . . . 0.0 109.242 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.72 -58.01 3.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.648 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -57.47 -33.75 68.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.435 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.51 -49.91 81.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.279 . . . . 0.0 111.101 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -43.82 98.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.399 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.549 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -78.1 -35.86 48.79 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.581 ' O ' HG12 ' A' ' 277' ' ' ILE . 23.3 t-80 -54.99 -56.45 19.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.515 0.198 . . . . 0.0 111.193 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -48.38 80.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.714 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -58.97 -31.87 69.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.231 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.991 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 2.4 ttt -76.23 -53.01 8.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 273' ' ' HIS . 23.6 pt -70.53 -35.88 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.677 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 94.3 m -64.26 -45.33 88.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.596 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -75.73 -40.75 55.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.431 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 287' ' ' LYS . 29.4 t -60.91 -31.66 71.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.505 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.94 131.49 40.33 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.226 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 97.04 -37.68 3.36 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 285' ' ' ASN . 17.4 mmtt -107.12 122.89 47.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -66.22 70.21 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 283' ' ' LYS . 3.1 m-20 -132.95 -172.14 2.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.534 0.683 . . . . 0.0 112.595 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.595 ' HE1' HD23 ' A' ' 217' ' ' LEU . 3.9 ttt -34.37 129.93 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.569 -1.196 . . . . 0.0 113.833 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.709 ' HB2' ' CD2' ' A' ' 189' ' ' TYR . 25.1 mtmt -140.87 168.43 19.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.796 178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.991 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -151.85 154.21 35.73 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.856 HG23 ' CE1' ' A' ' 189' ' ' TYR . 21.2 t -125.71 154.03 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.9 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' ' 289' ' ' VAL . 24.0 mt -92.1 124.92 36.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.222 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.906 HD11 HD23 ' A' ' 187' ' ' LEU . 8.9 mm -99.2 128.39 50.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.062 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.68 -83.48 0.33 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.413 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.61 146.02 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 110.811 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.14 96.05 45.05 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.521 2.147 . . . . 0.0 112.351 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.786 0.327 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.448 HD13 ' HD3' ' A' ' 184' ' ' LYS . 18.5 mt -86.38 138.45 34.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.09 -51.03 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.296 1.997 . . . . 0.0 111.925 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.408 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 0.6 OUTLIER -164.14 150.17 11.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.563 179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.448 ' HD3' HD13 ' A' ' 181' ' ' LEU . 4.0 mttt 173.76 76.64 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.38 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 1.2 ptm -117.37 154.79 30.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.731 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -116.71 136.87 52.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.725 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.652 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.1 pp -104.99 145.64 30.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.344 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.772 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 35.7 m -104.92 170.77 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 289' ' ' VAL . 0.2 OUTLIER -169.2 156.2 6.92 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 176.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.566 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 18.2 t0 57.19 45.57 20.32 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.028 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.71 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -97.55 -33.19 11.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.64 ' H ' HD22 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -83.32 -16.85 44.55 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.791 ' HB2' HG21 ' A' ' 255' ' ' THR . 6.9 tp -81.17 12.41 3.48 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 m -71.81 139.85 83.34 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.88 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.7 Cg_exo -52.35 -25.54 24.68 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.246 1.964 . . . . 0.0 112.348 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -35.5 50.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.488 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.639 HD11 HG22 ' A' ' 209' ' ' VAL . 3.4 tm? -85.54 -49.55 7.96 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 -91.23 -40.27 11.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -74.26 -41.89 60.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.6 tp -63.18 -37.28 86.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.222 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 59.21 113.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.224 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.3 m -75.85 125.49 88.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.27 -45.56 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.528 2.152 . . . . 0.0 112.555 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -92.11 166.76 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.003 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.55 105.48 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.027 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -172.53 105.45 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.495 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.29 48.56 81.68 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.833 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.3 OUTLIER -46.7 -155.65 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.917 0.487 . . . . 0.0 112.276 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.8 t -40.93 -28.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -62.67 -47.3 84.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.739 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.415 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 7.3 tt0 -75.58 -32.69 60.45 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -69.69 -45.76 67.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.5 p -74.37 -47.18 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.505 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -65.14 -44.29 89.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 111.738 -179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -67.08 -53.81 27.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.915 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -65.07 -34.95 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.74 0.305 . . . . 0.0 111.605 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.675 HD21 ' CD2' ' A' ' 221' ' ' PHE . 9.8 tt -73.8 -31.6 63.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.416 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -56.99 12.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.646 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -62.96 -49.07 76.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.508 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -31.8 70.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.4 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.675 ' CD2' HD21 ' A' ' 217' ' ' LEU . 2.9 m-85 -83.97 -42.33 16.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.035 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.8 -16.28 78.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.768 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.35 -47.28 79.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.74 0.305 . . . . 0.0 111.357 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.6 OUTLIER -99.66 -7.69 25.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.852 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 174.07 115.41 0.39 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.948 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.0 m -52.08 148.07 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.657 0.265 . . . . 0.0 111.147 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.804 ' CG2' HG23 ' A' ' 261' ' ' VAL . 0.1 OUTLIER -99.32 133.84 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 t -80.89 -36.87 30.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.721 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 t -170.19 143.91 2.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 227' ' ' ILE . 10.0 t -133.86 110.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.478 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -102.59 106.35 17.02 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 2.2 tt -96.68 129.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.488 HD22 ' CD ' ' A' ' 240' ' ' PRO . 0.6 OUTLIER -126.43 120.8 30.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.164 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.488 ' HG2' ' H ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -92.06 163.5 27.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.663 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 234' ' ' LYS . 9.2 Cg_endo -53.24 163.68 2.24 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 113.421 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.4 19.53 18.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.965 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . 0.49 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.8 mtp180 -139.07 -156.03 0.64 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.854 0.327 . . . . 0.0 110.985 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -52.39 98.27 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.567 0.222 . . . . 0.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 237' ' ' ARG . 2.7 mm? -116.03 95.23 44.01 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.767 ' HD2' HD11 ' A' ' 243' ' ' ILE . 32.4 Cg_exo -62.13 153.28 70.52 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.995 2.464 . . . . 0.0 112.838 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.547 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 68.2 Cg_exo -50.99 -24.54 14.23 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.771 2.314 . . . . 0.0 112.436 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.8 OUTLIER -57.06 -42.19 80.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.005 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.767 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -101.87 -27.92 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.969 0.414 . . . . 0.0 111.514 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 23.0 mtt180 -53.98 -49.34 69.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.922 0.392 . . . . 0.0 111.216 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.0 OUTLIER -84.55 -40.66 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.4 tt -84.44 -45.43 17.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.1 t -71.14 -40.39 71.4 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 t -76.13 -2.21 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -102.32 -31.59 10.44 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.1 OUTLIER -92.47 39.62 1.03 Allowed 'General case' 0 C--O 1.231 0.132 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.306 -179.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.1 m -46.09 117.44 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.759 0.314 . . . . 0.0 111.036 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.17 -26.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.835 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -77.03 21.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.73 15.27 0.09 OUTLIER Glycine 0 C--N 1.335 0.478 0 N-CA-C 114.325 0.49 . . . . 0.0 114.325 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.791 HG21 ' HB2' ' A' ' 193' ' ' LEU . 8.6 t -167.18 170.47 11.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.391 0.596 . . . . 0.0 109.883 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.59 95.38 3.14 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.709 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.603 ' HG2' HD21 ' A' ' 191' ' ' LEU . 4.5 tt0 -144.14 137.14 27.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.42 ' CB ' HG21 ' A' ' 243' ' ' ILE . 83.9 m -149.32 167.42 26.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.701 -0.8 . . . . 0.0 112.415 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.772 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -151.6 149.22 28.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.374 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 3.0 mm -98.33 112.9 31.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.442 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 227' ' ' ILE . 1.1 p -115.3 141.39 32.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 228' ' ' SER . 53.5 mt-10 -135.18 107.14 7.08 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.548 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.743 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 40.8 m-85 -85.18 -179.83 7.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.95 0.405 . . . . 0.0 111.509 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -22.26 65.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.731 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -162.75 153.59 17.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.133 0.492 . . . . 0.0 111.415 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 184' ' ' LYS . 5.1 t -61.26 -23.55 30.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.988 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.3 -55.54 17.72 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.728 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.07 -50.21 20.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.866 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.743 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -63.39 -43.91 96.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.643 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.07 -37.76 69.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 111.23 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -39.76 72.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -82.14 -35.07 28.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.571 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.553 ' O ' HG12 ' A' ' 277' ' ' ILE . 26.7 t-80 -53.01 -56.03 19.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.601 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -48.8 80.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -57.31 -36.22 70.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 3.0 mtp -73.92 -60.74 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.329 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 273' ' ' HIS . 7.5 pt -60.0 -32.68 50.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.506 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 277' ' ' ILE . 95.2 m -70.51 -42.74 70.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 110.469 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.6 -43.42 48.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.458 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.4 t -56.7 -25.74 54.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.735 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.49 145.6 14.43 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.195 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.92 -37.94 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 -167.0 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.817 0.342 . . . . 0.0 110.23 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.56 65.66 1.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.433 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 1.4 p30 -133.1 -170.46 2.47 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.524 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 0.8 OUTLIER -26.4 130.78 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.051 -0.977 . . . . 0.0 113.636 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.541 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 5.1 mttp -142.28 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.002 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.731 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -141.56 145.79 35.53 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 189' ' ' TYR . 50.0 t -143.18 126.56 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.988 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.703 ' CD2' HD12 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -79.07 115.1 18.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.307 179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.652 ' HB ' HD23 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -117.86 138.46 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.397 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 291' ' ' ILE . . . -99.94 139.71 14.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.354 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.1 ttp -80.94 -57.18 3.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.996 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.46 118.38 24.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.901 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--O 1.25 1.118 0 C-N-CA 122.457 2.104 . . . . 0.0 112.356 179.947 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.832 0.349 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.419 HD13 ' HB2' ' A' ' 184' ' ' LYS . 4.1 pp -78.44 145.38 67.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.65 -50.02 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.569 2.179 . . . . 0.0 112.221 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.5 m -166.46 140.77 4.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 266' ' ' VAL . 1.3 mttp -173.45 75.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.894 0.378 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.52 155.54 27.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.825 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.944 HD21 ' HB1' ' A' ' 288' ' ' ALA . 9.8 tt -123.59 134.53 53.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.466 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 291' ' ' ILE . 4.0 pp -111.77 145.66 38.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 259' ' ' ALA . 22.9 m -97.36 170.22 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.806 ' CE2' ' HB2' ' A' ' 287' ' ' LYS . 0.9 OUTLIER -164.41 144.84 7.91 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 113.04 -1.891 . . . . 0.0 115.826 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.61 ' OD2' HD22 ' A' ' 193' ' ' LEU . 8.4 t70 52.83 52.95 12.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 113.796 -1.547 . . . . 0.0 113.117 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.83 -25.86 14.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.802 0.334 . . . . 0.0 110.374 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.628 ' H ' HD22 ' A' ' 191' ' ' LEU . 1.3 p90 -82.82 -0.54 48.49 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.61 HD22 ' OD2' ' A' ' 190' ' ' ASP . 6.9 tp -83.62 10.18 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.5 m -66.14 140.16 96.82 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.757 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.7 Cg_endo -53.48 -31.98 60.89 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.994 1.796 . . . . 0.0 111.402 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 200' ' ' LEU . 2.0 mttt -78.51 -17.77 55.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.577 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.63 HD11 HG22 ' A' ' 209' ' ' VAL . 2.1 tm? -84.12 -58.8 2.62 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -100.52 -36.01 9.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.34 . . . . 0.0 111.669 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -78.06 -7.4 56.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.305 -178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' A' ' 196' ' ' LYS . 4.8 tt -123.93 -47.13 1.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.773 0.321 . . . . 0.0 111.349 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 197' ' ' LEU . . . -91.24 142.55 27.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.337 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.8 p -103.15 150.83 38.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.1 134.63 65.34 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.555 2.17 . . . . 0.0 112.382 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.53 159.9 28.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.611 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.52 91.79 6.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 174.11 77.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.753 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 63.82 51.41 53.86 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.345 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.15 -158.73 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.887 0.475 . . . . 0.0 112.144 -179.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 213' ' ' VAL . 24.8 t -40.85 -28.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.758 0.313 . . . . 0.0 111.786 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -58.64 -47.17 85.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.4 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.401 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 4.6 tt0 -75.55 -32.67 60.51 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.404 ' HD3' HD22 ' A' ' 197' ' ' LEU . 11.3 mttt -68.72 -48.83 62.82 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.0 m -74.4 -40.94 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -51.87 -52.59 48.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.707 0.289 . . . . 0.0 111.772 -179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -66.38 -52.59 45.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.912 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -55.95 -42.26 75.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.834 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.464 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.3 mp -67.45 -31.78 72.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 111.455 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 214' ' ' MET . 0.5 OUTLIER -55.17 -42.97 73.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.709 -179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.49 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -73.28 -49.15 29.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.632 -179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.43 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.7 OUTLIER -61.92 -50.6 71.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.492 ' CD2' HD11 ' A' ' 227' ' ' ILE . 3.8 m-85 -69.64 -47.21 64.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.891 0.377 . . . . 0.0 111.074 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.1 -22.54 65.09 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.039 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 219' ' ' LYS . 1.4 p -72.06 -47.95 47.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.207 0.503 . . . . 0.0 112.185 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' CE2' ' O ' ' A' ' 220' ' ' LEU . 2.3 p90 -103.06 -24.09 13.64 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -132.35 167.84 22.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.128 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.13 113.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.487 0.184 . . . . 0.0 110.888 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.891 HG21 HG22 ' A' ' 230' ' ' VAL . 0.5 OUTLIER -92.65 131.27 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.198 0.523 . . . . 0.0 111.159 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.77 -30.88 40.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.084 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.7 t -170.56 143.55 2.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.932 HG13 HG12 ' A' ' 261' ' ' VAL . 3.8 t -130.76 111.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 260' ' ' ILE . 41.3 mtt180 -102.04 106.31 17.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 232' ' ' ILE . 2.7 tt -96.71 125.59 49.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.925 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.762 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.0 OUTLIER -125.81 113.58 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.133 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -85.31 162.99 46.96 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.334 179.17 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 234' ' ' LYS . 26.3 Cg_endo -61.07 156.75 42.85 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 123.061 2.507 . . . . 0.0 114.068 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.92 28.22 57.53 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.573 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.29 -74.65 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.889 0.344 . . . . 0.0 111.048 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 28.9 mt-10 -143.06 109.76 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.762 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.5 mt -120.59 102.04 45.39 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.114 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.2 Cg_exo -68.7 153.86 72.43 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.276 2.65 . . . . 0.0 112.634 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.2 Cg_endo -48.91 -28.28 13.0 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.201 2.601 . . . . 0.0 112.911 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 246' ' ' ILE . 42.1 m-20 -64.68 -46.83 80.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.705 HG22 ' OG ' ' A' ' 247' ' ' SER . 0.0 OUTLIER -97.35 -40.09 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.8 ptm180 -52.83 -36.7 59.04 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.98 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 241' ' ' PRO . 5.0 mmt180 -85.02 -44.15 13.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.819 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.703 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.1 tt -84.66 -47.94 16.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.705 ' OG ' HG22 ' A' ' 243' ' ' ILE . 40.2 m -61.51 -45.23 95.1 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.5 m -74.96 -2.43 27.08 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -36.3 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 1.4 p90 -92.47 39.1 1.02 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 p -46.51 118.09 1.85 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.576 0.226 . . . . 0.0 110.893 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.76 -26.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -80.62 15.27 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 53.23 1.54 0.07 OUTLIER Glycine 0 CA--C 1.524 0.601 0 N-CA-C 114.876 0.71 . . . . 0.0 114.876 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 253' ' ' VAL . 0.4 OUTLIER -144.54 158.74 43.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.795 0.798 . . . . 0.0 109.439 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.4 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -127.36 97.8 5.03 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.559 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 189' ' ' TYR . 1.5 mt-10 -143.03 134.27 25.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 0.1 OUTLIER -145.88 156.04 43.28 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.334 -0.946 . . . . 0.0 112.818 -178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.67 162.38 36.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.533 HD11 HD11 ' A' ' 243' ' ' ILE . 1.6 mt -123.31 113.42 37.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.307 0.575 . . . . 0.0 111.602 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.932 HG12 HG13 ' A' ' 230' ' ' VAL . 5.3 m -102.17 146.48 10.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.355 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 228' ' ' SER . 4.7 mt-10 -132.67 96.05 3.73 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.092 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.765 ' CD1' HG23 ' A' ' 227' ' ' ILE . 3.2 m-85 -81.77 -179.87 7.55 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.277 0.561 . . . . 0.0 112.006 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.78 -24.05 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.709 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.44 133.77 3.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.753 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 184' ' ' LYS . 14.7 p -50.26 -23.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.189 0.519 . . . . 0.0 111.085 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.8 OUTLIER -58.52 -54.58 45.44 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.131 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.95 -56.18 11.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.21 -41.62 68.85 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.991 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 267' ' ' GLU . 35.8 mt -52.5 -36.18 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 111.052 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.87 -32.37 45.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -77.06 -47.22 21.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.918 ' O ' HD12 ' A' ' 277' ' ' ILE . 54.8 t-80 -54.27 -56.01 22.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.66 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.457 ' HA ' ' CD1' ' A' ' 277' ' ' ILE . 0.8 OUTLIER -52.19 -39.7 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.694 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.96 -33.22 57.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.301 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.579 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.6 OUTLIER -76.58 -61.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.83 0.348 . . . . 0.0 111.745 -179.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 1.037 HD13 ' N ' ' A' ' 278' ' ' THR . 0.0 OUTLIER -56.61 -29.32 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 1.037 ' N ' HD13 ' A' ' 277' ' ' ILE . 85.2 m -76.69 -45.77 28.24 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.54 -42.89 70.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.477 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 14.9 p -58.4 -26.31 63.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.787 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.77 137.51 44.48 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.729 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.63 -37.4 3.3 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.416 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 285' ' ' ASN . 10.7 mmtt -106.45 125.58 51.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -68.5 68.32 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' LYS . 0.8 OUTLIER -131.19 -171.76 2.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.338 0.59 . . . . 0.0 111.983 -178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.572 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 24.5 ttt -40.19 131.13 2.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.48 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.806 ' HB2' ' CE2' ' A' ' 189' ' ' TYR . 0.1 OUTLIER -147.02 166.3 27.24 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.686 177.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.944 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -142.73 161.82 37.09 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.629 HG12 ' HE1' ' A' ' 189' ' ' TYR . 11.2 p -149.06 149.41 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.823 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.38 113.16 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.657 HD13 ' N ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -118.18 129.55 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.782 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.657 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 174.29 82.75 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.61 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 5.7 mtm -162.84 137.84 6.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 110.839 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.47 129.63 83.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.787 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.373 2.048 . . . . 0.0 112.258 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.898 0.38 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.626 HD11 ' HG2' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -89.05 126.96 57.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.48 -52.48 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.361 2.041 . . . . 0.0 112.176 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.1 140.45 3.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.553 ' HG2' HG21 ' A' ' 266' ' ' VAL . 6.4 mttp 175.5 81.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 29.9 mtp -114.0 135.29 54.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.583 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.3 tt -102.74 137.23 41.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.82 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.649 ' HG ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -117.12 146.06 43.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.757 HG22 ' CB ' ' A' ' 259' ' ' ALA . 2.9 m -87.65 155.57 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 122.853 1.311 . . . . 0.0 114.516 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.674 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 4.3 m-85 -110.6 170.09 8.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 110.433 -3.076 . . . . 0.0 113.891 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.681 ' HB2' HG11 ' A' ' 253' ' ' VAL . 33.8 t0 -13.22 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.88 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.36 -22.32 16.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.998 0.428 . . . . 0.0 110.218 177.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.752 ' HE1' HG21 ' A' ' 209' ' ' VAL . 36.2 t80 -75.07 -30.09 60.88 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 1.6 mp -81.67 10.52 5.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.0 m -66.67 130.06 94.07 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.637 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 53.0 Cg_exo -52.54 -26.96 30.68 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.713 1.609 . . . . 0.0 111.333 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -78.39 -27.88 46.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.721 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -84.9 -58.3 2.76 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -92.83 -38.48 11.73 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -78.7 -14.36 59.33 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.6 tt -123.96 -47.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.756 0.313 . . . . 0.0 111.258 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 197' ' ' LEU . . . -88.82 145.86 25.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.274 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 20.9 p -141.27 156.9 67.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.92 125.83 12.51 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.552 2.168 . . . . 0.0 112.381 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -169.0 -52.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.93 168.86 12.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.24 164.23 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 56.55 63.94 4.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.392 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 207' ' ' GLY . 4.3 ttm180 -47.29 -155.55 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.054 0.454 . . . . 0.0 112.037 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.752 HG21 ' HE1' ' A' ' 192' ' ' TYR . 37.1 t -41.27 -28.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.649 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.55 -46.81 86.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.403 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -75.05 -32.67 61.6 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.638 0.256 . . . . 0.0 111.445 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -45.63 70.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.617 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.644 HG22 HD13 ' A' ' 217' ' ' LEU . 14.1 p -74.33 -46.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.487 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -57.53 -39.7 77.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.683 -179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.51 -53.83 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.749 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -58.67 -34.47 71.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.47 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.644 HD13 HG22 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -72.69 -31.01 64.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.353 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 2.8 tp -52.38 -51.42 59.06 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' THR . 7.7 mttp -73.17 -43.59 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -37.53 85.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.766 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.706 ' HB2' HD11 ' A' ' 227' ' ' ILE . 3.1 m-85 -83.75 -42.28 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 111.062 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -66.61 -19.75 69.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.561 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' LYS . 0.7 OUTLIER -68.17 -47.29 68.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' A' ' 272' ' ' ALA . 5.8 p90 -91.91 -15.45 28.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 177.63 129.58 1.28 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.177 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 m -57.74 136.45 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.706 HD11 ' HB2' ' A' ' 221' ' ' PHE . 0.8 OUTLIER -91.89 132.08 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 111.233 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.5 m -81.89 -36.37 28.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.539 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.0 t -171.71 144.26 1.81 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 227' ' ' ILE . 63.1 t -128.1 107.82 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.218 0.532 . . . . 0.0 109.587 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 260' ' ' ILE . 27.5 mtt180 -104.63 108.69 20.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.766 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 259' ' ' ALA . 0.3 OUTLIER -96.78 128.43 48.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.508 0.671 . . . . 0.0 112.419 -178.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.772 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -119.48 109.32 15.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.838 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.663 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.21 163.2 43.6 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.571 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 30.6 Cg_endo -64.03 157.04 55.25 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.528 2.152 . . . . 0.0 114.567 -177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.53 16.69 11.28 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 114.283 -1.326 . . . . 0.0 113.578 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.26 -77.91 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.326 0.563 . . . . 0.0 110.718 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 3.4 mm-40 -142.99 107.18 4.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.772 HD23 ' CD1' ' A' ' 233' ' ' LEU . 8.0 mt -112.17 102.82 54.68 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.319 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.523 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 16.8 Cg_exo -67.62 153.22 76.82 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.79 2.327 . . . . 0.0 112.367 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.93 -31.76 35.32 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.441 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.412 ' O ' ' CG1' ' A' ' 246' ' ' ILE . 4.0 m-20 -55.51 -41.25 72.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.241 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -97.3 -28.65 3.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.944 0.402 . . . . 0.0 110.955 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -32.22 64.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 9.3 mtt180 -84.29 -48.28 9.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.701 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.467 ' H ' HG13 ' A' ' 246' ' ' ILE . 1.2 pp -83.95 -50.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.72 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 243' ' ' ILE . 3.0 t -59.91 -40.86 90.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.38 -1.91 39.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.8 OUTLIER -102.65 -40.69 6.52 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.576 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 10.0 p90 -91.01 38.62 0.96 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.47 126.93 14.34 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.14 -0.35 . . . . 0.0 110.179 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.54 -25.33 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 190' ' ' ASP . 0.0 OUTLIER -78.13 23.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -178.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 49.53 14.69 0.66 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 121.155 -0.545 . . . . 0.0 114.406 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.571 HG21 ' OD1' ' A' ' 190' ' ' ASP . 11.2 t -167.22 172.04 10.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.381 0.59 . . . . 0.0 110.322 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.422 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 1.7 tt0 -133.27 99.15 4.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.945 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.66 125.49 17.04 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 16.6 m -141.06 148.26 39.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.571 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.757 ' CB ' HG22 ' A' ' 188' ' ' VAL . . . -127.43 162.35 26.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.741 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -126.09 112.87 31.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.85 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 44.6 t -113.75 145.02 20.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.822 0.82 . . . . 0.0 112.323 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 228' ' ' SER . 5.1 mt-10 -133.21 104.14 6.34 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.107 177.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.85 ' CZ ' HG11 ' A' ' 261' ' ' VAL . 57.1 m-85 -93.6 -179.84 5.15 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.934 0.397 . . . . 0.0 111.132 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -33.95 64.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.973 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.626 ' HG2' HD11 ' A' ' 181' ' ' LEU . 5.0 mt-10 -165.27 152.6 10.81 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.02 0.438 . . . . 0.0 111.146 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.668 ' CG2' HD21 ' A' ' 290' ' ' LEU . 14.5 p -59.81 -23.68 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.507 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.893 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -60.84 -53.03 62.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -50.25 -54.63 19.78 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -53.38 -42.23 66.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.996 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.893 HD12 ' HA ' ' A' ' 267' ' ' GLU . 16.0 mt -55.13 -33.29 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.7 0.286 . . . . 0.0 111.276 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -44.56 69.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.235 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . . . -81.36 -30.22 33.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 111.071 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.602 ' NE2' HD11 ' A' ' 277' ' ' ILE . 20.2 t-160 -51.72 -55.99 16.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.723 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.532 ' O ' HG22 ' A' ' 278' ' ' THR . 0.9 OUTLIER -65.98 -40.06 90.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.639 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -57.66 -47.92 80.92 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.396 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.587 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 3.5 ttp -76.62 -37.08 56.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.602 HD11 ' NE2' ' A' ' 273' ' ' HIS . 1.2 mt -63.27 -49.09 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.204 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 274' ' ' GLU . 11.2 t -67.61 -45.53 75.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.383 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' THR . 0.8 OUTLIER -68.63 -36.47 78.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.866 0.365 . . . . 0.0 110.742 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.422 ' OG ' ' CD ' ' A' ' 287' ' ' LYS . 33.1 t -57.03 -43.71 82.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.647 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -48.42 140.08 8.23 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.786 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.38 -38.37 3.22 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 285' ' ' ASN . 0.4 OUTLIER -107.7 117.67 34.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -70.66 62.64 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.955 0.407 . . . . 0.0 110.084 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 33.6 m120 -133.51 -171.33 2.68 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.029 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.591 ' N ' ' O ' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -28.26 131.87 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.674 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 4.5 mtmt -145.13 169.43 18.17 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.231 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.587 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -135.86 144.06 45.42 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.91 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.649 HG12 ' HG ' ' A' ' 187' ' ' LEU . 0.8 OUTLIER -138.33 153.71 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 111.283 179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.668 HD21 ' CG2' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -99.78 114.23 27.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.105 0.479 . . . . 0.0 111.941 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -119.56 124.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.433 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 291' ' ' ILE . . . -111.75 -139.49 7.82 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.1 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.1 143.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 14.0 mttm 61.66 93.21 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.249 1.033 0 C-N-CA 122.558 2.172 . . . . 0.0 112.267 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.11 132.61 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.25 -37.87 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.642 2.228 . . . . 0.0 112.287 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 184' ' ' LYS . 1.5 m -167.54 140.52 3.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.318 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.464 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 7.4 mttt -170.83 79.49 0.08 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.85 152.63 30.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.626 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.689 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -105.53 120.66 42.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 111.775 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.688 HD11 ' CG2' ' A' ' 243' ' ' ILE . 12.1 tp -100.83 146.43 27.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.593 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 259' ' ' ALA . 0.0 OUTLIER -119.8 164.66 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.799 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.1 OUTLIER -164.13 144.98 8.42 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 118.487 2.773 . . . . 0.0 118.487 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 286' ' ' MET . 25.8 t0 52.04 59.21 4.7 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.207 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.8 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -101.18 -28.53 12.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.922 0.391 . . . . 0.0 110.563 177.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.926 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.4 OUTLIER -82.46 0.03 44.2 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -80.42 10.48 4.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.0 m -70.94 140.49 86.11 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.846 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.9 Cg_endo -54.21 -28.99 54.56 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.218 1.945 . . . . 0.0 111.844 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 -20.83 51.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.206 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.926 HD13 ' HA ' ' A' ' 192' ' ' TYR . 2.5 tt -84.5 -58.38 2.76 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -99.88 -35.87 9.6 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.846 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -72.71 -10.97 60.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 201' ' ' ALA . 8.7 tt -103.34 -47.2 4.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.43 ' CB ' HD23 ' A' ' 200' ' ' LEU . . . -176.57 144.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.188 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 6.8 m -114.79 116.8 42.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.07 174.71 8.52 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.389 2.059 . . . . 0.0 112.226 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.42 155.89 20.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.3 -70.18 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -165.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -64.1 79.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.357 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.619 ' O ' ' O ' ' A' ' 207' ' ' GLY . 3.5 ttp-105 -47.05 -155.12 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 0.0 111.959 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 213' ' ' VAL . 7.3 p -41.09 -28.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.839 0.352 . . . . 0.0 111.6 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.449 ' CG ' HD11 ' A' ' 232' ' ' ILE . 8.0 tt0 -54.29 -47.37 72.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.996 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -75.7 -32.63 60.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -66.08 -49.08 68.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.7 m -74.45 -39.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 14.2 ttm -51.74 -43.37 62.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.884 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -53.96 16.23 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -56.97 -36.54 70.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.658 0.266 . . . . 0.0 111.659 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.585 HD11 ' HE3' ' A' ' 286' ' ' MET . 0.1 OUTLIER -71.68 -31.01 66.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.491 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.53 -46.73 66.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.637 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -73.36 -49.19 28.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.585 HD21 ' HE2' ' A' ' 275' ' ' PHE . 0.4 OUTLIER -61.98 -50.68 71.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.716 -179.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.84 ' CB ' HD11 ' A' ' 227' ' ' ILE . 4.8 m-85 -69.88 -40.14 75.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.0 111.158 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.88 -25.81 74.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.072 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 41.9 m -60.76 -47.4 86.5 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.819 -0.224 . . . . 0.0 111.474 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.49 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.7 p90 -101.7 -17.13 16.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -163.65 107.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.168 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.3 t -53.66 126.78 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.498 0.19 . . . . 0.0 110.54 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 221' ' ' PHE . 0.6 OUTLIER -87.59 132.35 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.178 0.513 . . . . 0.0 111.785 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 262' ' ' GLU . 1.6 m -79.95 -38.23 32.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.968 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.7 t -172.45 143.69 1.42 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.737 ' CG2' HG21 ' A' ' 227' ' ' ILE . 83.7 t -129.63 107.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.654 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' CG ' ' HB ' ' A' ' 260' ' ' ILE . 0.9 OUTLIER -105.69 108.35 19.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.752 HG22 ' CB ' ' A' ' 259' ' ' ALA . 6.8 pt -100.63 124.82 54.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.155 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.78 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -110.81 110.17 20.67 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.6 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.473 ' HE2' ' N ' ' A' ' 234' ' ' LYS . 0.0 OUTLIER -88.39 149.28 44.31 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.17 156.22 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.956 2.438 . . . . 0.0 113.598 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.67 28.26 69.6 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.012 -0.995 . . . . 0.0 113.141 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -136.25 -79.91 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.909 0.355 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 40.5 mt-10 -142.81 108.97 5.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.013 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.6 mt -116.33 101.76 53.71 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.527 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.632 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 14.9 Cg_exo -69.01 154.12 71.25 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.356 2.704 . . . . 0.0 112.309 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 7.0 Cg_endo -48.91 -30.59 17.93 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.249 2.632 . . . . 0.0 113.147 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.599 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.1 m-20 -63.38 -43.55 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.688 ' CG2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -97.01 -41.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 2.5 ptm180 -53.62 -34.08 57.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.097 0.475 . . . . 0.0 110.403 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -51.26 6.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.122 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.599 HG22 ' O ' ' A' ' 242' ' ' ASP . 4.7 tt -84.43 -45.59 17.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.52 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.3 OUTLIER -65.37 -39.33 92.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.839 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 t -79.5 -1.99 40.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.517 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 -36.77 11.81 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.548 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 2.1 p90 -91.9 38.85 1.0 Allowed 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 9.3 t -51.22 118.55 3.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.662 0.268 . . . . 0.0 110.612 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.7 -26.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.799 HG21 ' HD2' ' A' ' 189' ' ' TYR . 9.2 t -73.74 11.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.45 9.25 0.23 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.888 -0.672 . . . . 0.0 114.162 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 99.0 m -144.48 142.53 30.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.49 0.645 . . . . 0.0 109.261 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 98.17 6.45 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.229 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.8 OUTLIER -143.27 118.32 10.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.512 177.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 12.1 m -106.86 145.75 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.154 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 188' ' ' VAL . . . -148.75 140.65 23.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.58 HD13 ' C ' ' A' ' 259' ' ' ALA . 0.9 OUTLIER -117.81 113.43 42.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.26 0.553 . . . . 0.0 110.343 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.613 HG13 ' CG2' ' A' ' 227' ' ' ILE . 95.5 t -103.38 145.24 12.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.0 0.905 . . . . 0.0 112.191 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 228' ' ' SER . 0.6 OUTLIER -122.67 95.54 4.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.316 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 227' ' ' ILE . 1.4 m-85 -93.92 -179.94 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -40.03 69.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.228 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.1 mt-10 -165.37 148.44 8.04 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.286 0.565 . . . . 0.0 111.154 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.464 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 11.9 p -57.29 -23.73 19.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.511 ' CG ' ' HB3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -53.18 -51.97 60.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -52.26 -56.92 11.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -49.8 -32.82 14.9 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.208 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 266' ' ' VAL . 66.7 mt -60.04 -43.19 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.213 0.53 . . . . 0.0 109.645 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -79.42 -38.38 34.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.808 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.49 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -70.46 -50.84 33.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.14 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.825 ' CD2' HD12 ' A' ' 277' ' ' ILE . 1.6 p-80 -56.6 -53.06 61.97 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.606 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.578 ' N ' ' CD2' ' A' ' 273' ' ' HIS . 0.3 OUTLIER -51.97 -29.36 20.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.759 0.314 . . . . 0.0 110.57 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.585 ' HE2' HD21 ' A' ' 220' ' ' LEU . 3.1 t80 -76.02 -47.7 23.82 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.549 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.459 ' HE1' ' CG1' ' A' ' 188' ' ' VAL . 2.5 ttp -73.99 -53.94 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.484 0.659 . . . . 0.0 110.041 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.825 HD12 ' CD2' ' A' ' 273' ' ' HIS . 12.6 mt -50.44 -43.36 22.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.423 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 91.1 m -76.57 -45.58 29.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.51 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -62.49 -28.71 70.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.3 t -96.37 27.67 3.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.79 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 125.02 25.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.047 0.451 . . . . 0.0 112.004 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.85 -36.05 1.24 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.918 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -88.09 131.59 34.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.218 0.509 . . . . 0.0 111.125 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -68.29 72.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.619 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 0.5 OUTLIER -132.84 -171.8 2.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.649 -179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.585 ' HE3' HD11 ' A' ' 217' ' ' LEU . 0.7 OUTLIER -28.63 122.19 0.12 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.05 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.571 ' HE2' HG22 ' A' ' 253' ' ' VAL . 5.7 mttm -141.97 147.81 37.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.78 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -139.24 143.63 38.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.772 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' CE1' ' A' ' 189' ' ' TYR . 22.0 m -130.58 151.42 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.68 119.46 23.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.013 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 187' ' ' LEU . 35.9 mm -98.39 101.71 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.153 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 124.99 39.01 0.47 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -161.13 -89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.568 0.184 . . . . 0.0 110.936 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 32.07 91.81 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.249 1.038 0 C-N-CA 122.439 2.093 . . . . 0.0 112.375 179.85 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 11.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -89.25 126.96 56.99 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.036 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.43 -42.12 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.172 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.63 140.5 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.409 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.539 ' HB3' ' HB ' ' A' ' 266' ' ' VAL . 3.8 mttt -173.2 78.93 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.596 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -114.34 152.83 30.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.362 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.057 HD21 ' HB1' ' A' ' 288' ' ' ALA . 3.8 tt -117.49 135.12 54.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.856 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -111.19 146.92 36.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.119 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.0 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.6 m -105.2 175.9 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.632 ' CD1' ' N ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -164.26 152.63 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 110.378 -3.101 . . . . 0.0 116.488 173.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.528 ' HB2' ' CG1' ' A' ' 253' ' ' VAL . 20.1 t0 48.32 51.09 15.61 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.734 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.763 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -26.66 14.35 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.505 ' O ' HD12 ' A' ' 197' ' ' LEU . 2.9 p90 -82.97 -3.78 57.53 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.443 ' CB ' ' OD1' ' A' ' 190' ' ' ASP . 6.2 tp -87.37 10.42 17.42 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.5 m -58.91 146.82 75.25 Favored Pre-proline 0 C--N 1.332 -0.186 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.843 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.0 Cg_endo -53.63 -32.38 64.34 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.181 1.921 . . . . 0.0 111.546 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.38 -20.34 51.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.273 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 192' ' ' TYR . 1.6 tm? -84.31 -58.19 2.85 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -99.9 -34.75 10.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -73.34 -38.83 65.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.8 tp -104.75 -47.49 4.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.618 0.247 . . . . 0.0 111.284 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.39 109.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.24 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 m -101.21 98.89 9.64 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.52 144.0 28.11 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.497 2.132 . . . . 0.0 112.413 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 62.07 119.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -177.37 -59.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.53 -53.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.641 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -151.74 125.89 1.95 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.109 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.641 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.7 OUTLIER -45.53 -157.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 192' ' ' TYR . 39.5 t -41.05 -27.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 19.3 pt20 -62.06 -47.61 83.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.663 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.8 OUTLIER -76.22 -49.0 18.3 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.775 0.321 . . . . 0.0 111.865 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.82 -48.52 69.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.847 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.741 HG11 HD23 ' A' ' 191' ' ' LEU . 46.5 t -74.26 -33.97 35.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.785 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.0 OUTLIER -68.22 -42.05 80.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 0.0 111.461 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.874 ' HA ' HD12 ' A' ' 218' ' ' LEU . 2.9 tt0 -69.61 -53.34 19.26 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -55.54 -34.52 64.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 111.713 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.552 HD22 ' HE1' ' A' ' 221' ' ' PHE . 64.1 mt -72.65 -31.39 65.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' A' ' 215' ' ' GLU . 20.7 mt -53.02 -45.16 67.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.512 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -72.22 -49.09 38.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.361 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.27 -34.27 76.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.752 0.311 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.552 ' HE1' HD22 ' A' ' 217' ' ' LEU . 18.2 m-85 -84.67 -33.72 23.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.758 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.52 -22.43 78.97 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.457 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 91.6 m -65.22 -47.33 77.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.541 0.21 . . . . 0.0 111.508 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 7.7 p90 -98.14 -18.23 18.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 173.52 110.8 0.25 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.148 -1.025 . . . . 0.0 113.055 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 13.7 t -51.78 144.97 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.677 0.275 . . . . 0.0 110.75 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.798 HG21 HG22 ' A' ' 230' ' ' VAL . 1.7 mt -90.07 136.69 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 0.0 110.938 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.2 m -79.35 -33.63 42.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.1 m -166.18 143.61 5.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.798 HG22 HG21 ' A' ' 227' ' ' ILE . 17.4 t -129.24 107.93 16.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.447 ' O ' ' N ' ' A' ' 260' ' ' ILE . 83.3 mtt180 -104.7 107.18 18.0 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.693 HG22 ' HB1' ' A' ' 259' ' ' ALA . 7.9 pt -106.54 131.29 56.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.589 0.709 . . . . 0.0 112.911 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.79 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.6 OUTLIER -122.37 110.45 15.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.089 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -75.47 168.67 25.6 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.409 ' HG3' ' O ' ' A' ' 256' ' ' GLN . 58.2 Cg_endo -69.53 156.29 64.36 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 113.638 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 56.88 18.09 24.39 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.098 -0.955 . . . . 0.0 113.228 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -79.05 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.957 0.379 . . . . 0.0 110.388 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 2.7 tm-20 -143.74 105.82 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.136 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.79 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.3 mt -114.34 103.34 55.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.458 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.474 ' CD ' HD22 ' A' ' 233' ' ' LEU . 15.8 Cg_exo -68.92 153.8 72.0 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.093 2.529 . . . . 0.0 112.97 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 6.1 Cg_endo -47.31 -26.98 6.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.463 2.776 . . . . 0.0 112.278 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -48.84 80.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.389 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.826 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -98.76 -19.59 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 8.7 mtt180 -55.47 -50.12 70.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.963 0.411 . . . . 0.0 111.187 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 12.3 mtp180 -84.63 -32.57 23.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.099 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.0 tt -84.41 -45.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.649 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 7.0 t -74.06 -44.63 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 t -67.54 -6.25 18.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 3.3 mpt_? -108.86 -19.22 13.48 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.748 ' HE2' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -99.03 38.6 1.37 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.438 -178.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 t -52.5 121.92 7.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.548 0.213 . . . . 0.0 110.616 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -178.5 -25.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -78.97 19.92 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 50.24 4.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.595 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.417 ' HB ' HD22 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -151.64 159.9 43.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.734 0.767 . . . . 0.0 109.729 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 4.4 mt-30 -115.52 97.96 6.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.406 0.622 . . . . 0.0 111.72 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.441 ' HG3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -143.24 126.74 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.518 ' SG ' HG21 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -131.49 145.94 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.944 -178.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 1.0 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -143.76 162.11 36.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.586 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -129.26 112.51 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.403 0.621 . . . . 0.0 110.013 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.648 HG12 HG22 ' A' ' 230' ' ' VAL . 1.3 m -107.76 146.89 13.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.305 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 228' ' ' SER . 3.4 mt-10 -136.54 112.41 9.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.594 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 269' ' ' ALA . 0.1 OUTLIER -107.67 -179.33 3.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.17 0.509 . . . . 0.0 111.517 -178.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.16 -36.81 61.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.78 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -162.6 145.31 10.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.205 0.526 . . . . 0.0 111.932 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 184' ' ' LYS . 8.9 p -59.69 -22.65 24.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.0 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.873 ' O ' HG22 ' A' ' 270' ' ' ILE . 1.6 mt-10 -64.07 -45.03 90.53 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.068 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -55.08 -56.75 16.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.759 ' HB2' ' CE2' ' A' ' 263' ' ' PHE . . . -60.85 -37.15 81.1 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.873 HG22 ' O ' ' A' ' 267' ' ' GLU . 6.2 tt -51.76 -32.7 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.409 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -34.19 40.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.413 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -74.78 -51.0 15.29 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.543 ' O ' HG12 ' A' ' 277' ' ' ILE . 19.5 t-80 -48.98 -53.21 20.86 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.999 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.88 -50.06 61.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.848 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 272' ' ' ALA . 0.1 OUTLIER -74.96 -24.67 58.49 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.892 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.92 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -75.34 -57.47 3.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.99 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 273' ' ' HIS . 5.1 pt -70.97 -33.58 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 277' ' ' ILE . 54.6 m -65.18 -34.13 77.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.786 0.327 . . . . 0.0 110.558 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.97 -27.98 16.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 276' ' ' MET . 40.9 t -55.74 -28.98 58.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.711 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.55 146.9 38.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.97 -38.18 2.97 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.562 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.11 121.38 44.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.15 65.07 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.438 ' HA ' ' OD1' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -132.93 -171.26 2.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.741 -178.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.509 ' HE2' HD12 ' A' ' 191' ' ' LEU . 0.0 OUTLIER -27.79 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.312 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 189' ' ' TYR . 20.0 ttmt -144.97 163.95 32.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.812 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 1.057 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -151.17 154.89 37.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.524 -0.47 . . . . 0.0 112.251 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.513 ' HB ' ' OH ' ' A' ' 189' ' ' TYR . 7.4 p -156.37 140.87 8.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.659 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.449 HD23 HG23 ' A' ' 266' ' ' VAL . 3.3 mp -82.24 116.86 21.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.361 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.6 HG23 ' HG3' ' A' ' 185' ' ' MET . 0.0 OUTLIER -117.43 121.36 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.622 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.491 ' N ' HD13 ' A' ' 291' ' ' ILE . . . -101.99 147.4 17.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.912 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 53.9 mtm -83.33 -173.42 4.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.81 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.23 108.88 1.89 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 122.447 2.098 . . . . 0.0 112.26 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' H ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -89.3 147.26 37.85 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.52 -50.19 2.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.657 2.238 . . . . 0.0 112.271 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.52 140.86 16.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.472 ' HG2' ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -174.56 78.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.046 0.451 . . . . 0.0 111.182 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.405 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 2.2 mtm -118.92 120.37 37.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.585 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 261' ' ' VAL . 0.5 OUTLIER -89.38 134.94 33.86 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.803 HD23 HG21 ' A' ' 291' ' ' ILE . 0.3 OUTLIER -119.0 146.61 44.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.924 -179.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.95 HG22 ' HB3' ' A' ' 259' ' ' ALA . 17.6 m -102.31 167.55 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.512 ' CZ ' ' HG2' ' A' ' 287' ' ' LYS . 4.3 p90 -164.24 148.79 9.93 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.499 ' CB ' HG11 ' A' ' 253' ' ' VAL . 17.5 t70 59.9 54.95 4.04 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 112.993 -1.912 . . . . 0.0 114.056 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -98.54 -29.08 13.28 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 0.0 110.138 177.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.816 ' HA ' HD13 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -82.49 -8.66 59.61 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 255' ' ' THR . 0.3 OUTLIER -80.98 9.45 6.5 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.723 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.6 139.86 71.19 Favored Pre-proline 0 N--CA 1.454 -0.256 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.906 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 10.1 Cg_endo -53.61 -28.58 46.7 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.339 2.026 . . . . 0.0 112.025 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -77.99 -27.66 49.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.337 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.816 HD13 ' HA ' ' A' ' 192' ' ' TYR . 5.1 tt -84.84 -58.75 2.58 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -91.71 -38.89 12.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -70.49 -26.69 63.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.675 0.274 . . . . 0.0 111.395 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -26.76 54.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.052 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 65.93 125.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.203 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.8 t -148.3 107.5 3.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.55 -56.0 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.387 2.058 . . . . 0.0 112.418 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.46 145.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.963 0.411 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -156.02 -46.24 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.609 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -168.14 64.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.422 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.657 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 87.04 104.57 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.871 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.657 ' O ' ' O ' ' A' ' 207' ' ' GLY . 1.7 ttm180 -43.31 -158.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.7 t -41.12 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.142 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 214' ' ' MET . 0.0 OUTLIER -61.61 -47.51 85.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.816 -179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -76.03 -41.22 51.59 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -53.82 -48.73 69.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.001 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 209' ' ' VAL . 34.5 m -74.39 -44.54 48.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.467 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -51.63 -52.77 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -179.041 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.35 -53.81 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -56.7 -34.55 67.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.704 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.477 HD21 ' HE1' ' A' ' 286' ' ' MET . 1.2 mp -71.9 -31.26 66.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 111.502 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 8.7 tp -52.88 -56.91 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.768 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -64.73 -49.07 72.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.409 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.89 -36.17 74.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.23 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 224' ' ' PHE . 3.4 m-85 -82.79 -42.49 17.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.937 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.78 -25.32 65.53 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 60.6 m -64.73 -47.4 78.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.643 0.258 . . . . 0.0 111.15 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.623 ' CG ' ' HB2' ' A' ' 272' ' ' ALA . 5.0 p90 -96.06 -17.01 21.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.526 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 172.34 114.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.704 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.23 142.27 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.085 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.838 HG21 HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -92.61 132.28 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.789 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.5 -31.0 42.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.594 179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.1 t -167.53 143.75 4.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.838 HG22 HG21 ' A' ' 227' ' ' ILE . 2.3 t -134.22 108.76 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.523 ' HB3' HG12 ' A' ' 260' ' ' ILE . 0.4 OUTLIER -102.72 106.8 17.5 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.692 HD11 ' NZ ' ' A' ' 234' ' ' LYS . 3.9 tt -97.13 126.93 49.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.927 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.63 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.6 pp -126.09 111.54 14.8 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.07 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.692 ' NZ ' HD11 ' A' ' 232' ' ' ILE . 3.6 mptt -89.9 168.74 13.96 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.976 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 37.7 Cg_endo -66.57 157.84 58.72 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.133 2.555 . . . . 0.0 113.99 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.72 28.01 50.99 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.231 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -76.47 0.44 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.991 0.425 . . . . 0.0 110.584 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 23.6 mt-10 -142.74 116.25 9.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.183 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.63 HD23 ' CD1' ' A' ' 233' ' ' LEU . 7.2 mt -129.42 103.08 18.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.59 ' CD ' HD22 ' A' ' 233' ' ' LEU . 21.7 Cg_exo -64.77 153.18 79.12 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.597 2.198 . . . . 0.0 111.8 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.37 -33.8 23.56 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.658 2.239 . . . . 0.0 112.632 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.41 ' O ' HG12 ' A' ' 246' ' ' ILE . 0.5 OUTLIER -56.51 -35.03 67.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.641 HD13 ' N ' ' A' ' 243' ' ' ILE . 0.0 OUTLIER -96.69 -25.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.352 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 240' ' ' PRO . 7.5 mmt180 -56.47 -33.68 66.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.941 0.401 . . . . 0.0 110.747 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -84.31 -46.75 11.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.026 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.508 HG13 ' HA ' ' A' ' 243' ' ' ILE . 0.9 OUTLIER -84.0 -50.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.9 t -53.67 -47.36 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.927 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -1.97 42.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.949 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -40.85 9.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.475 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 29.0 p90 -96.66 38.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 75.2 m -56.47 120.16 7.24 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -26.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.499 HG11 ' CB ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -85.96 16.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 67.33 -6.0 2.63 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.726 -0.75 . . . . 0.0 114.009 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.589 ' CG2' HD13 ' A' ' 193' ' ' LEU . 2.1 t -153.97 145.02 22.76 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 117.094 0.447 . . . . 0.0 109.917 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.46 99.47 7.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.4 0.619 . . . . 0.0 111.678 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 133.95 54.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 86.8 m -135.99 146.24 46.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.221 -0.992 . . . . 0.0 113.346 -178.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.95 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -145.26 141.43 28.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.834 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.617 HD11 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -107.73 114.1 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.565 0.698 . . . . 0.0 112.125 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' A' ' 186' ' ' LEU . 1.2 m -97.76 146.79 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.807 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -127.04 96.12 4.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.566 177.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.8 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 10.2 m-85 -84.62 -179.93 7.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.153 0.502 . . . . 0.0 111.942 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.98 -30.04 63.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.694 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -160.4 144.29 13.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.055 0.455 . . . . 0.0 111.573 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.472 ' HB ' ' HG2' ' A' ' 184' ' ' LYS . 10.6 p -55.74 -23.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.76 ' HA ' HD12 ' A' ' 270' ' ' ILE . 1.5 mt-10 -64.22 -55.64 20.21 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.09 -54.91 11.59 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.8 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -51.49 -41.88 61.27 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.003 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 267' ' ' GLU . 20.9 mt -56.41 -39.61 62.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.585 0.231 . . . . 0.0 111.603 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.42 94.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.763 0.316 . . . . 0.0 111.274 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' A' ' 224' ' ' PHE . . . -84.84 -30.17 24.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.298 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.596 ' O ' ' HB ' ' A' ' 277' ' ' ILE . 13.3 t-80 -49.99 -56.94 8.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 278' ' ' THR . 3.1 mm-40 -72.35 -38.29 68.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 272' ' ' ALA . 26.2 t80 -57.12 -48.11 79.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.891 0.377 . . . . 0.0 110.104 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.465 ' CE ' ' HB2' ' A' ' 288' ' ' ALA . 0.8 OUTLIER -77.42 -43.03 33.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.254 179.083 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 273' ' ' HIS . 3.8 mt -57.9 -50.6 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.744 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 274' ' ' GLU . 69.9 p -66.42 -45.34 80.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.86 -46.46 87.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.999 0.428 . . . . 0.0 110.474 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 286' ' ' MET . 24.5 p -60.88 -31.8 71.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.516 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.41 136.62 53.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.13 -37.39 3.36 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.48 134.91 48.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.557 0.218 . . . . 0.0 110.625 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 64.73 1.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.96 0.409 . . . . 0.0 110.011 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -131.27 -174.29 3.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.247 0.546 . . . . 0.0 112.007 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.725 ' HG2' ' HB3' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -40.44 129.54 2.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.199 -0.91 . . . . 0.0 113.18 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.512 ' HG2' ' CZ ' ' A' ' 189' ' ' TYR . 43.0 tttt -146.83 157.43 43.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.504 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.465 ' HB2' ' CE ' ' A' ' 276' ' ' MET . . . -132.39 164.1 27.25 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 111.985 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.456 HG12 ' HE1' ' A' ' 189' ' ' TYR . 14.9 p -147.45 149.87 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.656 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.1 mt -86.69 123.55 31.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.803 HG21 HD23 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.14 144.45 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.32 0.581 . . . . 0.0 111.53 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 93.74 40.9 4.55 Favored Glycine 0 C--N 1.32 -0.343 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.647 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.07 -39.75 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.709 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.9 109.31 53.27 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.768 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.422 2.082 . . . . 0.0 112.353 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.769 0.318 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.666 HD13 ' HD3' ' A' ' 184' ' ' LYS . 3.6 pp -89.05 128.51 51.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 3.1 Cg_exo -74.43 -70.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.581 2.187 . . . . 0.0 111.955 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.44 150.47 31.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.423 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.666 ' HD3' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -179.03 75.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.019 0.438 . . . . 0.0 111.207 -179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.562 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.1 mtp -114.24 155.4 26.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.307 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.021 HD21 ' HB1' ' A' ' 288' ' ' ALA . 0.3 OUTLIER -123.54 138.87 54.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 111.261 -179.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.644 HD23 ' HB ' ' A' ' 291' ' ' ILE . 3.6 pp -119.72 146.09 45.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.271 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 259' ' ' ALA . 4.1 m -103.26 170.48 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.622 ' HD2' HG21 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -168.12 144.66 3.99 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.747 ' OD1' HD23 ' A' ' 193' ' ' LEU . 49.7 t0 60.52 50.44 5.85 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.785 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.863 HD12 ' N ' ' A' ' 192' ' ' TYR . 0.9 OUTLIER -100.36 -20.16 15.96 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.666 . . . . 0.0 109.622 176.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.863 ' N ' HD12 ' A' ' 191' ' ' LEU . 33.4 t80 -58.99 -30.41 67.95 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.747 HD23 ' OD1' ' A' ' 190' ' ' ASP . 0.5 OUTLIER -69.13 12.61 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.05 145.14 88.43 Favored Pre-proline 0 N--CA 1.456 -0.167 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 76.5 Cg_exo -51.72 -31.68 42.38 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.383 2.055 . . . . 0.0 113.281 -177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -78.19 -39.06 41.9 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.791 -0.363 . . . . 0.0 111.585 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.961 HD22 HG13 ' A' ' 209' ' ' VAL . 12.7 mt -87.47 -48.1 8.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -87.09 -44.33 11.62 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.5 -24.88 39.11 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 201' ' ' ALA . 0.4 OUTLIER -87.28 -37.02 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.692 0.282 . . . . 0.0 110.988 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 200' ' ' LEU . . . 67.52 -71.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.255 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 27.6 p -57.38 118.43 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.048 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 -167.96 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.541 2.161 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.06 143.71 24.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 169.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.31 129.28 39.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.777 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.656 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 103.25 88.87 2.08 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.244 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.656 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -43.94 -159.82 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.961 HG13 HD22 ' A' ' 197' ' ' LEU . 61.6 t -41.36 -27.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.816 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 214' ' ' MET . 9.2 pt20 -58.24 -48.05 81.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.185 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -42.54 46.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 0.0 111.454 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -47.69 71.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.581 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 217' ' ' LEU . 21.5 t -74.37 -36.74 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.573 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 210' ' ' GLN . 0.5 OUTLIER -51.63 -48.29 63.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.5 -179.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -64.98 -52.87 53.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.833 -179.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -55.96 -34.53 65.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.424 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.867 HD11 HG12 ' A' ' 213' ' ' VAL . 17.1 mt -71.47 -33.97 69.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.372 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 215' ' ' GLU . 46.4 mt -52.91 -43.77 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.656 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -73.19 -49.0 30.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.586 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.446 ' O ' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -65.99 -30.3 70.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.524 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.491 ' CE1' HD22 ' A' ' 217' ' ' LEU . 17.2 m-85 -90.96 -49.77 6.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.705 0.288 . . . . 0.0 110.919 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -56.36 -30.53 58.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.988 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 5.4 t -60.31 -47.54 85.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.589 0.233 . . . . 0.0 111.148 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 8.7 p90 -96.27 -17.54 20.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.584 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' O ' ' CZ ' ' A' ' 263' ' ' PHE . . . 177.01 125.33 0.89 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.919 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.34 135.26 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.516 0.198 . . . . 0.0 111.284 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 230' ' ' VAL . 0.6 OUTLIER -84.57 131.14 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.38 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.34 -30.94 42.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.755 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 18.9 m -164.59 143.65 7.12 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.795 HG13 HG12 ' A' ' 261' ' ' VAL . 1.4 t -135.91 108.91 8.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.263 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 260' ' ' ILE . 53.4 mtp180 -102.94 106.56 17.13 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 232' ' ' ILE . 6.5 tt -96.01 123.45 48.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.619 -177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.1 pp -125.67 113.54 17.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.804 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -94.43 154.82 40.19 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.258 178.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 9.4 Cg_endo -51.23 159.59 2.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.721 2.281 . . . . 0.0 113.119 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 61.53 28.51 69.76 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.617 -0.719 . . . . 0.0 113.112 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -140.78 -86.27 0.19 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.115 0.457 . . . . 0.0 111.404 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.551 ' O ' HD13 ' A' ' 233' ' ' LEU . 1.5 mt-10 -132.68 113.07 12.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.7 0.286 . . . . 0.0 111.139 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 233' ' ' LEU . 13.3 mt -118.83 94.96 48.71 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.007 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.428 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 22.4 Cg_exo -64.28 153.7 75.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.75 2.3 . . . . 0.0 112.32 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 10.1 Cg_endo -53.28 -34.07 68.43 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.745 2.297 . . . . 0.0 112.571 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 246' ' ' ILE . 8.3 m-20 -55.42 -36.34 66.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.321 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.696 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.75 -29.99 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.757 0.313 . . . . 0.0 111.327 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 56.9 mtp180 -53.92 -46.93 71.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.252 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 7.3 ttm-85 -84.28 -39.41 19.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.0 tt -84.16 -45.22 18.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 0.5 OUTLIER -64.38 -44.14 92.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.02 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.5 m -78.13 -2.22 36.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.443 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.0 -40.87 11.41 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 15.8 p90 -93.53 39.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.82 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.33 110.45 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.72 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -166.71 -28.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 189' ' ' TYR . 3.0 t -72.57 6.73 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.54 21.0 0.69 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.425 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.683 ' OG1' HD21 ' A' ' 193' ' ' LEU . 18.4 m -151.3 157.99 43.24 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.452 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -130.22 96.61 4.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.365 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -144.25 140.78 29.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 188' ' ' VAL . 16.8 m -151.33 152.77 33.62 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.268 -0.973 . . . . 0.0 113.343 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -147.9 162.12 39.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.416 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.506 ' N ' ' O ' ' A' ' 231' ' ' ARG . 7.0 mt -128.27 113.37 29.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.434 0.635 . . . . 0.0 111.876 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.795 HG12 HG13 ' A' ' 230' ' ' VAL . 27.4 m -98.1 147.73 6.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.044 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 228' ' ' SER . 0.0 OUTLIER -128.22 95.78 4.26 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.733 177.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 227' ' ' ILE . 2.1 m-85 -86.84 169.12 12.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -75.13 -27.12 59.65 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.494 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.8 129.72 11.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.289 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 184' ' ' LYS . 11.1 p -51.62 -23.16 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.918 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.865 ' HA ' HD12 ' A' ' 270' ' ' ILE . 0.7 OUTLIER -63.16 -52.01 64.12 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.193 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -49.51 -57.65 6.65 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.578 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -51.04 -33.68 26.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.325 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 267' ' ' GLU . 17.1 mt -65.63 -49.93 74.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.661 0.267 . . . . 0.0 111.537 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 272' ' ' ALA . 14.5 ptmt -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -84.77 -39.83 17.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.408 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.678 ' O ' HG12 ' A' ' 277' ' ' ILE . 2.3 t-160 -50.76 -56.82 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.422 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 278' ' ' THR . 2.0 mt-10 -59.54 -47.44 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.895 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -57.33 -35.08 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.747 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.521 ' HE3' ' HG2' ' A' ' 286' ' ' MET . 2.7 mtp -76.54 -50.09 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.397 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.678 HG12 ' O ' ' A' ' 273' ' ' HIS . 31.5 pt -70.44 -37.62 71.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.675 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 274' ' ' GLU . 13.1 t -60.96 -42.87 99.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.468 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.04 -41.05 26.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.339 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 46.8 t -59.73 -33.21 71.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.555 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -49.91 131.96 22.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.591 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.91 -36.74 3.84 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.779 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -106.18 123.95 48.82 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -70.27 65.63 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 110.137 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -170.61 2.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.731 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.521 ' HG2' ' HE3' ' A' ' 276' ' ' MET . 11.7 ttt -27.46 136.16 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.935 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.51 ' CB ' ' CZ ' ' A' ' 189' ' ' TYR . 9.8 mttm -145.67 167.94 21.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.564 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 1.021 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -145.2 144.01 30.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.83 0.348 . . . . 0.0 111.549 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.445 ' HA ' ' CE1' ' A' ' 273' ' ' HIS . 13.5 p -139.68 148.75 22.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.798 HD12 HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -82.82 121.39 26.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.552 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.807 HD13 ' N ' ' A' ' 292' ' ' GLY . 0.0 OUTLIER -108.87 133.09 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.817 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.807 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 126.89 118.32 2.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.26 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -179.55 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 0.0 111.172 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.29 103.9 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--O 1.249 1.071 0 C-N-CA 122.426 2.084 . . . . 0.0 112.343 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 139.2 34.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.19 -59.54 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.387 2.058 . . . . 0.0 112.597 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.5 m -164.07 150.94 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -178.57 75.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.667 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.443 ' O ' HG12 ' A' ' 291' ' ' ILE . 3.1 ttp -117.81 156.09 28.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.641 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.75 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -122.03 134.63 54.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.1 tp -110.74 145.29 38.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.648 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.762 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.2 OUTLIER -97.73 157.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.991 0.901 . . . . 0.0 113.106 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.627 ' HB2' ' CA ' ' A' ' 287' ' ' LYS . 5.4 m-85 -116.43 174.28 6.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.229 -1.805 . . . . 0.0 113.904 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.853 ' OD2' HG21 ' A' ' 253' ' ' VAL . 7.2 m-20 -13.03 76.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.984 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -97.68 -13.96 21.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.896 0.379 . . . . 0.0 110.378 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.624 ' N ' HD22 ' A' ' 191' ' ' LEU . 36.5 t80 -73.86 -33.67 64.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.944 HD13 HG21 ' A' ' 255' ' ' THR . 8.9 mp -75.29 13.19 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 145.76 89.69 Favored Pre-proline 0 N--CA 1.454 -0.248 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.3 Cg_endo -51.85 -31.69 43.69 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.584 2.189 . . . . 0.0 113.067 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 4.4 mttp -78.24 -39.23 40.91 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.702 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 209' ' ' VAL . 3.8 mm? -87.44 -48.12 8.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.601 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.29 -43.9 11.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -176.315 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.25 -41.08 25.72 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 1.0 OUTLIER -77.22 -37.11 54.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.755 0.312 . . . . 0.0 111.065 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.71 162.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.19 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 22.2 p -134.69 104.16 10.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.89 -50.85 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.552 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -147.48 133.4 19.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.78 155.37 0.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.89 -69.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.604 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -94.3 68.64 1.35 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.22 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.604 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -47.61 -155.27 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.968 HG23 HD12 ' A' ' 197' ' ' LEU . 7.6 p -40.76 -29.02 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -59.19 -47.59 84.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.137 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.437 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.6 OUTLIER -75.69 -46.53 30.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.351 . . . . 0.0 111.588 -179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 197' ' ' LEU . 35.6 mttm -53.91 -48.84 69.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.857 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.8 HG12 ' O ' ' A' ' 209' ' ' VAL . 12.6 p -73.08 -33.77 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.751 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -46.3 62.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.422 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -51.38 35.33 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -55.74 -46.95 77.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.234 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 213' ' ' VAL . 7.0 mp -58.39 -31.02 67.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 222' ' ' GLY . 1.8 tp -53.22 -55.73 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.701 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -49.48 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.201 . . . . 0.0 111.255 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 0.2 OUTLIER -62.13 -42.43 99.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.384 0.612 . . . . 0.0 109.706 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.675 ' HB3' HD11 ' A' ' 227' ' ' ILE . 2.7 m-85 -80.96 1.01 32.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.449 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 218' ' ' LEU . . . -99.47 -38.7 3.64 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.263 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -71.97 -33.51 68.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.273 -0.464 . . . . 0.0 112.027 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.1 p90 -102.43 -21.74 14.2 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 170.86 101.31 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 119.305 -1.426 . . . . 0.0 112.879 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.9 t -51.51 151.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.7 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 221' ' ' PHE . 0.3 OUTLIER -108.57 138.37 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.902 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -79.08 -28.73 43.12 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.5 t -167.51 144.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.057 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.724 HG22 HG12 ' A' ' 261' ' ' VAL . 13.9 t -130.67 107.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.08 0.467 . . . . 0.0 110.464 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.19 108.32 19.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.733 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 259' ' ' ALA . 10.2 pt -101.23 120.78 51.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.231 0.539 . . . . 0.0 111.903 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.645 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.9 pp -111.69 111.1 21.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.027 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.702 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -86.1 151.3 54.15 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.595 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.702 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 7.4 Cg_endo -48.09 165.77 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.373 2.715 . . . . 0.0 114.047 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.27 28.25 49.37 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.802 178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -142.13 -89.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.466 0.633 . . . . 0.0 111.922 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.7 mt-10 -124.37 104.71 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.645 HD23 ' CD1' ' A' ' 233' ' ' LEU . 16.0 mt -116.78 95.17 45.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.168 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.563 ' CD ' HD22 ' A' ' 233' ' ' LEU . 26.1 Cg_exo -62.67 153.34 72.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.811 2.341 . . . . 0.0 112.238 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -48.0 -36.72 28.37 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.734 2.289 . . . . 0.0 113.023 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 246' ' ' ILE . 4.7 m-20 -55.35 -36.51 66.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.421 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.649 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -100.99 -26.72 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.459 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -54.01 -49.51 68.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.995 0.426 . . . . 0.0 111.363 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -84.25 -39.98 18.59 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 243' ' ' ILE . 3.8 tt -84.21 -43.23 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 0.4 OUTLIER -67.74 -45.78 74.02 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.478 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.16 -2.11 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.881 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -92.41 -37.68 12.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 4.7 p90 -90.88 38.33 0.95 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.41 119.96 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.395 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.98 -26.36 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.853 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.3 t -82.03 23.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.97 18.86 0.3 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 121.211 -0.519 . . . . 0.0 114.173 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.944 HG21 HD13 ' A' ' 193' ' ' LEU . 5.9 t -159.31 166.19 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.323 0.562 . . . . 0.0 109.957 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 235' ' ' PRO . 1.3 mt-30 -140.33 105.3 4.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.098 0.475 . . . . 0.0 111.994 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 234' ' ' LYS . 2.0 mm-40 -143.31 137.52 28.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.412 ' HB2' ' HG ' ' A' ' 233' ' ' LEU . 5.1 m -131.59 146.89 52.44 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.728 -0.789 . . . . 0.0 112.535 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.762 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.29 141.53 35.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.026 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.458 HG12 HD12 ' A' ' 187' ' ' LEU . 2.4 mt -119.41 113.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.13 0.491 . . . . 0.0 111.768 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.724 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -107.67 143.52 18.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.018 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.5 mp0 -123.77 96.07 4.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.919 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.641 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 25.2 m-85 -84.83 177.71 7.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.009 0.433 . . . . 0.0 111.314 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.02 -24.78 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.912 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 27.7 mt-10 -161.8 161.03 28.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.093 0.473 . . . . 0.0 111.978 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 270' ' ' ILE . 7.8 p -67.83 -23.62 29.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.158 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -18.41 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.926 0.869 . . . . 0.0 108.694 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 265' ' ' GLU . . . -79.08 -60.4 2.39 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.75 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -61.01 -36.9 80.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.85 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.554 ' CD1' HG22 ' A' ' 266' ' ' VAL . 24.6 mt -58.01 -47.01 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -44.25 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -81.24 -30.34 34.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.67 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.82 ' CD2' HD13 ' A' ' 290' ' ' LEU . 2.3 t60 -50.73 -56.38 12.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.802 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -40.75 87.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.525 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.471 ' CE1' HD21 ' A' ' 220' ' ' LEU . 31.7 t80 -57.18 -47.67 80.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.858 0.361 . . . . 0.0 110.269 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.447 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.05 -39.35 55.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.18 179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -60.31 -52.51 60.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.158 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 3.6 m -66.34 -45.44 80.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.135 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -67.97 -32.01 72.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.993 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.522 ' HB2' ' HG2' ' A' ' 287' ' ' LYS . 58.1 p -69.56 -42.3 74.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.49 142.44 44.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.539 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 91.9 -36.86 3.52 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.562 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.87 -167.1 1.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.907 0.384 . . . . 0.0 110.557 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.5 50.74 2.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.95 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 2.1 m-80 -124.44 -171.79 2.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.851 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 191' ' ' LEU . 36.2 mtp -37.26 127.11 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.193 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.627 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 1.3 mtpt -134.43 168.64 18.57 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.509 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.447 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -135.13 151.24 50.52 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 291' ' ' ILE . 9.8 p -138.99 142.55 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.423 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.82 HD13 ' CD2' ' A' ' 273' ' ' HIS . 0.7 OUTLIER -90.38 116.46 28.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.388 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.635 HD13 ' N ' ' A' ' 291' ' ' ILE . 1.2 mm -84.97 108.31 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.77 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -109.21 -179.39 21.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.714 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.2 -46.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.813 0.34 . . . . 0.0 110.854 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -65.84 162.3 46.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.587 2.191 . . . . 0.0 112.266 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.782 0.325 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.625 HD13 ' HD3' ' A' ' 184' ' ' LYS . 1.2 pp -84.5 126.85 67.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.018 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.41 -49.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.65 2.233 . . . . 0.0 112.707 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.5 m -164.0 150.88 11.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.676 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.625 ' HD3' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -174.8 74.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.055 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.543 ' O ' HG22 ' A' ' 291' ' ' ILE . 1.9 ptt? -114.55 155.39 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.773 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.834 HD21 ' HB1' ' A' ' 288' ' ' ALA . 6.7 tt -118.73 141.83 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -116.1 145.96 42.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.028 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 259' ' ' ALA . 2.3 m -86.84 172.13 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 287' ' ' LYS . 59.8 m-85 -145.78 131.29 18.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.837 ' OD2' HD22 ' A' ' 193' ' ' LEU . 33.8 t0 43.11 54.06 5.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 113.624 -1.625 . . . . 0.0 114.34 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.0 OUTLIER -78.97 -18.59 53.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -75.59 -27.81 58.69 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.837 HD22 ' OD2' ' A' ' 190' ' ' ASP . 8.8 mp -75.92 13.54 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.9 t -71.42 144.74 89.54 Favored Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 7.8 Cg_endo -51.6 -31.69 41.24 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.615 2.21 . . . . 0.0 113.017 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -78.29 -39.11 40.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.594 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -48.24 8.13 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.594 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.12 -44.08 11.18 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.23 -14.92 58.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 tt -92.41 -35.65 13.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.758 0.313 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.55 110.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.146 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 33.9 p -134.61 101.06 12.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.29 -47.91 1.43 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.45 2.1 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.93 147.38 6.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -177.14 -50.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -177.55 102.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.634 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 58.48 74.07 0.39 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.107 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.628 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.8 ttm180 -43.93 -158.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 213' ' ' VAL . 21.4 t -41.22 -28.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.138 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -63.06 -43.35 98.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.627 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.485 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -75.63 -51.01 13.79 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 111.483 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -53.88 -40.91 67.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.821 HG23 ' HG ' ' A' ' 191' ' ' LEU . 11.1 p -74.42 -45.67 45.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG13 ' A' ' 213' ' ' VAL . 0.0 OUTLIER -69.03 -39.37 79.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.627 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -69.64 -53.8 16.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -62.27 -50.63 70.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.756 0.313 . . . . 0.0 111.455 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.69 HD21 ' CE2' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -53.77 -33.89 57.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.52 -179.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.75 -56.91 14.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.74 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -62.86 -49.07 76.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.682 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.34 -32.77 72.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.317 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 217' ' ' LEU . 3.5 m-30 -85.71 -35.13 21.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.748 0.308 . . . . 0.0 110.675 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -68.89 -26.13 74.83 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.26 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.7 p -61.28 -47.45 85.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.651 0.263 . . . . 0.0 111.013 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.551 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.4 p90 -91.12 -14.29 31.46 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.506 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 160.02 120.09 0.55 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.606 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 20.4 t -52.09 146.92 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.528 HG23 ' CD2' ' A' ' 263' ' ' PHE . 0.8 OUTLIER -93.58 139.52 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.4 OUTLIER -83.35 -29.67 28.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.953 179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 33.3 t -165.02 144.19 6.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.735 HG22 HG12 ' A' ' 261' ' ' VAL . 22.0 t -133.45 108.22 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.061 0.458 . . . . 0.0 110.234 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -106.95 108.25 19.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.476 179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -99.18 132.5 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.541 0.686 . . . . 0.0 112.38 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.764 ' C ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -120.49 136.41 54.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.374 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.609 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -112.16 169.21 6.59 Favored Pre-proline 0 C--N 1.31 -1.147 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 55.7 Cg_endo -73.77 164.41 34.78 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 121.811 1.674 . . . . 0.0 114.59 -177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.99 33.6 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.204 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -140.46 -89.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.25 0.525 . . . . 0.0 111.868 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 1.2 mm-40 -127.69 111.26 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.068 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.432 ' O ' ' CD ' ' A' ' 244' ' ' ARG . 1.0 OUTLIER -120.88 94.48 48.94 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.658 0.266 . . . . 0.0 110.572 179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.768 ' HD2' HD11 ' A' ' 243' ' ' ILE . 47.8 Cg_exo -56.65 153.92 33.67 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.929 2.419 . . . . 0.0 112.959 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 244' ' ' ARG . 87.9 Cg_exo -46.89 -23.65 2.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.966 2.444 . . . . 0.0 112.702 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.499 ' HB2' HD13 ' A' ' 243' ' ' ILE . 44.5 m-20 -61.91 -43.76 98.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.055 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.768 HD11 ' HD2' ' A' ' 240' ' ' PRO . 0.0 OUTLIER -102.35 -23.64 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.132 179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 241' ' ' PRO . 1.6 ttt180 -54.46 -49.98 68.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.591 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 -41.71 15.71 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.8 tt -84.52 -48.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 250' ' ' TYR . 0.9 OUTLIER -73.21 -35.92 66.41 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 244' ' ' ARG . 19.4 t -62.8 -38.23 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.834 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -97.97 12.7 33.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.76 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 189' ' ' TYR . 1.1 t80 -83.69 59.75 5.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.957 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.66 106.97 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 173.43 -26.5 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.68 0.276 . . . . 0.0 111.456 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 190' ' ' ASP . 0.1 OUTLIER -97.54 9.62 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 45.59 18.7 0.23 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 114.408 0.523 . . . . 0.0 114.408 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.661 HG21 HD13 ' A' ' 193' ' ' LEU . 0.9 OUTLIER -167.08 163.6 15.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.483 0.641 . . . . 0.0 110.132 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -118.27 94.38 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.272 0.558 . . . . 0.0 111.474 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -145.39 124.14 12.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 233' ' ' LEU . 7.9 m -141.96 166.72 23.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.481 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.736 ' HB3' HG22 ' A' ' 188' ' ' VAL . . . -140.55 163.14 33.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.818 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 231' ' ' ARG . 19.4 mt -131.64 112.95 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.025 0.44 . . . . 0.0 110.335 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.735 HG12 HG22 ' A' ' 230' ' ' VAL . 3.0 m -111.85 144.41 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.662 0.744 . . . . 0.0 112.149 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 228' ' ' SER . 2.2 mp0 -133.04 101.26 5.16 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.735 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 269' ' ' ALA . 2.2 m-85 -89.86 -179.51 5.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.671 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -19.05 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.855 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.428 ' HB3' ' CG ' ' A' ' 267' ' ' GLU . 1.3 tt0 -163.11 140.09 7.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.138 0.494 . . . . 0.0 111.572 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.57 -24.07 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.424 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.919 ' HA ' HD12 ' A' ' 270' ' ' ILE . 5.3 pt-20 -67.09 -48.02 69.47 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -47.99 -50.59 26.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.628 ' HB2' ' CD1' ' A' ' 263' ' ' PHE . . . -62.0 -38.47 88.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.153 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 267' ' ' GLU . 44.7 mt -52.38 -41.38 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.724 0.297 . . . . 0.0 111.203 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -72.85 -33.53 66.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.017 0.437 . . . . 0.0 110.386 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' CB ' ' CZ ' ' A' ' 224' ' ' PHE . . . -75.09 -33.03 61.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.44 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.731 ' CE1' HD13 ' A' ' 277' ' ' ILE . 49.4 t-80 -69.23 -55.61 10.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.492 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 278' ' ' THR . 0.0 OUTLIER -51.89 -50.12 61.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.062 -178.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 272' ' ' ALA . 0.2 OUTLIER -67.16 -26.58 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.528 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . . . . . . . . . 14.3 mmm -76.75 -58.65 3.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.07 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.731 HD13 ' CE1' ' A' ' 273' ' ' HIS . 16.0 pt -64.06 -36.26 76.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.798 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.4 t -63.76 -41.13 98.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -39.16 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.573 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 17.8 p -61.87 -29.89 70.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -57.56 144.03 38.75 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.04 -36.81 3.25 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.308 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.76 -175.97 2.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.509 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.05 58.0 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.952 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -132.92 -171.99 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.797 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 189' ' ' TYR . 2.0 mtp -28.1 110.38 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.409 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 189' ' ' TYR . 11.4 tttt -132.01 166.46 21.66 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.834 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -146.6 160.04 42.67 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.807 -0.757 . . . . 0.0 113.04 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.52 136.39 17.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.719 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 186' ' ' LEU . 2.7 mt -86.83 118.69 26.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.148 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 185' ' ' MET . 5.3 tt -110.3 143.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 95.09 87.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.51 -56.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -130.34 149.2 72.7 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.511 2.14 . . . . 0.0 112.362 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.827 ' OD1' HD12 ' A' ' 181' ' ' LEU . 6.7 p30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.745 0.307 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.827 HD12 ' OD1' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -77.14 126.89 84.68 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.82 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.59 -54.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.419 2.08 . . . . 0.0 112.72 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.1 m -164.24 150.91 11.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.907 0.384 . . . . 0.0 110.95 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.2 mttp 178.32 75.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.683 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.555 ' O ' HG22 ' A' ' 291' ' ' ILE . 7.1 ptm -114.43 155.84 25.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.062 HD21 ' HB1' ' A' ' 288' ' ' ALA . 1.4 tp -118.21 141.98 47.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.769 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.708 HD13 HG22 ' A' ' 243' ' ' ILE . 0.1 OUTLIER -114.26 145.97 41.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.288 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.938 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 2.5 t -89.25 153.47 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.582 ' CB ' ' HG3' ' A' ' 287' ' ' LYS . 3.5 m-85 -114.98 178.45 4.28 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.73 -2.032 . . . . 0.0 114.009 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 286' ' ' MET . 0.0 OUTLIER -11.32 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 113.36 -1.746 . . . . 0.0 115.044 178.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.676 HD22 ' N ' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -98.27 -21.15 16.82 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.758 177.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.676 ' N ' HD22 ' A' ' 191' ' ' LEU . 33.2 t80 -83.17 -37.37 23.77 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.8 tp -80.66 12.06 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 1.2 t -72.92 130.44 85.14 Favored Pre-proline 0 N--CA 1.453 -0.317 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.9 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 63.5 Cg_exo -51.88 -25.02 20.27 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.017 1.811 . . . . 0.0 111.882 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.15 51.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.403 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 191' ' ' LEU . 1.0 OUTLIER -85.39 -50.01 7.65 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -178.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -91.26 -40.56 11.45 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -75.18 -41.82 57.19 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.06 -37.27 61.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.691 0.281 . . . . 0.0 111.379 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 56.32 99.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.063 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.525 HG21 ' CE ' ' A' ' 212' ' ' LYS . 10.5 p -80.35 147.49 64.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.57 -167.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.587 2.192 . . . . 0.0 112.27 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.67 152.5 18.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.97 -41.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.964 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -151.1 -67.78 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.614 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -135.72 129.45 5.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.44 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.614 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -48.03 -155.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.973 0.416 . . . . 0.0 111.642 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 213' ' ' VAL . 39.0 t -41.4 -26.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.32 -47.98 81.87 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -76.16 -38.49 56.62 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.469 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.525 ' CE ' HG21 ' A' ' 202' ' ' THR . 0.0 OUTLIER -55.48 -44.67 76.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.547 ' CG1' HD21 ' A' ' 197' ' ' LEU . 34.9 m -74.31 -45.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.735 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.5 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -66.02 -41.83 90.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.629 -179.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.63 -54.23 14.97 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -59.96 -42.81 94.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.583 HD12 ' CE ' ' A' ' 286' ' ' MET . 8.4 tt -59.62 -32.54 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.414 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.417 ' HA ' HD12 ' A' ' 218' ' ' LEU . 6.9 tp -56.31 -57.16 13.43 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -53.69 -49.24 68.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 110.981 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.489 HD21 ' HE1' ' A' ' 275' ' ' PHE . 3.4 tp -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.282 0.563 . . . . 0.0 109.708 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE2' HG11 ' A' ' 261' ' ' VAL . 6.2 m-85 -79.2 0.44 28.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.04 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -99.96 -43.38 2.44 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.613 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.4 t -63.63 -36.25 83.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.025 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.696 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 1.2 p90 -102.48 -19.9 14.72 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 166.87 101.55 0.15 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.126 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 227' ' ' ILE . 17.9 t -51.72 157.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.715 ' H ' HD12 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -104.87 136.67 37.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 1.4 m -78.34 -26.01 46.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -163.52 143.13 8.43 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 261' ' ' VAL . 0.0 OUTLIER -133.2 107.69 11.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 260' ' ' ILE . 1.9 mtt180 -104.65 107.76 18.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.368 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 232' ' ' ILE . 7.4 tt -95.24 121.98 46.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.084 0.468 . . . . 0.0 111.114 -178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.724 ' CD1' HD23 ' A' ' 239' ' ' LEU . 2.3 pp -125.65 110.92 14.36 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.821 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.522 ' HG2' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -82.62 174.87 5.41 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.522 ' HD2' ' HG2' ' A' ' 234' ' ' LYS . 40.9 Cg_endo -70.15 166.29 28.56 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.282 1.988 . . . . 0.0 114.92 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 54.62 18.9 11.61 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.91 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -128.41 -88.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.585 0.692 . . . . 0.0 111.84 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 22.9 mt-10 -126.33 100.39 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.567 0.222 . . . . 0.0 111.039 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.724 HD23 ' CD1' ' A' ' 233' ' ' LEU . 6.1 mt -118.35 93.48 45.33 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.305 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.643 ' O ' HD13 ' A' ' 243' ' ' ILE . 47.9 Cg_exo -57.18 154.86 31.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.87 2.38 . . . . 0.0 112.567 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.553 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 4.6 Cg_endo -46.44 -22.87 1.85 Allowed 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.112 2.541 . . . . 0.0 112.88 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.3 m-20 -59.74 -49.56 77.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.75 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.708 HG22 HD13 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -102.02 -41.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.553 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 0.1 OUTLIER -53.09 -34.44 56.59 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.923 -0.486 . . . . 0.0 110.864 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -50.4 7.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.881 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 242' ' ' ASP . 6.5 tt -84.18 -43.05 17.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 5.1 t -63.59 -43.15 97.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.725 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 t -78.13 -2.34 36.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.387 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.71 12.94 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 3.6 p90 -90.78 44.21 1.18 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.31 . . . . 0.0 111.789 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.11 121.71 2.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.971 0.415 . . . . 0.0 111.182 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.46 -26.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.545 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.78 HG13 ' HB3' ' A' ' 284' ' ' GLU . 15.6 t -80.77 16.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 120.788 0.327 . . . . 0.0 111.793 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 43.7 17.89 0.07 OUTLIER Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.922 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.613 HG22 HG12 ' A' ' 253' ' ' VAL . 14.6 t -160.58 172.03 17.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.609 0.705 . . . . 0.0 110.812 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.4 OUTLIER -135.13 96.82 3.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.049 0.452 . . . . 0.0 111.282 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -143.06 135.22 27.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 13.0 m -154.8 157.83 38.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.324 -0.95 . . . . 0.0 112.62 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.938 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -136.51 161.94 34.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.856 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 233' ' ' LEU . 5.3 mm -120.53 113.24 39.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.073 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 1.055 HG12 HG12 ' A' ' 230' ' ' VAL . 33.5 m -115.23 138.75 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.444 0.64 . . . . 0.0 111.315 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 228' ' ' SER . 11.9 mt-10 -132.64 101.37 5.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -87.55 -179.43 6.33 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.135 0.493 . . . . 0.0 111.726 -178.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -60.31 -23.26 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.114 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -168.98 155.23 6.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.333 0.587 . . . . 0.0 112.001 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.74 HG23 HD21 ' A' ' 290' ' ' LEU . 14.4 p -57.76 -24.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.451 ' O ' ' CG1' ' A' ' 270' ' ' ILE . 0.0 OUTLIER -59.7 -59.17 5.86 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -46.45 -49.84 17.65 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 263' ' ' PHE . . . -54.65 -45.18 73.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 266' ' ' VAL . 2.3 pt -60.67 -31.38 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.663 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.464 ' N ' HG13 ' A' ' 270' ' ' ILE . 0.0 OUTLIER -68.77 -37.07 79.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.167 0.508 . . . . 0.0 110.015 179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -85.11 -30.37 24.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.106 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.667 ' NE2' HD11 ' A' ' 277' ' ' ILE . 13.0 t-80 -51.3 -56.71 11.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.469 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 277' ' ' ILE . 1.4 mm-40 -68.65 -39.18 80.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.055 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.489 ' HE1' HD21 ' A' ' 220' ' ' LEU . 36.0 t80 -60.62 -48.04 83.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 110.656 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.574 ' CE ' HG13 ' A' ' 188' ' ' VAL . 1.1 ttt -75.21 -30.94 60.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.198 0.523 . . . . 0.0 109.807 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.667 HD11 ' NE2' ' A' ' 273' ' ' HIS . 5.5 mt -70.76 -38.28 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 14.0 t -76.62 -45.54 29.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.283 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -35.87 78.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.11 0.481 . . . . 0.0 110.141 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 286' ' ' MET . 0.9 OUTLIER -94.78 16.24 16.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 179.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -68.59 146.12 53.34 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 -178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 74.71 -36.78 1.02 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 114.674 -1.148 . . . . 0.0 114.343 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.76 179.94 4.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.135 0.468 . . . . 0.0 111.391 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.78 ' HB3' HG13 ' A' ' 253' ' ' VAL . 12.4 mt-10 -102.32 61.19 0.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.304 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 287' ' ' LYS . 1.7 m120 -117.46 168.96 9.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.711 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.733 ' N ' ' O ' ' A' ' 190' ' ' ASP . 13.4 ttt -28.24 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.582 ' HG3' ' CB ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -131.25 169.86 15.39 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.951 178.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 1.062 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -135.52 149.94 49.62 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.54 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.438 HG12 ' HE1' ' A' ' 189' ' ' TYR . 2.8 p -142.15 149.62 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.093 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.755 HD12 ' CD1' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -96.02 125.63 40.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.622 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 185' ' ' MET . 4.2 tt -117.95 141.79 35.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.535 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -130.34 84.51 0.31 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.559 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.91 138.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . 0.464 ' CB ' ' CD ' ' A' ' 295' ' ' PRO . 0.0 OUTLIER -164.19 -65.33 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.968 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.464 ' CD ' ' CB ' ' A' ' 294' ' ' LYS . 61.0 Cg_endo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 122.331 2.02 . . . . 0.0 112.336 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 13.6 m120 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.795 0.331 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.01 127.12 56.88 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.027 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.15 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.411 2.074 . . . . 0.0 112.323 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -136.65 149.83 48.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.84 0.352 . . . . 0.0 110.565 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.673 ' HB2' HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER 176.33 78.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 72.4 mtp -113.22 149.49 33.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.934 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.864 HD21 ' HB1' ' A' ' 288' ' ' ALA . 7.0 tt -129.69 140.7 51.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.802 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.677 ' HA ' ' O ' ' A' ' 259' ' ' ALA . 0.7 OUTLIER -117.5 147.43 42.76 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.031 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.709 ' HB ' ' HB3' ' A' ' 259' ' ' ALA . 14.4 t -103.09 128.38 56.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.551 ' CE2' ' HB3' ' A' ' 287' ' ' LYS . 33.8 p90 -129.69 142.62 50.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.592 -2.094 . . . . 0.0 115.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.736 ' HB3' HG11 ' A' ' 253' ' ' VAL . 0.1 OUTLIER 71.42 39.25 0.93 Allowed 'General case' 0 C--N 1.341 0.23 0 CA-C-N 113.738 -1.574 . . . . 0.0 112.995 178.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.823 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.4 OUTLIER -98.14 -36.8 9.95 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.063 -0.398 . . . . 0.0 111.289 179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.594 ' HD1' HG21 ' A' ' 209' ' ' VAL . 66.5 t80 -70.21 -18.69 63.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.583 ' HB2' HG21 ' A' ' 255' ' ' THR . 2.1 tp -84.15 10.78 9.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.7 m -74.17 129.08 85.14 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.87 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.8 Cg_endo -52.76 -26.94 32.15 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 121.963 1.776 . . . . 0.0 111.461 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 200' ' ' LEU . 24.4 mmtt -78.09 -32.17 50.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.725 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.784 HD23 HG23 ' A' ' 209' ' ' VAL . 0.0 OUTLIER -85.93 -50.14 7.32 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -91.56 -41.0 11.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -75.82 -9.27 58.46 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' A' ' 196' ' ' LYS . 14.8 tp -114.07 -37.1 4.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.443 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 197' ' ' LEU . . . -55.6 117.37 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.47 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.9 t -118.41 144.44 35.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.713 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.01 121.39 8.02 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.515 2.144 . . . . 0.0 112.305 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.24 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -105.19 167.57 9.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -81.02 177.17 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 62.41 57.77 15.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.455 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.591 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -48.39 -155.17 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.957 0.408 . . . . 0.0 111.967 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.784 HG23 HD23 ' A' ' 197' ' ' LEU . 8.6 p -40.96 -28.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 111.776 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.476 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.409 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.3 OUTLIER -75.26 -32.78 61.17 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -48.64 52.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 209' ' ' VAL . 29.0 m -63.38 -44.71 99.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.469 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -54.78 -47.87 73.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.759 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.61 -52.26 27.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -38.8 70.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.27 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 0.5 OUTLIER -65.67 -31.95 73.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.1 -51.74 60.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.859 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -64.23 -49.53 71.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.552 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.583 ' O ' ' CD2' ' A' ' 224' ' ' PHE . 1.6 tp -62.0 -50.98 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.384 0.611 . . . . 0.0 109.785 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.653 ' CD2' HD11 ' A' ' 227' ' ' ILE . 5.2 m-85 -76.68 2.04 15.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.399 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -96.95 -38.84 4.25 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.907 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 21.8 m -80.29 -32.32 38.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.371 -0.415 . . . . 0.0 112.056 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.896 ' CD1' ' HB2' ' A' ' 272' ' ' ALA . 0.9 OUTLIER -102.76 -12.62 17.49 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . 162.96 104.1 0.18 Allowed Glycine 0 C--N 1.336 0.535 0 C-N-CA 118.949 -1.596 . . . . 0.0 113.354 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 18.8 t -51.56 153.48 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.917 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.728 HG21 HG22 ' A' ' 230' ' ' VAL . 1.8 mt -111.98 137.33 45.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.014 0.435 . . . . 0.0 111.221 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.4 t -79.62 -35.1 39.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.345 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.48 144.34 9.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.236 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.728 HG22 HG21 ' A' ' 227' ' ' ILE . 30.0 t -130.94 108.13 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.985 0.421 . . . . 0.0 110.986 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 260' ' ' ILE . 49.4 ttt180 -110.59 108.25 18.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.26 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.58 HG22 ' CB ' ' A' ' 259' ' ' ALA . 3.1 pt -99.1 123.63 51.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.159 0.504 . . . . 0.0 112.098 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -116.29 110.46 18.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.237 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.501 ' HG3' ' HD2' ' A' ' 235' ' ' PRO . 0.0 OUTLIER -88.52 146.93 38.51 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.979 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.501 ' HD2' ' HG3' ' A' ' 234' ' ' LYS . 6.3 Cg_exo -37.93 166.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 124.005 3.137 . . . . 0.0 113.81 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.38 20.27 21.86 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-N 115.032 -0.986 . . . . 0.0 113.863 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 19.4 mtt180 -135.79 -109.4 0.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.605 0.703 . . . . 0.0 111.797 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.577 ' O ' HD13 ' A' ' 233' ' ' LEU . 17.1 mt-10 -103.02 103.82 13.94 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.701 0.286 . . . . 0.0 111.225 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 5.6 mt -115.32 95.27 42.21 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.46 153.93 21.31 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.901 2.401 . . . . 0.0 112.448 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 244' ' ' ARG . 10.3 Cg_endo -51.11 -37.74 58.71 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.013 2.476 . . . . 0.0 112.902 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 246' ' ' ILE . 7.1 m-20 -67.39 -39.66 85.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.884 HG21 ' SG ' ' A' ' 258' ' ' CYS . 0.0 OUTLIER -91.74 -41.58 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.75 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 239' ' ' LEU . 7.6 ptt180 -55.01 -37.54 66.74 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 3.3 mtm105 -85.01 -40.79 16.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.932 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.804 HG22 ' HA ' ' A' ' 243' ' ' ILE . 2.2 tt -84.25 -47.07 17.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 243' ' ' ILE . 1.0 OUTLIER -59.89 -47.27 86.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.312 -179.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 m -75.01 -2.63 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.657 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -86.14 -39.03 17.11 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.486 ' O ' ' HD1' ' A' ' 250' ' ' TYR . 1.0 OUTLIER -89.32 38.85 0.92 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 6.6 m -53.21 111.72 0.74 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.575 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -171.74 -26.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.736 HG11 ' HB3' ' A' ' 190' ' ' ASP . 0.7 OUTLIER -85.27 25.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -178.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 46.28 22.8 1.03 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.095 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.583 HG21 ' HB2' ' A' ' 193' ' ' LEU . 14.8 t -168.43 161.08 11.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.064 0.459 . . . . 0.0 111.184 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.482 ' O ' ' HD3' ' A' ' 235' ' ' PRO . 4.5 mt-30 -145.44 95.93 2.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' A' ' 192' ' ' TYR . 1.1 mm-40 -124.77 137.11 54.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.884 ' SG ' HG21 ' A' ' 243' ' ' ILE . 5.0 t -123.42 146.17 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.704 0.764 . . . . 0.0 112.486 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.709 ' HB3' ' HB ' ' A' ' 188' ' ' VAL . . . -137.14 141.36 42.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.639 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 13.1 mm -115.11 112.32 39.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.894 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.706 HG12 HG22 ' A' ' 230' ' ' VAL . 2.8 m -115.18 129.55 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.36 0.6 . . . . 0.0 111.895 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.25 102.74 11.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.706 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.501 ' HD2' ' HB2' ' A' ' 269' ' ' ALA . 15.2 m-85 -91.53 172.95 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.278 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.45 -37.34 57.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.266 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.4 ' HG3' ' NZ ' ' A' ' 184' ' ' LYS . 0.4 OUTLIER -152.78 161.47 42.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.056 0.455 . . . . 0.0 111.554 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.812 HG12 HG23 ' A' ' 270' ' ' ILE . 6.5 t -66.95 -22.5 29.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.047 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.436 ' HA ' HG12 ' A' ' 270' ' ' ILE . 1.1 mm-40 -65.47 -21.04 66.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.944 0.878 . . . . 0.0 108.651 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -80.88 -59.66 2.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.111 176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.501 ' HB2' ' HD2' ' A' ' 263' ' ' PHE . . . -54.7 -42.79 71.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.375 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.812 HG23 HG12 ' A' ' 266' ' ' VAL . 2.5 pp -62.21 -43.32 97.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.746 ' N ' HD12 ' A' ' 270' ' ' ILE . 0.2 OUTLIER -60.76 -44.46 96.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 111.129 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.896 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -80.65 -31.34 36.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.532 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.751 ' O ' HG12 ' A' ' 277' ' ' ILE . 86.3 t60 -55.19 -56.56 18.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.835 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.36 -48.56 81.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -57.09 -35.37 69.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.92 0.391 . . . . 0.0 110.311 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.741 ' HE1' ' HB2' ' A' ' 288' ' ' ALA . 1.8 ttt -76.58 -55.08 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 273' ' ' HIS . 43.4 pt -68.81 -35.08 67.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 62.1 m -69.31 -45.37 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.69 0.281 . . . . 0.0 111.131 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.86 -28.14 61.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.379 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 286' ' ' MET . 4.4 t -87.75 9.69 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -68.73 145.99 53.34 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.285 0.564 . . . . 0.0 112.106 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.32 -36.04 1.13 Allowed Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.171 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.25 164.28 11.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.278 0.539 . . . . 0.0 111.55 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.636 ' HB2' HG12 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -93.75 71.21 4.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.439 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 190' ' ' ASP . 0.8 OUTLIER -132.75 -178.97 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.355 0.598 . . . . 0.0 112.24 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' A' ' 280' ' ' SER . 6.5 ttt -29.11 119.64 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.396 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.673 ' HG3' HG22 ' A' ' 277' ' ' ILE . 18.2 tttt -147.26 147.61 30.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.864 ' HB1' HD21 ' A' ' 186' ' ' LEU . . . -128.4 152.81 47.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 0.0 112.405 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.433 ' N ' ' HE1' ' A' ' 189' ' ' TYR . 14.6 p -131.86 153.88 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.607 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.432 ' N ' HG22 ' A' ' 289' ' ' VAL . 28.3 mt -84.89 122.46 29.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 0.0 110.939 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.544 ' C ' HD13 ' A' ' 291' ' ' ILE . 0.0 OUTLIER -118.95 114.98 46.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.972 179.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.411 ' N ' HD13 ' A' ' 291' ' ' ILE . . . 133.67 51.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.424 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 1.4 ttm -108.68 -178.43 3.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -139.44 148.88 58.23 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--O 1.249 1.03 0 C-N-CA 122.572 2.181 . . . . 0.0 112.278 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.706 0.288 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.739 HD13 ' HD3' ' A' ' 184' ' ' LYS . 0.7 OUTLIER -83.41 136.13 43.21 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.94 -54.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.482 2.122 . . . . 0.0 112.652 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.2 m -164.05 150.59 11.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.735 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.739 ' HD3' HD13 ' A' ' 181' ' ' LEU . 2.2 ptmt 174.41 77.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.736 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.514 ' O ' HG12 ' A' ' 291' ' ' ILE . 8.0 ptt? -114.5 155.95 25.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.221 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.844 HD13 ' HB1' ' A' ' 269' ' ' ALA . 1.0 OUTLIER -108.66 136.12 48.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.991 0.424 . . . . 0.0 111.285 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.69 ' HB3' HD11 ' A' ' 291' ' ' ILE . 1.7 tp -108.69 145.41 35.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.873 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.4 OUTLIER -96.98 164.95 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 122.107 0.955 . . . . 0.0 113.428 -178.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.623 ' HB2' ' C ' ' A' ' 287' ' ' LYS . 7.1 m-85 -124.87 174.04 8.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 112.711 -2.04 . . . . 0.0 115.491 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.881 ' OD2' HG21 ' A' ' 253' ' ' VAL . 2.6 m-20 -13.09 76.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 111.545 -2.571 . . . . 0.0 114.72 178.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.871 HD22 ' O ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -98.9 -23.13 15.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.266 0.555 . . . . 0.0 109.595 177.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.862 ' HA ' HD22 ' A' ' 197' ' ' LEU . 21.2 t80 -63.6 -37.22 86.49 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 255' ' ' THR . 9.6 mp -78.76 13.61 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 2.9 t -71.45 143.21 87.47 Favored Pre-proline 0 N--CA 1.456 -0.165 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 73.6 Cg_exo -51.32 -31.65 38.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.338 2.025 . . . . 0.0 113.083 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.686 ' HE2' HD13 ' A' ' 200' ' ' LEU . 3.2 mmtp -78.19 -38.69 42.73 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.283 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.014 HD11 HG13 ' A' ' 209' ' ' VAL . 0.6 OUTLIER -87.19 -48.12 8.3 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -178.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . 0.547 ' CB ' ' HA ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -88.99 -44.11 10.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 198' ' ' TRP . . . -80.78 -39.74 26.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.686 HD13 ' HE2' ' A' ' 196' ' ' LYS . 2.1 tt -92.47 -28.7 16.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.588 0.233 . . . . 0.0 111.486 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 63.56 -176.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 111.083 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.511 HG22 ' HE2' ' A' ' 212' ' ' LYS . 25.6 p -122.12 131.35 24.42 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.954 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.19 -167.82 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.355 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -67.67 113.07 5.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -175.48 147.77 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 132.82 46.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.772 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . 93.96 62.41 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.275 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -47.28 -155.56 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 1.014 HG13 HD11 ' A' ' 197' ' ' LEU . 69.5 t -40.87 -28.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -62.95 -44.32 96.39 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.417 ' HB2' ' CA ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -75.26 -48.99 20.72 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.511 ' HE2' HG22 ' A' ' 202' ' ' THR . 0.1 OUTLIER -53.97 -48.94 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 209' ' ' VAL . 5.0 m -74.88 -46.87 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . 0.475 ' N ' HG23 ' A' ' 213' ' ' VAL . 3.3 ttm -52.88 -49.15 66.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.47 -52.64 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.79 -44.55 77.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.699 HD23 ' CZ ' ' A' ' 221' ' ' PHE . 2.0 mp -63.91 -31.23 72.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.746 0.308 . . . . 0.0 111.075 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.0 -45.12 67.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.797 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -71.97 -49.15 39.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 0.0 111.589 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -32.69 74.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.699 ' CZ ' HD23 ' A' ' 217' ' ' LEU . 4.1 m-85 -84.49 -38.36 20.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.093 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -64.12 -26.64 70.52 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.509 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -47.41 80.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 221' ' ' PHE . 3.7 p90 -91.55 -19.07 23.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 221' ' ' PHE . . . -178.38 166.67 36.76 Favored Glycine 0 C--O 1.227 -0.326 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.957 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.65 134.85 35.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 122.618 -0.342 . . . . 0.0 111.173 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.788 HG23 ' CE1' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -96.84 128.78 47.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.856 0.36 . . . . 0.0 110.101 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 262' ' ' GLU . 2.7 m -78.77 -27.41 44.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.4 t -171.25 143.91 1.95 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.842 HG22 HG12 ' A' ' 261' ' ' VAL . 39.9 t -129.35 107.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.991 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 260' ' ' ILE . 4.4 mtt180 -104.76 107.44 18.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.772 HG22 ' HB1' ' A' ' 259' ' ' ALA . 10.3 pt -103.89 126.09 58.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.476 0.655 . . . . 0.0 112.557 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.726 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.3 pp -117.79 113.72 22.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.159 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.81 163.94 41.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.889 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.46 164.48 17.85 Favored 'Trans proline' 0 CA--C 1.527 0.16 0 C-N-CA 122.641 2.228 . . . . 0.0 113.867 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.93 28.13 52.39 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.934 -1.03 . . . . 0.0 113.326 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -140.55 -86.03 0.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.321 0.56 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 19.1 tt0 -129.66 105.37 8.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.635 0.255 . . . . 0.0 111.382 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.726 HD23 ' CD1' ' A' ' 233' ' ' LEU . 14.3 mt -119.75 94.98 49.0 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.002 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.457 ' HD2' ' CG1' ' A' ' 243' ' ' ILE . 34.7 Cg_exo -61.06 153.35 64.91 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -48.56 -27.46 10.59 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.705 2.27 . . . . 0.0 112.681 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 246' ' ' ILE . 0.3 OUTLIER -61.89 -37.31 84.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.016 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.46 -28.38 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.107 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -45.36 83.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 111.085 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 249' ' ' ARG . 0.3 OUTLIER -84.27 -40.49 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.212 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.683 HG22 ' HA ' ' A' ' 243' ' ' ILE . 4.6 tt -84.52 -44.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.583 ' HA ' ' CE2' ' A' ' 250' ' ' TYR . 1.3 t -71.49 -46.1 60.69 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -2.27 16.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 245' ' ' ARG . 0.0 OUTLIER -101.4 -30.65 11.34 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 247' ' ' SER . 0.2 OUTLIER -89.0 38.78 0.9 Allowed 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 t -52.24 117.51 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.601 0.239 . . . . 0.0 110.511 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -168.45 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.881 HG21 ' OD2' ' A' ' 190' ' ' ASP . 3.4 t -88.68 18.11 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 52.93 2.9 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.72 HG21 HD13 ' A' ' 193' ' ' LEU . 5.8 t -142.62 172.1 13.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.232 1.016 . . . . 0.0 109.705 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -141.14 105.96 4.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.16 134.81 26.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 3.4 m -134.87 147.31 49.83 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.673 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.873 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -140.58 146.81 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.104 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.423 HG12 HD12 ' A' ' 187' ' ' LEU . 1.9 mt -118.52 113.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.232 0.539 . . . . 0.0 111.782 -178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.842 HG12 HG22 ' A' ' 230' ' ' VAL . 3.5 m -106.73 145.49 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.938 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 228' ' ' SER . 1.2 mm-40 -131.97 96.09 3.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.074 178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.788 ' CE1' HG23 ' A' ' 227' ' ' ILE . 15.2 m-85 -90.62 -179.34 5.53 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.239 0.542 . . . . 0.0 111.997 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -27.89 69.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.765 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -160.78 136.39 8.06 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.076 0.465 . . . . 0.0 111.528 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.413 ' CG1' ' HE2' ' A' ' 184' ' ' LYS . 8.7 p -54.29 -23.88 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.619 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.753 ' HA ' HD12 ' A' ' 270' ' ' ILE . 12.6 mt-10 -59.27 -51.81 68.37 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.07 -52.93 18.23 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.844 ' HB1' HD13 ' A' ' 186' ' ' LEU . . . -55.9 -35.58 66.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.09 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 267' ' ' GLU . 84.6 mt -57.95 -38.76 68.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.053 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -71.58 -44.71 63.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.861 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 224' ' ' PHE . . . -72.08 -44.51 63.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.662 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.799 ' CE1' HD13 ' A' ' 277' ' ' ILE . 44.5 t-80 -48.85 -56.05 9.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -52.49 -44.48 65.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.542 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -66.62 -32.71 74.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.451 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.549 ' HE3' ' HB2' ' A' ' 288' ' ' ALA . 0.0 OUTLIER -76.34 -60.65 2.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.359 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.799 HD13 ' CE1' ' A' ' 273' ' ' HIS . 15.5 pt -61.04 -36.19 70.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.431 ' N ' HG13 ' A' ' 277' ' ' ILE . 94.6 m -69.02 -41.74 77.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.656 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 -32.85 55.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.55 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.1 p -68.8 -33.2 73.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.621 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.8 142.94 52.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.087 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 90.77 -37.12 3.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.136 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -106.37 -171.38 1.89 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 0.0 110.287 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.53 58.98 1.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -131.34 -172.7 2.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.376 0.608 . . . . 0.0 112.139 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.571 ' SD ' HD23 ' A' ' 191' ' ' LEU . 26.4 mtp -36.08 128.44 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.564 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.623 ' C ' ' HB2' ' A' ' 189' ' ' TYR . 15.6 tttp -140.48 169.02 18.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.584 177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.549 ' HB2' ' HE3' ' A' ' 276' ' ' MET . . . -140.1 162.72 34.55 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 9.4 p -145.78 152.86 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.113 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 15.8 mt -99.06 113.45 25.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.597 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 187' ' ' LEU . 3.3 mm -81.6 127.84 39.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 151.62 -154.8 25.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.559 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 67.34 -72.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -150.28 148.72 25.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.249 1.066 0 C-N-CA 122.521 2.148 . . . . 0.0 112.287 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.802 0.334 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 16.7 mt -89.0 127.69 54.74 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 181' ' ' LEU . 19.9 Cg_exo -64.0 -59.74 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.308 2.005 . . . . 0.0 111.544 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 184' ' ' LYS . 2.0 m -158.0 150.51 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.165 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.455 ' HG2' HG21 ' A' ' 266' ' ' VAL . 8.5 mttt 176.71 72.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.72 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.494 ' O ' HG22 ' A' ' 291' ' ' ILE . 19.0 mtm -116.8 152.28 34.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.972 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.625 HD21 ' HB1' ' A' ' 288' ' ' ALA . 10.2 tt -124.62 141.85 51.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.094 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -118.97 145.13 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.641 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.831 ' CG2' ' HB3' ' A' ' 259' ' ' ALA . 0.8 OUTLIER -85.33 169.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.436 0.636 . . . . 0.0 111.494 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.791 ' O ' HD13 ' A' ' 191' ' ' LEU . 8.3 m-85 -123.78 176.97 5.96 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 114.094 -1.412 . . . . 0.0 113.282 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.807 ' CB ' HG11 ' A' ' 253' ' ' VAL . 5.3 m-20 -26.01 72.22 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.988 -1.915 . . . . 0.0 114.572 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -92.03 -18.8 23.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.271 -179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.658 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -85.23 -8.57 58.49 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.604 HD12 ' HB ' ' A' ' 255' ' ' THR . 0.7 OUTLIER -86.08 11.33 11.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 28.7 t -73.02 139.34 79.63 Favored Pre-proline 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.274 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.826 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.5 Cg_endo -53.23 -23.61 23.69 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.326 2.017 . . . . 0.0 112.003 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.5 -36.18 52.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.589 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.711 ' HG ' HG23 ' A' ' 209' ' ' VAL . 3.0 tm? -85.33 -50.1 7.61 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -91.58 -40.86 11.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -76.18 -39.09 55.63 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.03 -30.41 16.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . 61.46 114.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.61 HG22 ' HG3' ' A' ' 204' ' ' GLN . 3.1 m -79.1 110.64 15.44 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.049 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 202' ' ' THR . 8.6 Cg_exo -71.86 61.74 3.07 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.642 2.228 . . . . 0.0 112.119 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.61 ' HG3' HG22 ' A' ' 202' ' ' THR . 31.4 mt-30 -96.86 156.0 16.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.83 31.05 4.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -148.62 -47.36 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 208' ' ' ARG . . . -139.1 84.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.189 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.578 ' O ' ' O ' ' A' ' 207' ' ' GLY . 7.1 mtp-105 -48.71 -155.19 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.699 0.4 . . . . 0.0 111.838 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.711 HG23 ' HG ' ' A' ' 197' ' ' LEU . 11.3 p -40.99 -27.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.22 -43.9 92.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.102 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . 0.484 ' HB2' ' HA3' ' A' ' 207' ' ' GLY . 0.4 OUTLIER -75.02 -41.41 59.36 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.683 0.278 . . . . 0.0 111.38 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -37.33 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.119 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 209' ' ' VAL . 96.9 t -74.43 -33.87 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.259 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -46.58 69.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.662 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.11 -49.91 52.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.816 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' HIS . . . . . 0.408 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 1.3 t60 -57.09 -34.05 67.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 111.425 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.538 HD23 ' CE2' ' A' ' 221' ' ' PHE . 0.0 OUTLIER -68.91 -40.83 78.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.39 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.3 mt -52.94 -49.92 65.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.866 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER -69.5 -49.03 58.5 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 1.1 tp -66.26 -42.53 88.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.668 0.271 . . . . 0.0 111.292 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 224' ' ' PHE . 1.9 m-85 -78.84 -33.27 46.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.334 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 225' ' ' GLY . . . -70.24 -25.75 75.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.025 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.866 HG23 ' O ' ' A' ' 219' ' ' LYS . 20.4 p -64.5 -47.67 78.06 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.611 ' CZ ' ' HB1' ' A' ' 272' ' ' ALA . 4.6 p90 -89.79 -19.62 24.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.585 ' O ' ' HA2' ' A' ' 222' ' ' GLY . . . -175.46 -171.56 39.53 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.567 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 16.8 t -115.91 140.21 38.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.702 0.287 . . . . 0.0 110.867 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.556 HG23 ' CE2' ' A' ' 263' ' ' PHE . 0.2 OUTLIER -93.8 133.09 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.14 0.495 . . . . 0.0 111.017 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 262' ' ' GLU . 0.2 OUTLIER -82.23 -33.53 29.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.888 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 70.6 m -164.99 144.21 6.78 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.836 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 261' ' ' VAL . 47.5 t -129.64 109.06 17.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.019 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.479 ' O ' ' N ' ' A' ' 260' ' ' ILE . 0.0 OUTLIER -107.18 107.55 18.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.76 HG22 ' HB1' ' A' ' 259' ' ' ALA . 11.0 pt -103.66 132.69 49.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.632 ' CD1' HD23 ' A' ' 239' ' ' LEU . 1.2 pp -125.5 110.31 13.74 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.755 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.445 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -79.07 174.43 6.11 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.908 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 234' ' ' LYS . 61.3 Cg_endo -75.57 163.85 33.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.163 1.909 . . . . 0.0 114.524 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 55.69 20.06 23.14 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 114.361 -1.291 . . . . 0.0 113.557 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -129.17 -86.39 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.203 0.502 . . . . 0.0 111.592 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 233' ' ' LEU . 42.2 mt-10 -126.68 103.97 7.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.714 0.293 . . . . 0.0 111.078 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD23 ' CD1' ' A' ' 233' ' ' LEU . 9.6 mt -117.69 95.66 48.18 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.86 153.58 77.27 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.741 2.294 . . . . 0.0 112.252 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.57 -23.57 11.1 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.848 2.366 . . . . 0.0 112.321 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 246' ' ' ILE . 1.0 OUTLIER -60.13 -40.05 88.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.314 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.71 ' HA ' HG22 ' A' ' 246' ' ' ILE . 0.0 OUTLIER -101.98 -30.63 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.419 ' CD ' ' O ' ' A' ' 239' ' ' LEU . 3.3 mtp180 -54.11 -46.75 72.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.835 0.35 . . . . 0.0 111.558 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.03 -38.7 20.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.213 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.71 HG22 ' HA ' ' A' ' 243' ' ' ILE . 6.4 tt -83.99 -45.87 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.702 0.287 . . . . 0.0 111.729 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 250' ' ' TYR . 1.5 t -67.29 -41.99 84.52 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.351 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.9 t -75.38 -2.22 27.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.428 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -95.82 -36.85 10.98 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 247' ' ' SER . 0.7 OUTLIER -91.02 39.03 0.98 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.1 119.77 3.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.655 0.264 . . . . 0.0 110.866 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.37 -31.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.807 HG11 ' CB ' ' A' ' 190' ' ' ASP . 1.8 t -83.8 12.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 51.61 -2.5 0.01 OUTLIER Glycine 0 CA--C 1.52 0.371 0 N-CA-C 115.211 0.844 . . . . 0.0 115.211 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.716 HG22 ' OD2' ' A' ' 190' ' ' ASP . 0.6 OUTLIER -134.5 172.42 12.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.89 1.345 . . . . 0.0 109.642 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 103.31 6.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.404 ' OE2' ' CG ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -143.56 127.65 17.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' CYS . . . . . . . . . . . . . 8.9 m -135.63 151.21 50.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.576 -0.849 . . . . 0.0 113.041 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.831 ' HB3' ' CG2' ' A' ' 188' ' ' VAL . . . -143.88 157.2 44.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.779 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 230' ' ' VAL . 7.3 mt -124.92 138.75 53.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.293 -179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.694 HG12 HG22 ' A' ' 230' ' ' VAL . 15.9 m -139.01 144.89 28.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.521 0.677 . . . . 0.0 111.338 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 228' ' ' SER . 1.3 mt-10 -136.52 108.64 7.21 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.426 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CE2' HG23 ' A' ' 227' ' ' ILE . 14.2 m-85 -94.77 -179.22 4.78 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.273 0.559 . . . . 0.0 112.125 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -17.71 62.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.156 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -164.76 132.93 3.32 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.985 0.421 . . . . 0.0 111.368 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.645 HG23 HD21 ' A' ' 290' ' ' LEU . 13.3 p -53.24 -24.1 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.234 0.54 . . . . 0.0 110.6 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.907 ' HA ' HD12 ' A' ' 270' ' ' ILE . 3.2 mm-40 -62.58 -49.69 74.23 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.196 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -48.95 -50.78 33.84 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.58 78.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.364 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.907 HD12 ' HA ' ' A' ' 267' ' ' GLU . 34.5 mt -52.6 -48.61 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.663 0.268 . . . . 0.0 111.341 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.11 -22.86 44.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.611 ' HB1' ' CZ ' ' A' ' 224' ' ' PHE . . . -80.94 -51.07 8.96 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.56 ' HB3' HD11 ' A' ' 186' ' ' LEU . 1.7 p80 -60.1 -51.56 69.07 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.748 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 273' ' ' HIS . 0.1 OUTLIER -52.38 -44.47 65.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 110.534 179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' PHE . . . . . 0.419 ' HA ' HG22 ' A' ' 278' ' ' THR . 0.2 OUTLIER -68.7 -28.23 66.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.131 179.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' MET . . . . . 0.659 ' HE2' ' HB2' ' A' ' 288' ' ' ALA . 1.5 ttt -76.52 -44.01 36.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.559 HG22 ' HG3' ' A' ' 287' ' ' LYS . 10.6 pt -70.65 -41.24 77.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.464 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 274' ' ' GLU . 8.9 t -61.26 -40.76 95.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.396 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -50.68 11.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.377 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 18.3 t -55.18 -26.05 36.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.632 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -53.15 145.8 12.79 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.58 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.09 -37.67 2.71 Favored Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.825 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.68 136.44 46.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.599 0.237 . . . . 0.0 110.783 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLU . . . . . 0.406 ' HA ' HG13 ' A' ' 253' ' ' VAL . 6.0 pt-20 -77.17 64.56 2.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -128.82 -172.54 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.35 0.595 . . . . 0.0 112.208 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 2.0 ttt -39.62 121.59 1.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.688 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.702 ' CA ' ' HB2' ' A' ' 189' ' ' TYR . 0.0 OUTLIER -135.52 169.85 16.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.673 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 276' ' ' MET . . . -141.32 156.0 45.89 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.633 -0.667 . . . . 0.0 112.474 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 189' ' ' TYR . 2.7 p -152.9 137.77 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.81 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.645 HD21 HG23 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -86.22 119.44 26.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.86 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 185' ' ' MET . 3.1 tt -105.8 143.45 16.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . -113.18 84.77 0.37 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.479 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 2.9 tpp -144.89 153.21 41.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.299 . . . . 0.0 110.987 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -71.05 142.61 87.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 C--O 1.249 1.051 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 179.937 . . . . . . . . 0 0 . 1 stop_ save_